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Abstract 
The 22q11.2 Deletion Syndrome is caused by a deletion on the chromosome 22q11.2. 
Individuals carrying 22q11.2 deletion have an increased risk to develop schizophrenia 
and Parkinson disease. However, how this deletion leads to the development of these 
diseases and the specific role of the individual 22q11.2 genes remains largely unknown. 
In order to understand the neuronal cell types and developmental stages in which the 
22q11.2 genes may function, we investigated the temporal and spatial expression profile 
of the genes located in the 22q11.2DS by RT-PCR. Human embryonic stem cells (hESCs) 
was used to generate excitatory projection neurons, cortical interneurons, GABAergic 
medium spiny neurons (MSN) and dopaminergic neurons. This study revealed that 
several genes appear to exhibit a specific temporal expression profile. Moreover, another 
group of genes were found to be preferentially expressed in dopaminergic neural lineage. 
Within the 22q11.2 deletion region, ZDHHC8 is an interesting candidate due to its 
implication in the physiology and morphology of the neurons. I generated a hESCs 
cellular model carrying a heterozygous deletion of ZDHHC8. These cells can be induced 
toward cortical projection neuron fate in a comparable temporal kinetics to that of the 
parental control cells. However, phenotypic characterisation revealed that ZDHHC8 
mutation altered the motility and the spontaneous calcium activity in ZDHHC8+/- 
neurons. Interestingly, transcriptomic analysis of excitatory progenitors identified altered 
expression of genes regulating calcium activity and axonal growth (motility). 
Furthermore, this study suggests that ZDHHC8 may also be involved in neuronal 
development, patterning and synaptic signalling. 
In conclusion, this thesis provides further knowledges regarding the expression of the 
22q11.2DS genes which would be valuable to guide future studies either in cellular or 
animal models. Furthermore, this study indicates that ZDHHC8 function is involved in 
several aspects of neuron development that potentially plays a role in the aetiology of 
22q11.2DS. 
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1. General Introduction 
 
1.1. The 22q11.2 deletion syndrome 
22q11.2 Deletion Syndrome (22q11.2DS) is a genetic disorder caused by a hemizygous 
deletion on the long arm (q) of the chromosome 22 (Rump et al. 2014). 22q11.2DS is the 
most common microdeletion in human and the second most common chromosomal 
disorder after down syndrome (Bassett et al. 1999; Swillen et al. 2015). Due to the wide 
range of disorders that arise from this mutation, 22q11.2DS is also known as DiGeorge 
Syndrome (DGS), Velocardiofacial Syndrome (VCFS) or CATCH-22. Table 1.1 presents 
a historical background associated with 22q11.2DS. 
 
Table 1-1 Historical overview of the syndromes associated with the 22q11.2 deletion Event From 
Hendrik Paul De Decker and John Bernard Lawrenson, 2001(De Decker and Lawrenson 2001) 
Event Date 
Congenital thymic hypoplasia associated with hypocalcaemia 1959 
DiGeorge syndrome described 1992 
Takao syndrome described (conotruncal anomaly face syndrome) 1996 
Velocardiofacial syndrome described (Shprintzen syndrome) 1978 
DiGeorge syndrome speculatively linked to chromosome 22 1981 
Partial monosomy of chromosome 22 described 1982 
“CATCH-22 syndrome” described 1989 
Cayler syndrome associated with del22q11.2 1994 
 
1.1.1. Genetics of 22q11.2DS 
1.1.1.1.  Prevalence of 22q11.2DS 
This disorder is associated with a high prevalence with a range from 1 in 3000 to 1 in 
6000 live births, which was estimated by the diagnosis of infants with major birth defects 
(Driscoll et al. 1993; Goodship et al. 1998).The disease occurs as a de novo mutation in 
90% of the patients while it is inherited in an autosomal fashion in the remaining 
22q11.2DS individuals (Carlson et al. 1997; Karayiorgou et al. 1995). 
1.1.1.2. Causes of 22q11.2DS 
The 22q11.2 region is unstable due to the presence of low copy repeats (LCRs). Sequence 
analysis of the chromosome 22 has identified four LCRs in the 3Mb deletion from LCRs 
A-D (Shaikh et al. 2000). These LCRs have high similarity with DNA sequences that 
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span other regions in the chromosome 22 which result in non-allelic crossing also called 
non-allelic homologous recombination (NAHR) (Colnaghi et al. 2011; L Edelmann, 
Pandita, and Morrow 1999). NAHRs occur during meiosis and in the case of 22q11.2 
results in the appearance of copy number variant (CNV). 
It was estimated that around 90% of the 22q11.2 deletion carriers have a 3Mb deletion 
between LCRA and D, 8% are carrying a 1.5Mb deletion between LCRA and B while the 
remaining 2% are carrying rare deletion that overlap the typical region (Shaikh et al. 
2000). 
The 3Mb deletion region contains around 46 proteins coding genes and about 90 known 
or predicted genes for pseudogenes and non-coding RNAs, including 7 microRNAs, 
MIR185, MIR1306, MIR1286, MIR3618, MIR 649, MIR4761 and MIR6816. 
Conversely, the 1.5Mb deletion contains around 29 proteins coding genes (McDonald-
McGinn et al. 2015). Strikingly, it was demonstrated that the 1.5Mb deletion was able to 
recapitulate the phenotype observed in patients with the 3Mb deletion. 
 
1.1.2. Clinical manifestations of 22q11.2DS 
The clinical expression of the 22q11.2DS is extremely wide, more than 180 phenotypic 
representation have already been found (Demily et al. 2015) (Figure 1.1). The classical 
features include congenital heart defects, facial anomalies such as cleft palate, speech and 
learning difficulties and many others (Digilio et al. 2005). Interestingly, while the 
prevalence of schizophrenia in the general population is about 1%, it was shown to be 
about 30% in patients with 22q11.2DS, which makes this disorder the most frequent 
known cause of schizophrenia (Chow et al. 2011; Gambini 2016; Schneider et al. 2014). 
Other neuropsychiatric pathologies associated with 22q11.2DS are ASD, attention deficit 
hyperactivity disorder (ADHD), affective anxiety and obsessive-compulsive disorders. 
In addition, it was recently reported that, at 37.10%, ADHD was the most frequent 
diagnosis in children with 22q11.2DS followed by ASD and schizophrenia at 12.77% and 
1.97%, respectively. Conversely, at adulthood the proportion of patients with ADHD drop 
at 15.59% while it remains relatively constant for 22q11.2 patients with ASD at 16.10%. 
However, 22q11DS patients with schizophrenia drastically increase in adulthood to reach 
in some study 42% (Schneider et al. 2014). 
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Although these patients have higher susceptibility to develop psychosis, the mechanism 
by which the 22q11.2DS elevates the risk for the psychotic disorders mentioned above 
remains largely unknown. Nevertheless, several hypotheses might be able to explain these 
genetic variabilities such as 1) the breakpoint heterogeneity which corresponds to the 
region of the LCRs, 2) the allelic variation, 3) the multiple hit model (Jonas et al. 2014). 
The multiple hit model suggests that patients with 22q11.2DS will develop schizophrenia 
due to the presence of additional CNVs at other locations on the genome (Bassett et al. 
2017; Hywel et al. 2013). 
 
 
Figure 1-1 Organs affected in 22q11.2 deletion syndrome. In orange are the organs commonly affected 
in 22q11.2DS. In blue are the organs less affected and in grey are the minor malformation observed in 
patients. This schematic shows that the brain, palate, parathyroid gland, heart, kidney, gastrointestinal 
system, thymus and immune system are the organs commonly affected in individuals with 22q11.2DS. Less 
frequently, organs such as the thyroid gland, the haematological system, the eyes, the ear nose and throat 
and bone are affected. While minor malformation can affect the craniofacial features and also result to 
polydactyly in patients with 22q11.2DS. Figure adapted with permission from Springer: Nature reviews. 
Disease primers, McDonald-McGinn 2015 (4271450447971) Copyright (2015) 
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Schizophrenia 
Schizophrenia is a neuropsychiatric disorder with an onset at late adolescence and early 
adulthood. Clinically, schizophrenia is characterized by symptoms usually classified as 
positive, negative and cognitive. The positive symptoms are typically associated with the 
psychotic symptoms (delusion, hallucination) and tend to relapse and remit. These 
symptoms result from an increase in the dopamine D2 receptor activation (Walter et al. 
2009). The negative symptoms are generally chronic and associated with a decrease in 
motivation and social withdrawal and conversely to the positive symptoms, are due to a 
reduction in the activation of the dopamine D1 receptor (Walter et al. 2009). On the other 
hand, cognitive symptoms include an impairment in memory performance, attention as 
well as poor language ability (Moyer, Shelton, and Sweet 2015). 
The dopamine hypothesis arose from the study of Jean Dealy and Pierre Deiner in 1952 
in which they studied the chlorpromazine and its antipsychotic effects (Delay et al., 
1952). Therefore, the dopamine hypothesis stated a hyperactive dopamine transmission 
as the pathophysiology of schizophrenia. Because the antipsychotic drugs act on the 
dopamine D2 receptor, they are able to alleviate partly the positive and negative 
symptoms. However, post mortem examination were unable to provide evidence of an 
alteration of the dopamine levels or dopamine receptors, therefore it was proposed that 
the dopaminergic overactivity was secondary to the change of other neuronal systems 
(Coyle 2004; Knable et al. 1994). A new hypothesis, the glutamatergic hypothesis is 
based on the ability of anaesthetics phencyclidine (PCP) but also the ketamine to bind to 
N-methyl-D-aspartate (NMDA) receptors and induces schizophrenia like symptoms in 
healthy subjects while it worsen the positive symptoms in schizophrenic patients (Lahti 
et al. 1995; LUBY et al. 1962).  
Thereby, the glutamate hypothesis asserts that in the cortico-striatal projection, the 
glutamate hypofunction produces an increase in the sensory input through facilitation of 
the thalamocortical circuit and thus increases the dopaminergic input (Lang et al. 2007). 
In addition to this assumption, there are the global disinhibition of the cerebral cortex 
which imply the loss of the tonic regulation by the GABAergic neurons (Lisman et al. 
2008). Many studies therefore focused on the glutamate hypofunction and more 
particularly on the decrease inhibition by the GABAergic neurons which were observed 
to be related to a loss of a specific types of neurons, the parvalbumin interneurons. 
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1.1.3. Neurobiology of 22q11.2DS 
1.1.3.1. Cognitive impairments 
Children carrying 22q11.2 mutation are reported to have by average 30 points lower IQ 
compared to their siblings (Niarchou et al. 2014). Children with 22q11.2 mutation usually 
achieve higher scores in verbal than non-verbal task. These children have mathematical 
disabilities and have difficulties to compare numbers or to perform calculations (De 
Smedt et al. 2008). 
Furthermore, while the ability to understand a speech is usually strong in pre-school, 
general language delays appears by school age (Gerdes et al. 1999; Scherer et al 1999). 
Studies suggest that children have problems at finding and interpreting salient spatial and 
temporal information, suggesting that they are less able in integrating goal relevant 
information (Bish et al. 2007; Corbetta et al. 2002). 
Because the attention is thought to be crucial for inhibiting irrelevant information, 
children with 22q11.2DS are reported to have impaired sensorimotor gating (Brocki et al. 
2004; Sobin et al. 2005). In addition, patients with 22q11.2DS have difficulties in 
identifying novel auditory stimulus when using the mismatch negativity paradigm 
(Cheour et al. 1997). Finally, children with 22q11.2DS have impaired working memory 
performance (Wong et al. 2014). 
1.1.3.2. Neuroanatomical deficits 
Given the impairment in cognitive function in patients with 22q11.2DS, there are good 
reasons to expect anatomical change in these patients. Brain of children with this deletion 
have a 8-10% reduction in the volume of the posterior and inferior brain regions (Simon 
et al. 2005). These reductions appear to affect white matter to greater extent than grey 
matter (Simon et al. 2005). Furthermore, it is also demonstrated that the total surface area 
is decreased in 22q11.2DS. On the other hand, the cortical thickness as well as the volume 
of the corpus callosum is increased in 22q11.2 individuals (Lin et al. 2017). 
 
1.1.4. Genes located in the 1.5Mb deletion region 
1.1.4.1. DGCR6 
Located at the proximal part within the 22q11.2 deletion, DiGeorge Syndrome Critical 
Region Gene 6 (DGCR6) is thought to contribute to the apparition of 22q11.2DS, 
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however its function is still unclear (Gao et al. 2015). DGCR6 was shown to have 
similarity with Gonadal (Gdl), a drosophila melanogaster gene of unknown function. In 
addition, this gene was shown to be expressed in brain, the neural tube, pharyngeal arches 
and the nasal process at E11.5 (Edelmann et al. 2001; Lindsay et al. 1997). DGCR6 
protein is a nuclear phosphoprotein expressed in the liver, heart and skeletal muscle (Pfuhl 
et al. 2005). Interestingly, DGCR6 was suggested to regulate TBX1, another gene located 
within the 1.5Mb deletion. Therefore DGCR6 is postulated to be responsible for 
abnormalities such as heart defect which is one of the outcome of TBX1 dysregulation 
(Gao et al. 2015). Within the brain, a study showed that DGCR6 may interact with 
GABAB1, a receptor modulating excitatory and inhibitory synapses therefore, DGCR6 
mutation might alter synaptic transmission (Zunner et al. 2010). 
1.1.4.2. PRODH 
The proline dehydrogenase (PRODH) is an enzyme located on the inner mitochondrial 
membrane that catalyses the first step of the proline degradation (Bender et al. 2005). In 
turn the product of this catabolic reaction the Δ-1-pyrroline-5-carboxylate (P5C) is a 
precursor of glutamate and γ-aminobutyric acid (GABA) (Jacquet et al. 2002). In addition 
to its role in the metabolism of glutamate, proline was also demonstrated to act as a co-
agonist for the NMDA receptor (Zwarts et al. 2017). Prodh was further suggested to 
potentiate excitatory transmission of pyramidal neurons between different regions of the 
hippocampus (Cohen et al. 1997). PRODH deletion has been associated with an increased 
risk of developing schizophrenia (Willis et al. 2008). However a recent study failed to 
replicate this result and found no association between PRODH and the risk to develop 
schizophrenia (Williams et al. 2003). It was demonstrated that patients with 22q11.2DS 
have an elevated serum level of proline which can be implicated in learning impairment 
as well as epilepsy and schizoaffective disorders (Karayiorgou et al. 2004). Homozygous 
Prodh mice were observed to be viable with normal brain morphology. However 
behavioural assessment revealed that these mice have a sensory gating deficits (Gogos et 
al. 1999). Finally, it was demonstrated that there is an epistatic interaction between Prodh 
and catechol-O- methyltransferase (Comt).  
1.1.4.3. DGCR2 
DGCR2 encodes for a putative adhesion receptor. This gene is also found to be associated 
with schizophrenia although this result is still controversial has other study found no 
association with schizophrenia (Shifman et al. 2006; Skowronek et al. 2006). DGCR2 
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expression is increased in the DLPC of patients with schizophrenia relative to matched 
controls (Shifman et al. 2006). DGCR2 protein is also observed to be weakly expressed 
in myelinating Schwann cells but strongly expressed in dorsal root ganglia (Spiegel et al. 
2006).  
1.1.4.4. DGCR14 
DGCR14 was identified as essential for early embryonic development (Wang et al. 2006). 
In situ hybridization revealed high expression in the embryo from E7 onwards with 
relatively higher expression in the central nervous system specifically in a sub-region of 
the pons (Lindsay et al. 1998). DGCR14 is also associated with higher risk to develop 
schizophrenia in the Chinese Han population (Wang et al. 2006). 
1.1.4.5. TSSK2 
The Testis-specific serine/threonine protein kinase 2 (TSSK2) is predominantly expressed 
in the testis. This gene was shown to be important for the formation and the function of 
the sperm cells. Mutation of Tssk2 was demonstrated to cause infertility which was 
attributed to an impair of spermatogenesis in humans (Zhang et al. 2010). Real-time 
polymerase chain reaction (RT-PCR) carried out on different human tissue revealed that 
TSSK2 is also expressed in the fetal brain (Hao et al. 2004). 
1.1.4.6. GSC2 
Goosecoid Homeobox 2 (gsc2) was observed to be expressed in the mouse embryo during 
development (Wakamiya et al. 1998). This gene is also suggested to be expressed while 
neural crest are maturing and differentiating into in the pharyngeal arches (Saint-Jore et 
al. 1998). Gsc2 was shown to be present during gastrulation at E6.5 therefore suggesting 
its involvement in axis formation. However knockout for gsc2 was unable to demonstrate 
the presence of abnormal axis formation (Wakamiya et al. 1998). In addition, at E11 and 
postnatal day 7 (P7), Gsc2 was shown to be robustly expressed in the interpeduncular 
nucleus, a region important for the generation of the hippocampal theta rhythm and also 
for the control of rapid eye movement (REM) (Funato et al. 2010). Although Gsc2 is 
suggested to be present during the development its exact role is still unclear in both mouse 
and human.  
1.1.4.7. SLC25A1 
The solute carrier family 25 member 1 (SLC25A1) is part of a family of nuclear encoded 
transporters which are encored in the inner membrane of the mitochondria. SLC25A1 
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protein promotes the export of citrate from the mitochondria to the cytoplasm which is 
thought to be crucial for the energy balance in the cell. Recessive SLC25A1 mutation from 
unrelated family was demonstrated to be responsible of severe clinical phenotype which 
in 61% of the cases led to the death of the individual shortly after birth (Chaouch et al. 
2014). Individuals diagnosed with SLC25A1 mutation appeared to primarily present 
neuromuscular junction (NMJ) defect (Chaouch et al. 2014). Whole genome sequencing 
identified that heterozygote of two pathogenic variant of SLC2AI might be responsible of 
agenesis of the corpus callosum due to the loss of activity of the citrate transporter 
(Edvardson et al. 2013). On the other hand, knockdown in the zebrafish of Slc25a1 was 
demonstrated to lead to characteristic features observed in 22q11.2DS such as 
proliferation defect (Napoli et al. 2015). Furthermore, SLC25A1 activity is influenced by 
two pro-inflammatory factors, the tumor necrosis factor-α (TNFα) and interferon- γ 
(IFNγ), suggesting that SLC25A1 might be central for cytokine induced inflammation 
signals (Infantino et al. 2014).  
1.1.4.8. CLTCL1 
The clathrin heavy chain like 1 (CLTCL1) encodes for the protein CHC22 which was 
shown to be expressed at various level in fetal tissue. CHC22 was recently demonstrated 
to be required for endosomal sorting (Esk et al. 2010). Furthermore, it was observed that 
CLTCL1 was upregulated in the developing brain suggesting that it might be important 
early in the patterning of the brain, conversely, in postnatal brain the level of the CHC22 
protein was observed to be downregulated (Nahorski et al. 2015). Interestingly, 
knockdown of CHC22 in hESCs derived neural crest cells induces neurites outgrowth in 
neurons precursor cells , therefore it was concluded that the loss of CHC22 is necessary 
for the development (Nahorski et al. 2015). 
1.1.4.9. HIRA 
Histone cell cycle regulator (HIRA), also known as DGCR1, regulates cell cycle 
dependant histone transcription (Magnaghi et al. 1998). Hira was shown to be expressed 
in the neural crest during embryogenesis and also to interact with Pax3, a transcription 
factor important during embryonic development. Importantly, homozygous mutation of 
hira occurred to be lethal at E11 emphasizing its possible crucial function during 
embryogenesis (Roberts et al. 2002). Although the role of HIRA during development is 
thought to be important, its implication during early neurogenesis is still unknown. 
However, it was recently suggested that HIRA modulates the expression of β-catenin 
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which in turn was demonstrated to regulate neurogenesis through neuronal progenitors 
proliferation and differentiation (Li et al. 2017). 
1.1.4.10. MRPL40 
The mitochondrial ribosomal protein L40 (MRPL40) encodes for a protein responsible of 
protein synthesis in the mitochondria (Devaraju et al. 2017). Mitochondrial ribosomes 
are constituted of different subunits, a small 28S and large 39S subunits. Heterozygous 
mice for Mrpl40 were observed to alter the mitochondrial permeability transition pore 
(mPTP) which result in an abnormal control of the mitochondrial calcium at the 
presynaptic terminals which was shown to impair short-term plasticity. (Figure 1.2).  
 
 
 
 
Figure 1-2 Schematic of the calcium dysregulation due to Mrpl40+/-. In control , the presynaptic 
neurons mitochondrial calcium buffering is controlled by mitochondrial uniport, the sodium-calcium and 
proton-calcium exchanger and also throught slow extrusion from the mitochondrial permeability 
transition pore. Instead, in the mutant, the slow extrusion from the mitochondrial pore is altered resulting 
to accumulation of calcium in the mitochondria and the presynpatic neurons, therefore creasting an 
increase release of vesicle of neurotransmitter. The trace represents the calcium transient in the cytosol 
and the mitochondira in the control and mutant. Figure adapted with permission from Springer: 
BioEssays : news and reviews in molecular, cellular and developmental biology, Devaraju 2017
(4296970486895) Copyright (2017). 
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1.1.4.11. C22ORF39 
Chromosome 22 Open Reading Frame 39 (C22ORF39) is a protein coding gene however 
its function remains unknown. 
1.1.4.12. UFD1L 
Ubiquitin recognition factor in ER associated degradation 1 (UFD1L) is expressed by 
several tissues during embryogenesis, it encodes for a component involved in the 
degradation of ubiquitin fusion proteins (Mohamed et al. 2005). In yeast, UFD1L protein 
was observed to be important for the ubiquitin dependent proteolytic degradation 
pathway. Interestingly, mice lacking this gene was shown to die before organogenesis 
therefore implies an important role for this gene during embryogenesis (Yamagishi et al. 
2003). UFD1L was also observed to be important for the development of the neural crest 
cells. 
1.1.4.13. CDC45 
Cell division cycle 45 (CDC45) is necessary for DNA synthesis during genome 
duplication as it forms the replicative DNA helicase in eukaryotes. CDC45 protein was 
shown to be expressed in neuronal precursors during brain development (Meechan et al. 
2015). Although its role in 22q11.2DS appeared to be important especially during cortical 
development, no study was performed to investigate the function of this gene alone during 
brain development. 
1.1.4.14. CLDN5 
Claudin 5 (CLDN5) is part of the claudin family composed of about 26 members which 
are localized at the level of the tight junction (Günzel et al. 2013). CLDN5 protein is the 
most expressed claudin in endothelial tight junction in the vascular endothelium of the 
brain. Indeed, its defect was responsible for the alteration of the blood brain barrier 
(BBB), a structure particularly important to restrict the diffusion of molecules to the brain 
(Irudayanathan et al. 2016). Evidences also suggest that this gene may be involved in the 
vulnerability to schizophrenia (Omidinia et al. 2014; Sun et al. 2004; Wu et al. 2010). 
Mouse model homozygous for cldn5 were observed to die at birth. While the BBB of 
these mice were shown to be unaffected, the selectivity of molecule inferior to 800 Dalton 
but not larger was affected (Nitta et al. 2003). 
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1.1.4.15. SEPT5 
SEPT5 encodes for the protein SEPTIN5, which was originally identify as a GTPases 
required for cytokinesis. However, it was later demonstrated that SEPTIN5 is robustly 
expressed in the central nervous system suggesting it might have an additional role than 
its involvement in the cell cycle (Beites et al. 1999). In the mouse brain, SEPT5 was 
found to be localized at the presynaptic neurons where it binds to syntaxin, a SNARE 
(soluble NSF attachment protein receptor) protein and thus involved in the exocytosis of 
neurotransmitter vesicles (Asada et al. 2010; Beites et al. 1999). Furthermore, SEPT5 
was observed to be a substrate of the protein PARKIN, a ring finger protein that is an E3 
ubiquitin protein ligase (Choi et al. 2003). Mutation in PARKIN has been associated with 
familial Parkinson disease. 
1.1.4.16. GP1BB 
This gene was demonstrated to be part of the GPIb-V-IX system which composed the 
receptor for von Willebrand that mediates platelet adhesion in the blood circulation. 
While the main transcript of this gene is expressed in platelets and megakaryocytes, a 
smaller and less abundant transcript was observed to be expressed in other tissues such 
as the brain. 
1.1.4.17. TBX1 
The T-box transcription factor (TBX1) is a member of the family that share a common 
DNA binding domain, the T-box. TBX1 was shown to be expressed during embryogenesis 
primarily in the pharyngeal arches which coincides with the neural crest cells migration 
(Chieffo et al. 1997). TBX1 homozygous displays important cardiovascular, thymic, 
craniofacial and parathyroid defects (Ghosh et al. 2017; Kispert 2017). Mouse model for 
TBX1 exhibits several pathologies related to the heart and facial structure abnormalities. 
This gene was demonstrated to be responsible of the development of the pharyngeal arch 
artery during development. Interestingly, the expression of Tbx1 in the pharyngeal arches 
was demonstrated to overlap with Shh which was shown to regulate Tbx1 (Garg et al. 
2001). Surprisingly, a mouse model of Trp53 which encodes for the protein p53, was 
demonstrated to be able to rescue the phenotype due to Tbx1 haploinsufficiency in mice 
heterozygous for both genes. It was shown that the Trp53+/- restored the level of 
expression of Gbx2, a gene requires for aortic arch outflow in Trp53+/-, Tbx1+/-. It was 
also recently observed that Tbx1+/- mice disrupt corticogenesis due to an early 
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differentiation of the region that give rise to the somatosensory cortex. In addition, mouse 
model of Tbx1+/- were demonstrated to have PPI alteration.  
1.1.4.18. GNB1L 
GNB1L or G Protein Subunit Beta 1 Like encodes for a protein which contains six WD40 
repeats which are known to enable the formation of heterotrimeric or multiprotein 
complex. This gene was shown to be expressed in the embryonic brain but in less extend 
in the adult brain (Sun et al. 2015). GNB1L was suggested to be associated with 
schizophrenia (Li et al. 2011; Williams et al. 2008), This gene is also thought to be 
involved in cell cycle progression, signal transduction, apoptosis and gene regulation. 
1.1.4.19. C22ORF29 
Chromosome 22 Open Reading Frame 29 (C22ORF39) is a gene coding protein of 
unknown function. 
1.1.4.20. TXNRD2 
Thioredoxin reductase 2 (TXNRD2) is part of the thioredoxin reductase family which is 
thought to regulate the cellular redox balance (Soerensen et al. 2008). Txnrd2 encodes for 
a mitochondrial protein which was observed to be ubiquitously expressed in cells and 
tissues. The reductase activity depends on the availability of selenium due to the presence 
of selenocysteine residue onto the TXNRD2 protein. Furthermore, selenium was shown 
to be strongly retained in the brain thus its deprivation in transgenic mice was responsible 
to developmental and degenerative damages (Burk et al. 2007; Pillai et al. 2014). Mice 
specifically missing Txnrd2 in the nervous system develop normally and do not display 
any histopathology alteration and have a similar lifetime than control mice. While its role 
in the brain is suggested to not be critical, it was demonstrated to be crucial for heart 
development and function (Conrad et al. 2004). 
1.1.4.21. COMT 
COMT is a key enzyme for modulating the dopamine level in the prefrontal cortex. As 
dopamine was demonstrated to be important for cognitive function, deficit in comt has 
been associated with psychiatric disorders (J. Chen et al. 2004; Tunbridge et al. 2007). 
COMT is a cytosolic enzyme present either in a soluble or membrane bound form, S-
COMT or MB-COMT respectively (Harrison et al. 2008). Despite homozygous mouse 
for Comt showed normal basal level of dopamine, its clearance was slower suggesting a 
prolonged phasic activation of dopaminergic receptors. COMT has a functional 
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polymorphism, a valine substituted by a methionine at the codon 108 in S-COMT and 
158 in for the transcript MB-COMT (Lachman et al. 1996). This is resulting to an 
alteration of the activity of both COMT isoforms. 
1.1.4.22. ARVCF 
ARVCF encodes for the ARVCF protein (Armadillo repeat gene deleted in 
Velocardiofacial syndrome). It is a member of the catenin family and was demonstrated 
to be the closest relative to the p120, a catenin (Mariner, Wang, and Reynolds 2000). The 
catenin family plays important role in the formation of adherents’ junction by facilitating 
the communication between the inside and outside of cell (Sirotkin et al. 1997). Despite 
ARVCF is widely expressed, it was demonstrated to be present at very low amount 
compared to other catenins therefore suggesting that high expression is not necessary for 
its function or else ARVCF expression is temporally or spatially expressed (Kausalya, 
Phua, and Hunziker 2004). In addition, ARVCF was observed to be expressed in the 
ganglionic eminence (GE) during the development suggesting its involvement in cell 
rearrangement and migration from the GE but also a role in tangential migration towards 
the cortex (Ulfig and Chan 2004). 
1.1.4.23. C22ORF25 
Chromosome 22 open reading frame 25 is also known has TANGO2 (Transport and Golgi 
organization 2). This protein was suggested to be responsible of the redistribution of the 
Golgi membrane into the endoplasmic reticulum in drosophila while in mice it was found 
to have a mitochondrial function (Kremer et al. 2016). Although is function is still unclear 
it was speculated that TANGO2 deficiency might be associated with an alteration of 
electron transfer from the FAD-dependant dehydrogenases of the respiratory chain of the 
mitochondria (Kremer et al. 2016). 
1.1.4.24. DGCR8 
DGCR8 is an RNA binding protein which is part of the microprocessor complex with 
Drosha in order to process long primary microRNAs (miRNA) (Petri et al. 2014). 
Furthermore, miRNA alteration was observed in post-mortem brain samples from 
individuals with schizophrenia and 22q11.2DS (Fénelon et al. 2011; Moreau et al. 2011). 
Analysis of heterozygous mice for Dgcr8 resulted in perturbation of miRNAs expression 
which were usually reduced by 20-70%. In addition, these mice resulted in smaller 
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dendritic spines and tree but also exhibited working memory impairment, all of which are 
features also observed in patients carrying 22q11.2DS (Stark et al. 2008). 
1.1.4.25. TRMT2A 
TRNA Methyltransferase 2 Homolog A (TRMT2A) encodes for a protein of unknown 
function. However, it was suggested to act as a cell cycle regulated protein. Furthermore, 
this gene was associated with clinical outcome in subset of breast cancer (HER2+) (Hicks 
et al. 2010; Zhou et al. 2002). 
1.1.4.26. RANBP1 
RAN Binding Protein 1 (RANBP1) encodes for a protein responsible of 
nucleocytoplasmic transport. RANBP1 messenger RNA (mRNA) was shown to be 
present throughout the embryo during development (Mangos et al. 2001). This protein is 
part of the Ran family, together with RANBP1, Ran and RCC1 (Regulator of 
chromosome exchange factor 1) form a complex important for the guidance of the mitotic 
spindle assembly. Indeed, RANPB1 was demonstrated to stimulate the activity of Ran 
GTP production which is important for the formation of this trimeric complex. Depletion 
of RANPB1 exhibited hyperstable spindle microtubules, disorganized microtubule asters 
and also defective chromosome segregation (Zhang et al. 2014). Furthermore, the 
expression of RANBP1 was shown to be misregulated in cancers (Rensen et al. 2008). In 
term of influence on the brain, RANBP1 was established as being important during the 
process of axonal injury. Indeed, upon injury, there is a local translation of RANBP1 
creating a retrograde injury signalling that promotes axonal protein synthesis. Thereby 
RANBP1 perturbation reduces the conditioning of the neurons in response to the lesion 
(Pathak et al. 2016; Yudin et al. 2008). Following observation using a 22q11.2 mouse 
model, Paronett et al., generates a homozygous knockout for ranbp1. Although it was 
demonstrated that 60% of the embryos were exencephalic, the remaining embryos 
showed alteration in neuronal migration. Indeed, authors observed a decrease of the layer 
2/3 of the cortex (Paronett et al. 2015). Finally, RANBP1 was also suggested to play a 
role in the development of autistic spectrum disorder (ASD) (Wenger et al. 2016). 
1.1.4.27. ZDHHC8 
ZDHHC8 encodes for a palmitoyl transferase that share a DHHC domain, the Zinc Finger 
DHHC-Type Containing 8 protein (ZDHHC8). This enzyme is responsible of the addition 
of a 16 carbons fatty acid onto a cysteine residue also known as palmitoylation. This gene 
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was found to palmitoylate the post synaptic density 95 PSD-95 which is an adaptor 
protein localised at the postsynaptic neurons (Mukai et al. 2015). PSD-95 is the member 
of the membrane associated guanylate kinase family (MAGUK). This protein is 
particularly important for neurons as it was demonstrated to be involved in excitatory 
neurons maturation (El-Husseini et al. 2000). Primary culture from both homozygous and 
heterozygous knockout for Zdhhc8 were shown to affect dendritic arborisation (Mukai et 
al. 2008). This deficit was demonstrated to also alter the density of glutamatergic 
synapses which were visualized by a reduction of PSD95 and VGLUT1 puncta. ZDHHC8 
deficit was shown to alter both the axonal complexity and the regulation of spine density 
which was established to be due to a decrease palmitoylation of cdc42palm, a CDC42 
variant only expressed in the brain (Moutin et al. 2017; Mukai et al. 2015). Interestingly, 
by reintroducing back the full-length ZDHHC8 protein into neurons was able to recover 
the axonal arborisation and length in Zdhhc8-/-(Mukai et al. 2015). Furthermore, the lack 
of dendritic complexity and spine density was also recover upon reintroduction of 
ZDHHC8 in a mouse model of 22q11.2DS (Mukai et al. 2008).  
In addition to its role in the morphology of the neurons, ZDHHC8 was also demonstrated 
to interact with proteins responsible of synaptic transmission. Indeed, AMPA receptor 
trafficking which are mediated by GRIP1b and PICK1, was altered by ZDHHC5/8 and 
ZDHHC8 alone respectively (Thomas et al. 2012, 2013). Thereby, decrease 
palmitoylation of PICK1 was demonstrated to impair the induction of the cerebellar long 
term synaptic depression (LTD) while decrease GRIP1b was observed to alter AMPA 
receptor trafficking.  
Despite, several substrates have already been shown to be associated with ZDHHC8, it 
remains unknown whether they are targeted by other palmitoyl transferase. However, the 
Parelemmin-1 protein encoded by the gene PALM gene was demonstrated to be only 
palmitoylated by ZDHHC8 (Huang et al. 2009). Furthermore, ankyrin G, a protein highly 
enriched at the axon initial segment was observed to require to be palmitoylated by 
ZDHHC5/8. In an experiment, He et al., reported that palmitoylation of ankyrin G by 
ZDHHC5/8 was necessary to its appropriate targeting to the lateral membrane of MDCK 
cells (He et al. 2014).  
Recently, ZDHHC8 was observed to be localized in synaptic mitochondria of 
glutamatergic neurons (Maynard et al. 2008). This study by Maynard et al., also showed 
the association between ZDHHC8 and Ubiquinol-Cytochrome C Reductase Core Protein 
I (UQCRC1) using immunofluorescence. UQCRC1 is part of the complex III of the 
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respiratory chain whose expression was found to be decreased in brain of schizophrenic 
subjects but increased in individuals with Rett-syndrome and mood disorders (Johnston-
Wilson et al. 2000; Kriaucionis et al. 2006; Prabakaran et al. 2004). Furthermore, their 
study also revealed using immunocytochemistry that ZDHHC8 colocalized with 
Synaptophysin, a protein localized at the presynaptic site of neuron, although few puncta 
colocalized with parvalbumin (PV) expressing neurons they preferentially found that 
ZDHHC8 colocalized in glutamatergic neurons. Surprisingly, the same authors 
discovered that overexpression of ZDHHC8 in fibroblast was toxic upon transfection 
therefore leading to cell death which was shown to be likely through apoptosis. This effect 
was thought to be responsible by the DHHC domain of the protein (Maynard et al. 2008). 
In addition to its palmitoyl transferase, ZDHHC8 was also identified as a modulator of 
G2/M phase of the cell cycle in response to DNA damage (Sudo et al. 2012). 
Mice deficient for Zdhhc8 were observed to have alteration in sensory gating and also 
open field behaviour (Mukai et al. 2008; Swerdlow et al. 2008). Furthermore, this mice 
were observed to have an alteration in the hippocampal medial prefrontal synchrony 
which is thought to also be altered in individual with 22q11.2DS (Mukai et al. 2015). 
This thesis aims to evaluate the function of ZDHHC8+/- in glutamatergic neurons at the 
phenotypic level, and the analysis of the transcriptome of neuronal progenitors 
heterozygous for ZDHHC8. 
1.1.4.28. RTN4R 
Reticulon 4 receptor is also known as Nogo-66 receptor, a protein encoded by the RTN4R 
gene. RTN4R is a glycosylphosphatidylinositol (GPI)-linked protein highly expressed in 
the frontal cortex and also localized on the axonal membrane of the pre and post synaptic 
neurons (Josephson et al. 2002; Wang et al. 2002). This receptor is a crucial regulator of 
neurite outgrowth, indeed, the activation of RTN4R leads to the inhiation of a signalling 
cascade activating RhoA which ultimately inhibits axonal growth (Hsu et al. 2007; 
Sinibaldi et al. 2004). In addition, it was also demonstrated as being important for axon 
regeneration following injury (Hsu et al. 2007; Hunt et al. 2002). 
1.1.4.29. DGCR6L 
DGCR6L is a duplicate copy of DGCR6, they share 97% similarity, they only differ on 
only 220 residues (Chakraborty et al. 2012). DGCR6L encodes a homologous functional 
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copy of DGCR6, expression study identified that this gene was also expressed in fetal and 
adult tissue (Lisa Edelmann et al. 2001). 
 
1.1.5. Animals model of 22q11.2DS 
Several mouse models were generated to study the 22q11.2DS. The chromosome 16 in 
mouse harbour a syntenic region of the chromosome 22 except CLTCL1 (Karayiorgou et 
al. 2010). As presented in Figure 1.3, these mice models of 22q11.2DS harbour different 
deletions which span various region (Kimber et al. 1999; Lindsay et al. 2001; Lindsay et 
al. 1999; Merscher et al. 2001; Mukai et al. 2008; Noritake et al. 2009; Stark et al. 2008). 
These models gave a valuable insight into the different aspects of 22q11.2DS. Indeed, 
they exhibited similar behavioural impairment than those observed in 22q11.2 carriers 
such as decrease of sensorimotor gating or prepulse inhibition (PPI) (Paylor et al. 2006). 
In addition to behavioural studies, these mice models were found to alter cortical 
development such as the alteration of the tangential migration of interneurons or the 
cortical layering which was demonstrated to be altered in 22q11.2DS (Meechan et al. 
2015). 
 
 
Figure 1.3 Human 1.5Mb deletion of the 22q11.2 region and the syntenic region in mouse (MMU16). 
Legend on next page 
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1.1.6. 22q11.2 Duplication 
Because the 22q11.2 region is predisposed to rearrangement due to the presence of 
multiple LCRs, both deletion and duplication can occur and may be expected in equal 
proportion. Only few duplications were detected however (Ensenauer et al. 2003). 
Moreover, individuals with 22q11.2 duplication have far less distinct phenotypic 
characteristics than those carrying the deletion. Therefore, 22q11.2 duplication are 
usually underdiagnosed (Yobb et al. 2005). Surprisingly, in a study that comprised 47005 
individuals, in which they were 6882 schizophrenia case and 11255 controls, the CNV 
analysis revealed that 22q11.2 duplication have a protective effect against the risk to 
develop schizophrenia (Rees et al. 2014). Furthermore, 22q11.2 duplication was absent 
amongst the schizophrenic cases while they were 10% amongst the controls to have this 
CNV. 
 
1.2. Brain development  
1.2.1. Induction and patterning of the nervous system 
During embryonic development, gastrulation results from the formation of the three-
layered organization named, endoderm, ectoderm and mesoderm. The inner layer referred 
as endoderm was observed to form cells such as the lung and pancreatic cells. The middle 
layer, the endoderm becomes cells such as muscle, cartilage or bone cells. The outer layer 
also named ectoderm becomes tissues such as the epidermis as well as the nervous system. 
Experiments from Spemann and Hilde Mangold in which they transplanted the blastopore 
from an embryo to another resulted to the generation of an entire second axis including 
brain. Later, they discovered that this region have the capacity to promote neural 
induction and named the Spemann organizer or organiser (Spemann et al. 1924). By 
transplanting smaller pool of complementary DNA (cDNA) at each of its experiment, 
Harland managed to isolate the first morphogen NOGGIN (Smith et al. 1992). Indeed, in 
an experiment, embryos treated with UV irradiation therefore making them unable to 
Figure 1-3 Human 1.5Mb deletion of the 22q11.2 region and the syntenic region in mouse (MMU16). 
The genes are presented in centromeric-telomeric order. This deletion is mediated by the aberrant 
homologous recombination of the LCRA and C, red rectangles. It is important to note that in the mouse the 
genes are not displayed in the same order than in human. CLTCL1 and DGCR6L are not present in the 
mouse (yellow boxes). The genes content of the different mouse models is depicted along with their names. 
Original figure adapted from Paylor & Lindsay 2006 
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develop dorsal part, the injection of NOGGIN mRNA was able to restore the development 
of the dorsal part of the embryo (Sasai et al. 1994). It was later demonstrated that 
NOGGIN binds with high affinity to BMP2 and BMP4 therefore preventing their 
interaction with their receptors (Zimmerman et al. 1996). CHORDIN, which was isolated 
by DeRobertis, was demonstrated to have similar characteristics than NOGGIN (Sasai et 
al. 1994). Indeed, CHORDIN binds to BMPs therefore antagonizing the BMP signalling 
by preventing activation of their receptors (Piccolo et al. 1996). Finally, FOLLISTATIN 
known as activin-binding protein, was shown to be able to bind and inhibit activin 
therefore is involved in mesoderm differentiation. However, experiments from Hemmati-
Brivanlou and Melton showed that a truncated activin receptor which is part of the TGF-
β/BMP signalling was able to induce the generation of neurons at the expense of 
mesodermal tissue (Hemmati-Brivanlou et al. 1994). Therefore, FOLLISTATIN was 
considered as the third neural inducer. Experiments shows that without signal from the 
organiser, cells secret BMPs and therefore promote ectodermal cells formation. 
Conversely, the action of these three morphogens promotes the signalling that initiates 
the formation of the neural plate by inhibiting BMP and TGF-β signalling (Zimmerman 
et al.1996).  
The organiser homologous structure in mammals is the node. Both structures are 
responsible of the simultaneous formation of the neural plate that overlie the notochord, 
a structure that elongates along the rostrocaudal axis and produces secreted factors in its 
surrounding therefore providing fate and position information. Soon after these structures 
form, the neural plate fold to form the neural tube in a process known as neurulation. 
Along the rostrocaudal and dorsoventral part of the embryo, cells are exposed to different 
levels of morphogens which are important for their fates. While the rostral part of the 
neural tube forms the telencephalon, midbrain and hindbrain, the caudal part is 
responsible of the formation of the spinal cord.  
1.2.1.1. WNT signalling 
Wnt is part of a family of secreted glycoproteins regulating several cellular behaviours 
during embryogenesis. Interestingly, several WNT proteins require to be palmitoylated 
for their function (Willert et al. 2003). During the development of the brain, Wnt was 
shown to be particularly important, the secretion of DKK1 by the organiser is crucial for 
the patterning of the rostrocaudal axis and the telencephalon. Indeed, DKK1 inhibits the 
gradient of Wnt at the rostral part of the embryo (Yamaguchi 2001). Experiments in which 
DKK1 is deleted result to a loss of the rostral structure, more specifically these mice lack 
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head and brain structure anterior to the hindbrain. Conversely, ectopic expression of 
DKK1 is observed to be responsible of an enlargement of the head (Mukhopadhyay et al. 
2001). FrzB another inhibitor of Wnt contains a domain similar to the putative Wnt 
binding domain of the frizzled receptors. FrzB protein, that is secreted by the organiser, 
binds to the WNT proteins preventing them from binding to their receptors. It was later 
demonstrated that FrzB inhibits β-catenin signalling by biding to Wnt1 and Wnt8 which 
led to the formation of head larger than normal (Leyns et al. 1997; S. Wang et al. 1997). 
While these two inhibitors demonstrate the importance of Wnt signalling for the 
patterning of the rostrocaudal axis, Wnt is also associated with the establishment of the 
dorsoventral axis. In an experiment, Kelly et al.¸ demonstrated that an ectopic expression 
of β-catenin, a component of Wnt signalling, was associated with the formation of dorsal 
axis duplication in zebrafish (Ungar et al. 1995). In addition, Wnt signalling is also 
associated with the patterning of the dorsal telencephalon. Thus, overexpression of β-
catenin in mouse disrupts the expression of several genes along the dorsoventral axis. 
Therefore, dorsal genes such as Pax6 and Pax7 saw their expression to be expended 
ventrally at the expense of progenitors with a ventral identity such as Olig2 or Nkx6.1. In 
addition, inactivating β-catenin demonstrated that Wnt signalling was necessary to 
preserve dorsal identity by suppressing the expression of ventral genes (Alvarez-Medina 
et al. 2008; Backman et al. 2005).  
Cerberus is a secreted protein expressed in the anterior endoderm. This protein was shown 
to inhibit both the Wnt and BMP signalling. Experiment using Xenopus demonstrated that 
Cerberus mRNA injection differs from the three neural inducers in that it induces the 
formation of an ectopic head but also suppresses posterior mesoderm formation (Shawlot 
ety al. 1998).  
While at the neural tube stage Wnt is required for proliferation of progenitors, Wnt genes 
start to be expressed when the neural tube fold. Once the neural tube is closed, several 
Wnt can be detected: Wnt1, Wnt3, Wnt3A, Wnt4 and Wnt7b are expressed in the dorsal 
region while Wnt5a and Wnt7a are in the ventral region (Gunhaga et al. 2003; Harrison-
Uy et al. 2012). 
Wnt signalling is composed of three main intracellular signalling, the canonical or 
WNT/β-catenin pathway, the planar cell polarity pathway and the WNT/Calcium 
pathway. The canonical WNT pathway involves WNT to bind its receptor Frizzled a 
seven-transmembrane protein that interacts with its coreceptors the low-density 
lipoprotein receptor related protein 5 and 6 (LRP5, 6). These coreceptors are crucial for 
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the canonical pathway signalling. Upon activation by WNT, the Dishevelled (DVL) is 
activated and induced the disassembly of the destruction complex composed of AXIN, 
adenomatous polyposis coli (APC) and glycogen synthase kinase 3 β (GSK3β) therefore 
allowing the β-catenin to be translocated into the cytoplasm and activate the target of 
WNT. On the other hand, in absence of WNT, β-catenin is phosphorylated by GSK3-β 
and therefore results to the degradation of β-catenin by the proteasome. The planar cell 
polarity pathway, activation of DVL induces Rho GTPases and JNK which are 
responsible of tissue polarity and dendritogenesis through cytoskeleton changes (Habas, 
Dawid et al. 2003). Finally, upon binding of WNT to frizzled, DVL induces calcium 
influx from the endoplasmic reticulum that activates the protein kinase C (PKC) as well 
as the calcium/calmodulin dependant kinase II (CaMKII).  
1.2.1.2. Sonic Hedgehog (SHH) signalling 
SHH is a protein part the Hedgehog family that is secreted by the notochord (Placzek et 
al. 1991). SHH expression is concomitant with the notochord and therefore extend from 
the caudal part to the rostral part of the head. While the expression of SHH in mouse and 
fish was observed to precede its initial expression by the floor plate, its expression in the 
chick coincides in the floor plate and notochord. In vivo, SHH was demonstrated to be 
important for telencephalic patterning and more specifically for the ventral patterning of 
the telencephalon. While embryos lacking SHH do not develop ventral telencephalon, 
ectopic expression results in the expression of floor plate markers, thus markers of ventral 
identity (Gaiano et al. 1999; Johnson et al. 1994). An SHH signalling gradient is 
necessary for the generation of different neurons type along the dorsoventral axis. 
Thereby, SHH along the dorsoventral axis is capable to direct different cell fates at 
different concentration thresholds. 
Upon release from the notochord, SHH binds to its receptor Pached (PTC) and relieves 
the repression of the receptor on Smoothened (SMO) therefore avoids GLI truncation by 
inhibiting the protein kinase A. GLI proteins can then promote or repress the transcription 
of specific target genes (Le Dréau and Martí 2012). Conversely, in absence of SHH, the 
activity of SMO is inhibited by PTC. The GLI family are downstream of the SHH 
signalling. The GLI family is composed of three members, GLI1, GLI2 and GLI3 that are 
expressed in the neural tube. An incorrect expression of GLI1 mimics SHH signalling 
such as the induction of the floor plate but also dopaminergic and serotoninergic markers 
in the dorsal midbrain and hindbrain (Hynes et al. 1997). GLI2, that is expressed along 
the dorsoventral axis in the neural tube, is suggested to cooperate with GLI1 to control 
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cell fate (Hynes et al. 1997). Interestingly, GLI3 is repressed by SHH. Indeed, the gradient 
of GLI3 is higher in the dorsal telencephalon where the SHH gradient is the weakest 
(Rallu et al. 2002).   
1.2.1.3. The transforming growth factor beta (TGF-β) signalling 
TGF-β is a large family of proteins composed of two subfamilies, TGF-β, Activin and 
Nodal family and the bone morphogenetic proteins (BMPs) and growth and 
differentiation factors (GDFs) family. These proteins were demonstrated to be 
responsible of cell proliferation but also differentiation and cell migration. 
In addition to its antagonizing role on Wnt signalling, Cerberus also inhibits nodal. Nodal 
is important for the formation of the floor plate thus its loss result to Cyclop mutant that 
involves an absence of the floor plate therefore resulting to important alteration of ventral 
forebrain development. 
As previously mentioned, inhibition of the BMP signalling, mainly BMP4 by the three 
neural inducers is crucial for neural induction (Piccolo et al. 1996; Zimmerman et al. 
1996). Experiments aiming to silence BMP2, BMP4 and BMP7 identified that the 
strongest dorsalization phenotype was achieved by BMP4. Furthermore, complete 
inactivation of these three BMPs causes complete neuralization of the ectoderm in 
Xenopus, interestingly, their reintroductions in the same embryo result to restoration of 
epidermal patterning (Reversade et al. 2005). Early during the development, the 
expression of NOGGIN and CHORDIN by the organiser is regulated by β-catenin which 
reduces BMP4 expression.  
The TGF-β receptors family is composed of type I and II receptors serine threonine 
kinase. Upon binding of TGF-β onto its receptors, this one is phosphorylated which in 
turn induces the phosphorylation of the receptors activated smads (R-SMADs). 
Subsequently, R-SMADs form a complex with SMAD4 which is translocated into the 
nucleus to regulate the transcription of target genes (Derynck et al. 2003). R-SMADs 
activation through type I receptors kinase were observed to be inhibited by SMAD6 or 
SMAD7. SMAD6 and 7 acts by binding to the receptor therefore preventing its 
phosphorylation and subsequent recruitment of R-SMADs. 
BMPs are secreted by the roof plate, they are important for the dorsoventral patterning of 
the neural tube. BMP concentration dependant mechanism is high at the dorsal part and 
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weak in the ventral neural tube which is in opposition with SHH thus the two-signalling 
pathways antagonised one another.  
In vitro, it was demonstrated that the complex, TGF-β/Nodal/activin signalling was 
important for the pluripotency in hESCs. Thus, its inhibition was shown to induce 
neuroectodermal fate. Thereby in undifferentiated cells, TGF-β/Nodal/Activin are 
activated through SMAD2 and SMAD3 (James et al. 2005). 
In this thesis, the action of NOGGIN, CHORDIN an FOLLISTATIN is mimicked in vitro 
by the action of the small molecule LDN193189 and SB431542 that allow the neuronal 
conversion of our hESCs and iPSCs culture. 
 
1.2.2. Cerebral cortex development  
During embryogenesis, the developing forebrain is divided into prosomeres along the 
rostrocaudal axis. The prosomere 1 is next to the mesencephalon, prosomere 2 and 3 
divide the diencephalon while prosomere 4, 5 and 6 divide the telencephalon (Puelles et 
al. 2003). 
The vertebrate forebrain is divided along the dorsoventral axis into the subpallial and 
pallial. While the pallium generates the cerebral cortex, the subpallium is composed of 
the GE, the lateral, medial and caudal ganglionic eminence (LGE, MGE and CGE). 
Therefore, the pallial and subpallial boundary, at the level of the LGE, coincides with the 
expression of Pax6 dorsally and Dlx1/2 as well as Gsx2 ventrally. Pax6 and Dlx1/2 were 
shown to have complementary effect for the patterning of the forebrain (Yun et al. 2001). 
Due to the dorsoventral gradient of SHH, it was suggested that SHH could be responsible 
of the distinction between the LGE and MGE. The transcription factor, NKX2.1 is highly 
expressed in the MGE and give rise to cortical interneurons and striatal interneurons.  
The brain is constituted of different neuronal population which are dispersed in different 
brain area. The most documented has been the cortical neurogenesis. The mammalian 
neocortex is composed of two classes of cortical neurons, the interneurons and the 
glutamatergic neurons which respectively makes local connection and extend axons either 
intracortical or to other part of the brain (Molyneaux et al. 2007).  
 
1.2.2.1. Cortical Interneurons generation  
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Cortical interneurons release as neurotransmitter GABA, they are originated from the 
MGE in the subpallium (Molyneaux et al. 2007). Upon generation, these neurons 
expressed the transcriptional marker NKX2.1 whose expression is activated by SHH. 
However, reduction of SHH signalling was shown to reduce the proportion of NKX2.1 
progenitors. In addition, mutant mice for Nkx2.1 exhibit a 50% reduction of cortical 
interneurons. Furthermore, it was observed that the MGE transforms into LGE. 
Interestingly, in interneurons migrating to the striatum the expression of NKX2.1 is 
maintained while it is downregulated for interneurons of the cortex.  
The MGE primarily gives rise to PV and somatostatin interneurons (SST) whose fate 
depend upon the level of Shh, indeed, it was demonstrated that high level of SHH 
preferentially give rise to SST expressing neurons (Kelsom et al. 2013; Xu et al. 2005). 
These cells are then migrating tangentially in order to populate the pallium. During 
tangential migration, the interneurons precursors are expressing LHX6 (Figure 1.4). In 
mouse deficient for LHX6, interneurons were still shown to properly populate the pallium, 
however they did not express either PV or SST, while on the other hand, an increase of 
interneurons expressing neuropeptide Y (NPY) was observed. NPY expressing 
interneurons is another class of cells originating from the MGE. Once interneurons 
progenitors achieve their tangential migration in the pallium, they switched to radial 
migration and move towards the appropriate cortical layer within the cortical plate. 
Another transcription factor, SOX6 which is expressed by the MGE was shown to be 
important together with LHX6 for the specification of PV and SST neurons. Mice 
deficient for sox6 exhibit a strong reduction of SST neurons while PV neurons were 
absent (Azim et al. 2009; Batista-Brito et al. 2009). 
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1.2.2.2. Cortical excitatory neurons generation 
Cortical projection neurons originate from the lumen of the pallium, a region called the 
ventricular zone (VZ) and also from an additional proliferative layer above the VZ called 
the subventricular zone (SVZ). There are three different types of progenitor’s present in 
the developing cortex, the neuroepithelial cells (NEC), the radial glial cells (RGC) and 
the intermediate progenitors (IP) (Figure 1.5). Initially, division is symmetrical, one NEC 
give rise to two NEC, this step is important to expand the proportion of multipotent cells. 
A transition from NEC into RGC appears following the expression of bHLH (basic helix 
loop helix) transcription factor form Hes (hairy/enhancer of split) family together with 
Fgf10 (Hatakeyama et al. 2004; Sahara et al. 2009). This transition was also observed to 
be dependant of Notch signalling, indeed upon binding of delta localized on a 
neighbouring cell to the Notch receptors, it leads to the release of the intracellular part of 
Notch, named Notch-ICD which once translocated into the nucleus promotes the 
transcription of the Hes genes (Pierfelice et al. 2011). The RGC have long process that 
extend from the ventricular wall to the pial surface. In addition to their role in the 
neurogenesis, RGC were also demonstrated to be important to guide neurons into their 
final cortical layers. At the beginning of the corticogenesis, RGCs from the VZ divide 
symmetrically in order to expand their population. On the other hand, at the onset of the 
neurogenesis, the RGCs divide asymmetrical following different modes which can be 1) 
Figure 1-4 Different migration 
route for pyramidal or cortical 
interneurons. Cortical interneurons 
origninating from the MGE 
tangetially migrate towards the 
neocortex together with cells from the 
LGE respectively in orange and green. 
Conversely, pyramidal neurons 
generated in the ventricular zone of 
the developing pallium are migrating 
radially to populate the different 
cortical layer of the neocortex. Figure 
adapted with permission from 
Springer: Nature reviews. 
Neuroscience, Rowitch 2004
(4296970336434) Copyright (2004). 
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a neurogenic division which results in a self-renewing RGC and a neuron, 2) an 
asymmetric progenitor division of a RGC into an IP or basal radial glial cells (bRGC) and 
a self-renewing RGC and finally 3) gliogenic division that corresponds to the division of 
a RGC into a neuron and an astroglia which will be translocated away from the VZ 
(Kriegstein et al. 2006; Noctor et al. 2004). Additionally, another subdivision of the 
pallium called the outer SVZ which is absent from mouse is populated by the bRGC 
(Hansen et al. 2010). During the asymmetrical division, the bRGC can divide into a self-
renewing bRGC and an IP.  
Neurons constituting the cortex were shown to radially migrate in the developing cortex. 
The earliest neurons constitute the preplate and then further neurons constitute the cortical 
plate which split the preplate into the marginal zone also known as the layer I and the 
subplate which is localized below the layer VI. The cortex is composed of 6 layers which 
are generated in an inside-out manner. Thus, the early neurons are populated the deep 
layer (layer VI and V) while the late neurons are migrating to the upper layer (layer IV 
and II/III). 
 
 
Figure 1-5 Overview of the cortical neurogenesis. The principal types of NPCs with the progeny they produce 
are indicated by different colors. Additional NPC types that are typically found in mammalian neocortex are 
indicated in the box; note that only some of the possible daughter cell outcomes are depicted. Figure adapted 
with permission from Springer: EMBO reports, Paridaen 2014 (4296970210648) Copyright (2014). 
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1.3. Disease modelling using pluripotent stem cells 
The majority of studies about disease modelling have been performed using animal 
models or primary tissues. Although rodent primary tissues can be used routinely in 
laboratory, human primary tissues are limited and do not allow to study early 
developmental stage of a disease.  
Embryonic stem cells (ESCs) have the ability to differentiate into any type of tissues of 
the human body. Our laboratory has the expertise to differentiate ESCs into the four-main 
neurons population which are excitatory projection neurons, cortical interneurons, MSN 
and dopaminergic neurons.  
Disease modelling can be achieved either by using the novel CRISPR/Cas9 technique 
described in detail below or taking advantage of the novel technique of induced 
pluripotent stem cells (iPSCs) to study polygenic disorder which would be more difficult 
to generate in vitro.  
 
1.3.1. Pluripotent stem cells 
Embryonic stem cells (ESCs) are derived from the inner mass of the embryo. They have 
the characteristic to possess unlimited self-renewal capabilities and can thus be 
maintained in culture indefinitely under the right conditions. The maintenance of 
pluripotency is controlled by essential genes such as Nanog, Oct4 (Pou5f1) and Sox2  
Mouse embryonic stem cells (mESCs) were first used to explore the characteristics of 
these cells. In culture, mESCs require the addition of myeloid leukaemia inhibitory factor 
(LIF) to allow their self-renewal and proliferation. Indeed, experiments by Martins et al. 
demonstrated that upon transfer of these cells from feeder layer to gelatin, differentiation 
occurs (Martin 1981). Later, it was demonstrated that the addition of the recombinant LIF 
factor to gelatin coated mESC culture was able to maintain the cells into an 
undifferentiated state (Smith et al. 1987). It was also shown that the self-renewal property 
of LIF factor results from the activation of the transcription factor STAT3 (Niwa et al. 
1998).  
While human embryonic stem cells (hESCs) also originate from the inner mass of the 
embryo, these cells do not require LIF for self-renewal; instead, support by Fgf2, Nodal 
and activin is necessary for their self-renewal (Vallier et al. 2009). The SMAD2/3 
signalling pathway is particularly important for hESC self-renewal. Indeed, SB531542 
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inhibit SMAD2/3 phosphorylation resulting in decrease expression of oct3/4 (Laping et 
al. 2002).  
Another type of pluripotent stem cells, the induced pluripotent stem cells (iPSCs) were 
discovered by Yamanaka et al. in 2006. They demonstrated that mouse fibroblasts could 
be reprogrammed into iPSCs by viral transduction of four transcriptional factors, Oct3/4, 
Sox2, c-Myc and Klf4 (K. Takahashi et al. 2006). The following year the same authors 
reported the reprograming of human adult dermal fibroblast into iPSCs using the same 
four transcriptional factors (K. Takahashi et al. 2007). Figure 1.6 presents the ability of 
ESCs to differentiation into any types of tissues. 
 
 
1.3.2. Genome editing using CRISPR/Cas9 
The recent discovery of the CRIPSR/Cas9 technology make it possible to efficiently edit 
the genome of hESCs. The RNA guided clustered regularly interspaced short palindromic 
Figure 1-6 ESCs differentiation. Schematic of the potential of embryonic stem cell 
lines. ESCs are extraceted from the inner mass of the blastocyst. Following various 
treatment, they can give rise to any cell types such as muscle cells, blood cells,  
neurons, instestinal cells, pancreatic cells or liver cells. Picture from Meregalli et 
al.(K. Takahashi and Yamanaka 2006) 
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repeats (CRISPR) contain several short repeats conferring immunity to bacteria and 
archaea. In addition, the Cas9 in an RNA guided endonuclease cleaving DNA upon 
recognition of the foreign DNA/RNA therefore confer protection against further 
infection. The CRISPR/Cas system can be classified into two mains categories which are 
further classified into six different categories. This classification is based respectively on 
the presence of multiple or a single protein effector (Cas) which carried out the 
interference.  
The defence mechanism that convey the protection against further posterior infection is 
divided in three stages, 1) adaptation, 2) crRNA biogenesis and 3) target degradation. The 
adaptation also called protospacer acquisition enables the host to memorize the unknown 
genetic material that is subsequently transcribed into a crRNA which is a small guide 
RNAs. A duplex formed between the crRNA and a tracrRNA (trans activating CRISPR 
RNA) is then processed by RNase III yielding to the mature small guide RNA that once 
hybridized to the Cas will confer interference to avoid further infection. 
The CRISPR-Cas system as we use it in the laboratory is part of the second family and 
derived from the bacteria Streptococcus pyogenes. The only requirement is a 20 
nucleotides guide sequence complementary to the targeted DNA which is immediately 
preceded by a 5’NGG protospacer adjacent motif (PAM). These three nucleotides 
sequence are responsible of triggering the transition between target binding and cutting 
conformation of the Cas9. Upon cleavage by the Cas9, the targeted sequence undergoes 
one of the two pathways responsible of DNA damage repair, respectively, the error-prone 
Non-Homologous End Joining (NHEJ) or the high fidelity Homologous Direct Repair 
(HDR). NHEJ has a higher capacity of repair and cause the introduction of unpredicted 
insertion or deletion (INDELs) in one or two alleles that can cause frameshift in the 
protein coding region by the introduction of a premature STOP codon, leading to loss of 
function mutation. Unlike NHEJ, HDR uses a donor template similar to the targeted 
regions allowing integration of an exogenous DNA sequence. Although this method is 
used worldwide as a tool for genome editing, a major drawback is the possibility for the 
nuclease to cleave off-target DNA targets called off-target mutagenesis. However, the 
addition of two extra base pair, a guanine, was demonstrated to reduce the off-target effect 
(Kim et al. 2015). This technique was demonstrated to efficiently edit the genome to 
generate KO in our laboratory. Furthermore, as an example, report demonstrated the 
generation of hESCs line deficient for DNMT3B (Horii et al. 2013). More recently it was 
also used to correct disease such as Huntington disease or Parkinson disease(Chung et al. 
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2013; X. Xu et al. 2017). Finally, it was reported that CRISPR/Cas9 could also be used 
for generating microdeletion and microduplication (Tai et al. 2016). 
 
1.3.3. HESCs and or iPSCs to study the development of neurons 
Due to their ability to give rise to any type of tissue, hESCs and iPSCs (hPSCs) offer a 
powerful tool to study neuronal development. In vitro differentiation of hPSCs into 
neurons can be achieved either through embryoid body formation or monolayer 
differentiation. Cells differentiating as monolayer are exposed to the various exogenous 
factors relatively uniformly and exhibit more synchronous differentiation than those 
differentiating in embryoid bodies. Therefore, unless for addressing question that require 
a 3D structure, such as cortical layer specification, studies in our laboratory use 
monolayer differentiation as a routine. 
Monolayer differentiation was first described by Chambers et al., in which TGF-β and 
BMP inhibitor was used to convert hPSCs into neurons fate (Chambers et al. 2009). The 
molecule SB431542 (SB) was used to block the phosphorylation of ALK4, ALK5 and 
ALK7, therefore inhibit SMAD2/3 phosphorylation and thus inhibit the 
TGFβ/Activin/Nodal pathway. Thereby, dual smad inhibition by noggin and SB was 
demonstrated to be able to convert hPSCs into neurons. Later, noggin was replaced by 
LDN193189 (LDN), this molecule inhibits the BMP signalling pathway and was 
demonstrated in combination with SB to efficiently give rise to PAX6 positive cells, a 
neuroectodermal marker. Compared to dorsomorphin which is another BMP antagonist, 
LDN was demonstrated to be less toxic (Surmacz et al. 2012). Interestingly, this protocol 
was demonstrated by default to give rise to neurons from the dorsal telencephalon. 
While neuronal conversion of hPSCs preferentially give rise to neurons from the dorsal 
telencephalon and therefore excitatory projection neurons, it is necessary to add further 
molecules to promote the generation of others neuronal population.  
To generate cortical interneurons, an additional factor is necessary during the neural 
conversion, XAV939. This small molecule that substitute DKK1 is a WNT signalling 
inhibitor that simulates the degradation of β-catenin, therefore strongly increases 
telencephalic commitment and thereby increases the proportion of neural progenitors 
expressing FOXG1. Time window expression of SHH and its agonist purmorphamine 
promotes the induction of cells with a ventral identity expressing NKX2.1. Therefore, 
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progenitors with a MGE identity are expected to express protein such as NKX2.1 and 
FOXG1 but also OLIG2, a marker of cells originating from the MGE.  
Medium spiny neurons (MSN) are primarily GABAergic projection neurons that form 
the striatum which is one of the nuclei of the basal ganglia. MSN originates from the 
LGE, a structure of the forebrain. The location of the LGE below the pallium requires the 
precise concentration of SHH with or without WNT inhibitor. Thereby several 
experiments over the years investigated the time window and concentration of WNT 
inhibitor and SHH that would lead to the highest proportion of dopamine and cAMP-
regulated neuronal phosphoprotein (DARPP32) positive cells, a MSN marker (Aubry et 
al. 2008; Delli Carri et al. 2013; Ma et al. 2012; Nicoleau et al. 2013). A recent 
publication from our laboratory reported the generation of MSN using activin A which 
was demonstrated to promote the generation of neurons with an LGE identity (Arber et 
al. 2015). Therefore, following conversion into neurons, cells require the addition of 
activin A to obtain an LGE identity which is known to express the transcription factor 
GSX2 as well as CTIP2. 
Compared to the other three neuronal populations previously presented, dopaminergic 
arise from the ventral midbrain. During development, the midbrain hindbrain boundary 
(MHB) is formed through the repression of the transcription factor orthodenticle homolog 
2 (OTX2) and gastrulation brain homeobox 2 (GBX2). The patterning of the MHB is 
regulated by a gradient of WNT1 and FGF8 respectively from the midbrain and hindbrain. 
It was demonstrated that brain explants at distance from the source of FGF8 was able to 
generate midbrain dopamine neurons (Arenas et al. 2015). Therefore, midbrain 
dopaminergic neurons induction employs both SHH and FGF8.  
In this thesis, all these four neuronal types were generated in order to evaluate whether 
the expression of specific genes differ depending on the neuronal population. 
 
1.3.4. Disease Modelling using iPSC 
Since the discovery of iPSCs, it is now possible to study the development of neurons from 
individuals with genetic background associated with monogenic neurological disorders 
such as Huntington disease or Amyotrophic lateral sclerosis. In addition, iPSCs are 
particularly valuable for the study of polygenic disorders such as 22q11.2DS which 
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results of the haploinsufficiency of more than 30 genes or also diseases with a genetic 
background not yet identified.  
Thereby, Brennand et al., report the first study modelling schizophrenia using iPSCs. 
They demonstrated that neurons from individuals with schizophrenia had an impaired 
neuronal connectivity using a modified rabies virus (Brennand et al. 2011; Wickersham 
et al. 2007). They also observed an alteration of the overall morphology of neurons and 
identified using transcriptomic analysis novel signaling pathways such as NOTCH 
signaling that were not previously linked to schizophrenia. Physiological assessment was 
performed using electrophysiology and calcium imaging, the last one will be further 
discussion later. This study was the first to report the use of iPSCs to study schizophrenia. 
However, this study uses iPSCs from patients with idiopathic schizophrenia therefore an 
heterogenous genetic background, because schizophrenia is a multigenic disorder the 
results observed in this study might differ between individuals. 
Several other studies reported the use of iPSCs from Parkinson disease patients. 
Schöndorf et al., reported the use of iPSCs from individuals with glucocerebrosidase 
(GBA1) mutation. While homozygous mutation is responsible of Gaucher syndrome, a 
lysosomal storage disease, heterozygous mutation of GBA1 is associated with higher risk 
to develop Parkinson disease. In this study, iPSCs were differentiated into midbrain 
dopaminergic neurons. The dopaminergic population was further enriched using 
fluorescence-activated cell sorting. They examined the overall expression of key markers 
of midbrain dopaminergic neurons differentiation, they also observed lysosomal and 
autophagic defect in mutant neurons therefore emphasizing that iPSCs can replicate in 
vivo pathology. In addition, they also observed an impairment of the calcium homeostasis 
in the neurons with GBA1 mutation.   
Another study from Paşca et al., used fibroblasts from individuals with Timothy 
syndrome which were reprogramed to obtain iPSCs. This pathology was demonstrated to 
cause a missense mutation in the L-type calcium channel, CACNA1C gene. The study 
investigates the development of the iPSCs into a protocol of cortical neurons precursors 
and neurons. They evaluated the calcium activity using Fura 2AM, a radiometric dye able 
to measure intracellular calcium which allow them identified calcium activity defect in 
neurons with Timothy syndrome mutation. Furthermore, they also performed single cell 
q-PCR which identified a decrease expression of lower cortical layer genes. 
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Several studies also evaluated neurons derived iPSCs from individuals with 22q11.2DS. 
In their study, Belinsky et al., used two hPSC from individual with 22q11.2DS. Their 
study investigated the electrophysiological and calcium imaging activity in neurons with 
a forebrain identify which was compared to a healthy individual. Electrophysiology and 
calcium imaging activity were performed simultaneously several times from day 13 to 
88. No important differences were observed regarding action potential property and 
frequencies.  
However, most study investigating iPSCs from 22q11.2DS primarily focused on 
transcriptomic analysis such as study from Toyoshima et al, as well as Lin et al, which 
investigated the transcriptome of neurons derived from individuals with 22q11.2DS.  
Instead of studying the entire 22q11.2 deletion, we aimed to understand the function of 
one specific gene within this deletion. Therefore, we investigated its role during neuronal 
development using assays such as calcium imaging to determine whether the physiology 
of the neurons was altered in our mutant neurons. 
 
1.3.5. Calcium Imaging a technique to assess neuronal activity in neurons 
derived stem cells 
Calcium ion is responsible of many function in cells, such as muscle contraction but it is 
also involved in several steps of the cell cycles. In neurons, calcium is essential for several 
functions such as propagation of action potential and acts as second messenger through 
G protein couple receptors (GPCRs). In resting neurons, calcium concentration varies 
from 50 to 100nM. However, during electrical activity, this concentration can transiently 
rise ten or even hundred times higher (Berridge, et al. 2000). Overall, the calcium 
concentration is maintained lower enough at rest to allow a significant change without 
extensive energy cost during electrical activity. The calcium homeostasis is determined 
by the calcium efflux and influx (Figure 1.7). Calcium efflux is mediated by the plasma 
membrane ATPase, the sodium calcium exchanger and the endo/sarcoplasmic reticulum 
calcium ATPase (SERCA). Instead, the calcium influx is composed of the voltage gated 
calcium channel (VGCC), the ionotropic receptors (NMDA, AChR, AMPA). Finally, 
internal storage of calcium can be released through the ryanodine receptor or the inositol 
1,4,5-trisphosphate receptor (IP3). 
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The process of neurotransmitter release requires the calcium to have a dual role. First the 
calcium enters axons terminal through the VGCC following depolarization of the plasma 
membrane. Then the calcium binds to the calcium sensor synaptotagmin which is 
localized at the surface of the synaptic vesicle. Upon binding, synaptotagmin interact with 
SNAP25 and synaptobrevin (SNARE protein) which are anchored at the presynaptic 
membrane and allow the release of the neurotransmitter within the synaptic cleft 
(Mohrmann et al. 2013). 
The plasma membrane calcium channel is comprised of four different groups which 
are composed of calcium influx, the VGCC, the NMDA receptors, the alpha-amino-3-hy-
droxy-5-methyl-4-isoxazole propionic acid-sensitive receptors (AMPARs). Calcium 
signalling can further be mediated through GCRPs located on the neurons, the 
metabotropic glutamate receptors. 
Upon depolarization, the VGCCs are important to initiate the calcium signalling cascade. 
The VGCCs are composed of two main classes based on their thresholds of activation, 
the high and low voltage activated channel respectively, HVA and LVA (Catterall 2000). 
Figure 1-7 Calcium signalling in neurons. Schematic of the neurons depicting the differente available 
source of calcium. AMPA, NMDA, VGCC, nAChR and TRPC are source of calcium influx. IP3R, RyR 
are source of calcium released from the internal store. PMCA, NCX and SERCA are source of calcium 
efflux. Figure adapted with permission from Springer: Neuron, Grienberger 2012 (4296970017957) 
Copyright (2012). 
35 
 
The HVA can be further subdivided into four categories, the L-type composed of the 
Cav1.1 to Cav1.4, the P/Q type (Cav2.1), the N type (Cav2.2) and the R type (Cav2.3). The 
LVA instead is only composed of the T type (Cav3.1 to Cav3.3).  
Amongst the L-type calcium channel, the Cav1.2 is encoded by the CACNA1C gene which 
was shown to be expressed in neuronal cell body and dendrites. This channel permits 
large influx of calcium that activates pathways necessary for long term potentiation 
(Benarroch 2010). The Cav1.3 (CACNA1D) is expressed by auditory hair cells (Kollmar 
et al. 1997). Overall the Cav1 family is important for synaptic transmission, 
neurotransmitter release and generation of calcium transient in dendrites (Brini et al. 
2014). 
The Cav2 family are present at the presynaptic membrane but also on cell body and 
dendrites where they are responsible for the fast neurotransmitter releases. The P/Q 
channel type (Cav2.1), encoded by CACNA1A, is expressed at the excitatory synapses but 
also by the Purkinje cell from the cerebellum. The N-type channel (Cav2.2), encoded by 
CACNA1B, is involved in the neurotransmission at the inhibitory neurons, but also 
noradrenergic and the dorsal root ganglia. Both Cav2.1 and Cav2.2 were observed to be 
regulated through G protein coupled (Hille 1994).  
The T type channel corresponding to the LVA channel were demonstrated to be located 
at the soma as well as the dendrites in most brain region. It was observed that gain of 
function of the Cav3 channel was responsible of epilepsy in human and genetic mouse 
model (Khosravani et al. 2006). This family composed of three channels, Cav3.1, Cav3.2 
and Cav3.3 encoded respectively by CACNA1G, CANA1H and CANA1I. 
 
The calcium permeable AMPA receptor is anchored to the postsynaptic membrane. Upon 
binding of glutamate, different types of ions can enter into the cell through the channels 
pore. This receptor is responsible of the fast-synaptic transmission. AMPA receptors are 
permeable to sodium Na+, potassium K+ and also in some case calcium and zinc et al 
2007). The AMPA receptor is an heterotetramer composed of GluA1, GluA2, GluA3 and 
GluA4 which are encoded by different genes known respectively as, GRIA1, GRIA2, 
GRIA3 and GRIA4. It was reported that the AMPA receptor in the brain is mainly in the 
form of an heteromeric complex composed between  GluA1 with GluA2 or GluA2 and 
GluA3 subunits (Lu et al. 2009). Instead, the GluA4 subunit is developmentally regulated 
and expressed at adult synapse (Lu et al. 2009). There are two forms of GluA2 subunit, a 
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permeable to calcium which can be either GluA2 lacking or unedited GluA2-contaning 
and a calcium impermeable named edited GluA2-containing. The difference between the 
unedited and edited is the presence of a glutamine or an arginine respectively on the 
GluA2 subunit at the 607 amino acids. 
The NMDA receptor is localized at the postsynaptic membrane of neurons. The receptor 
is an heteromeric complex which is composed of either GluN1, GluN2 or GluN3 subunits. 
Each NMDA receptor contain at least a GluN1 subunit. The GluN2 subunit is subdivided 
into four, GluN2A, GluN2B, GluN2C and GluN2D. During development, the majority of 
NMDA receptors are composed of GluN1 and GluN2B subunits, however during 
postnatal development, there is a switch in subunit composition from GluN2B to GluN2A 
(Berridge, Lipp, and Bootman 2000). Compared to the AMPA receptor, the NMDA 
receptor has a high permeability for calcium which usually occur upon triggering of long 
term potentiation (LTP) or LTD. 
Upon release of glutamate by the presynaptic neurons, the neurotransmitter binds to the 
AMPA receptor. Thus, the channel of the AMPA receptor opens provoking an influx of 
Na+ into the postsynaptic neurons which in turn induce depolarization of the postsynaptic 
membrane. If the depolarization if strong enough, it removes the magnesium block on the 
NMDA receptor and therefore allows an influx of calcium in the postsynaptic neurons 
which lead to activation of several molecular pathways (Brini et al. 2014). 
The metabotropic glutamate receptors (mGluRs) are composed of 7 transmembrane G 
coupled receptors. The mGluRs are classified into three categories. The group I includes 
mGluRs 1 and 5 and are mostly expressed at the postsynaptic membrane than the 
presynaptic membrane of glutamatergic neurons. The group I is couple to Gq/G11, which 
are responsible of downstream activation of the phospholipase C and therefore induces 
calcium inside the cells. Often, the function of mGluR1 and mGluR5 are different 
depending of the neuronal population. The group I also plays an important role in fast 
synaptic transmission conveyed by glutamate, it also involves in the induction of LTP 
and LTD (Bellone et al. 2008; Kullmann et al. 2008). The group II includes the mGluR2 
and 3. Conversely to the group I, the group II is couple to Gi/o which results in the 
inhibition of the adenylate cyclase and thus calcium channel. The mGluR2 and mGluR3 
are usually found on presynaptic membrane and inhibit neurotransmitter release at both 
glutamatergic and GABAergic synapses. In addition, the group II of metabotropic 
receptor can also be localized at the postsynaptic membrane where it induces 
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hyperpolarization (Muly et al. 2007). Also, the mGluR3 was found to be expressed by 
glial cells. 
Finally, the group III of metabotropic receptors is composed of mGluR4, mGluR6, 
mGluR7 and mGluR8. Similarly to the metabotropic receptors of the group II, the group 
III is couple with Gi/o and thus is also inhibiting calcium channel but also regulates 
potassium channels. However, it was demonstrated that group III is couple with other 
signalling pathways than the adenylate cyclase, such as the MAPK or the phosphatidyl 
inositol 3-kinase (Iacovelli et al. 2002). The metabotropic group III was observed to be 
in similar location than the group II. 
Calcium indicator  
Several techniques exist to record and evaluate the calcium activity in vivo and in vitro. 
While most of these techniques involved the loading of the calcium indicator using sharp 
micropipette during whole cell path clamp recording. It is currently possible to load bulk 
of neurons either in vivo and in vitro using dye conjugated with acetoxymethyl ester 
(AM). Once loaded, cells are able to remove the ester because of the presence of 
intracellular esterase. In addition, new generation of genetically encoded calcium 
indicators (GCaMP) enable to evaluate calcium activity without injection of a dye. 
Furthermore, they can be used to target specific neuronal population in vivo.  
In this thesis, we used Fluo-4-AM, a dye derived from the Fluo-3. Fluo-4 exhibits brighter 
dynamic range than Fluo-3 therefore is able to detect smaller change in the calcium 
activity. The excitation emission of this dye ranges from 494/506 nm respectively and 
therefore do not necessarily require the use of a confocal microscope.  
 
1.4. Aims 
The overall aims of this thesis are: 
- To investigate the temporal and spatial expression profile of the genes between 
LCR A and B of the 22q11.2DS in different neuronal population 
- To examine the role of ZDHHC8 during cortical excitatory projection neurons 
development. 
The thesis is then subdivided into the three following results chapters: 
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1. The 22q11.2 mutation is composed of a multitude of genes whose function during 
brain development is not clear yet. Therefore, this study aims to explore whether 
genes within this mutation revealed a specific temporal and spatial expression 
profile through the examination of gene expression at different time points and/in 
different neuronal population (cortical interneurons, glutamatergic projection 
neurons, dopaminergic neurons and medium spiny neurons). The results would be 
an indication of the potential underlying function of those genes during brain 
development which therefore might guide which gene to study in future study. 
 
2. In the chapter 4, I have used the novel CRISPR/Cas9 technique to generate a 
hESCs line deficient for ZDHHC8 whose function will further be studied in a 
protocol of glutamatergic neurons differentiation. The chapter 4 also aims to 
investigate whether ZDHHC8 haploinsufficiency alters the kinetics of 
glutamatergic neuronal differentiation and alters the expression of several key 
genes necessary for proper neuronal maturation. Moreover, both to elucidate its 
physiological role during neurons differentiation and due to its association with 
reduced dendritic and axonal arborisation, the motility and the spontaneous 
calcium activity was also investigated in neurons derived from hESC 
heterozygous for ZDHHC8. 
 
3. Lastly, the chapter 5 investigates the transcriptome of ZDHHC8+/- at the neuronal 
progenitor level in order to determine whether heterozygous deletion of ZDHHC8 
affects signalling pathways responsible of neurons differentiation and maturation. 
These results were then compared to the transcriptome of progenitor cells from 
22q11.2 derived hiPSC to identify if similar pathways are altered. 
 
.  
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2. Materials and Methods 
 
2.1. Cell Reprogramming 
2.1.1. 22q11.2 patient 
The 22q11.2 hiPSC line analysed in this PhD was recruited via clinic assessment at the 
National Centre for Mental Health by Professor Jeremy Hall. The individual consented to 
the DEFINE/ECHO and NCMH consent form. The patient is a female of 27 years old 
who was diagnosed with 22q11.2DS at the age of 14. She is thought to have inherited the 
22q11.2 CNV from her mother who also carries a 22q11.2 mutation. She had speech and 
language delay during her childhood and was diagnosed with dyslexia. She also 
experienced delayed motor skills development. Her current medication is Aripiprazole 
10mg and Fluoxetine 20mg twice a day. In terms of psychiatric disorders, the patient was 
diagnosed with ASD, intellectual disability as well as schizophrenia. 
 
2.1.2. Control subject 
The subject is a 27 years male who has been recruited and agreed to the NCMH participant 
consent form. The patient did not report any psychiatric disorders. His medical history 
did not mention any known disease. 
 
2.1.3. Fibroblast reprogramming 
A skin biopsy from individuals consenting to take part in the study was performed by a 
dermatologist and further processed by Craig Joyce. Directly after collection, the biopsy 
was kept in fibroblast media prior to being plated. The fibroblast media was composed of 
90% DMEM (GIBCO), 10% of Fetal Bovine Serum (FBS, GIBCO), 1% of MEM Non-
Essential Amino Acids Solution (Life technologies), 10mM and 0.1% of β-
mercaptoethanol 55mM (Life technologies). After plating, fibroblasts were grown for a 
couple of passages and either frozen down or processed for reprogramming.  
The CytoTune®- iPS 2.0 Sendai Reprogramming Kit (Life technologies) was used to 
reprogram the fibroblasts. Two days prior the transduction, the fibroblasts were replated 
onto two wells of a 6-well plate and kept in the fibroblast media. The day of the 
transduction, fibroblasts were usually at 50-80% confluency. A volume of fibroblast 
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medium was pre-warmed prior to harvesting cells. Cells were harvested in 0.5ml of 
TrypLE™ per 1 well of a 6-well plate and incubated at room temperature until cells 
started to detach, at which point a double volume of fibroblast medium was added to the 
cells to inactivate the TrypLE. A portion of cells was taken out to perform cell counts 
using Trypan Blue exclusion criteria. The volume of virus was calculated using the 
formula below. 
 
The MOI for each virus were as follow, hKOS = 5, hcMyc = 5, hKLF4 = 3. The 
appropriate volume of virus was added to 1ml of fibroblast medium and subsequently 
added into the wells. The following day, the medium was replaced with fresh solution 
and then changed every day until the sixth day post transduction. At day 7, a second run 
of transduction was performed with the hKLF4 virus using similar concentration to that 
in the first transduction. Fresh medium was replaced every day for the next seven days. 
On the fourteenth day, iPSCs colonies were picked and replated onto Matrigel coated 
plates in mTeSR™1 (STEMCELL). After a couple of passages, mTeSR1 was switched 
to TeSR™-E8™ (STEMCELL). 
 
2.2. Cell culture 
All cell cultures were maintained in an incubator (Galaxy 170R, New Brunswick) at 37°C 
and 5% CO2. All cell work was performed under a laminar flow hood (Maxisafe 2020, 
Thermo Scientific). The cells were grown on treated plastic 6-, 12- or 24-well plates 
(Thermo Scientific) or glass coverslips (VWR). 
 
2.2.1. hESCs and hiPSCs culture 
Experiments were carried out using an H7 hESC, iCas9 hESC, 22q11.2 iPSC, and 900 
iPSC lines. Cell culture dishes were coated with hESC qualified Matrigel (Corning). An 
aliquot of Matrigel was resuspended into 6ml of Nutrient Mixture F-12 (DMEM/F12, 
GIBCO) media then 1ml/well of the solution were added and incubated for at least 1h at 
37°C. Cells were maintained in TeSR-E8 medium except where mentioned otherwise. 
While media was changed every day, cells were passaged as follows once reached 60 to 
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80% confluence. Media was aspirated and cells were washed with Dulbecco's phosphate-
buffered saline (DPBS, GIBCO) and incubated with Ethylenediaminetetraacetic acid 
(EDTA) 0.02% (Sigma) at 37°C for up to 5 minutes. Once the EDTA was removed, the 
cells were manually scratched to dissociate colonies into small clusters using a serological 
pipette. Cell suspension was gently centrifuged at 1150 rotation per minute (rpm) for 3 
minutes. Cell pellet was then resuspended in fresh medium and seeded at 1:1, 1:2 and 1:5 
ratios. 
 
2.2.2. Freezing and thawing of stem cells 
Cells were passaged as mentioned in Section 2.2.1. Once centrifuged, the pellet was 
resuspended in a solution of TeSR™-E8™ medium containing 10% of Dimethyl 
sulfoxide (DMSO, Sigma) for cryoprotection. Cell suspension was transferred into a 
1.5mL cryovial (Thermo Scientific) and placed into a cell freezing container which allows 
a slow freezing rate of -1°C/min (Bioscision) when placed at -80°C. Cells were ready to 
be placed in liquid nitrogen after at least 3 hours at -80°C.  
Thawing cells compared to freezing needs to occur quickly to stop ice crystals from 
damaging the cells. Cells were transferred from liquid nitrogen straight to 37°C in a water 
bath. They were then resuspended in 5 volumes of DMEM-F12 and centrifuged at 
1150rpm for 3 minutes in order to dilute and remove DMSO. Cells were resuspended in 
TeSR™-E8™ medium and seeded into a well of a 6-well plate. 
 
2.2.3. Neuronal differentiation 
To begin with neuronal differentiation, cells reaching 70-80% confluence were replated 
into an appropriate number of wells coated with reduced growth factor Matrigel 
(Corning). Cells were let to grow in stem cell media for up to two days until they reached 
80% confluence. Then cells were treated accordingly depending on the protocol. 
A basal neuronal medium was prepared as follow, 100 ml of DMEM-F12 + 1ml of B27 
supplement 50X w/o Vitamin A (Life technologies) with 50 ml of Neurobasal (Life 
technologies) + 1 ml of N2 supplement 100X (Life technologies), the total volume was 
supplemented with 2mM of L-glutamine (Life technologies) and 1:500 MycoZap™ Plus-
CL (Lonza) and 0.1mM of β-mercaptoethanol (Gibco). 
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2.2.3.1. Cortical projection neurons  
To start cortical excitatory neuron differentiation, TeSR™-E8™ media was removed and 
cells were washed with DPBS. Media was replaced with the basal neuronal media 
supplemented with 10μM SB431542 (Tocris) and 100nM LDN (STEMCELL), a 
modified dual-smad inhibition protocol (Arber et al. 2015; Chambers et al. 2009) to 
promote neuroinduction. Every other day, half of the media was changed. Between days 
9 and 10, cells were passaged onto fibronectin coated plates (15μg/ml, Millipore). In brief, 
manual dissociation of the cells was performed using 0.02% EDTA in a similar way to 
that used for stem cells (see Section 2.2.1). Cells were collected and gently homogenised 
in neuronal media supplemented with 10uM ROCK inhibitor (Tocris) to promote cell 
survival. Cells were then replated at a 2:3 ratio and half of the media was replaced every 
other day. At day 12, LDN and SB were removed from the basal neuronal media and 
media was changed every other day. About 10 days after the first passage, cells were 
incubated in StemPro Accutase Cell Dissociation Reagent (Thermo Fisher Scientific) for 
up to 10 minutes, collected and triturate with a P1000 (Eppendorf) in order to obtain a 
quasi-single cell solution. Cells were replated onto wells coated with a solution of poly-
D-lysine (Sigma) at 0.01mg/ml and laminin (Sigma) at 10μg/ml at a density of 75000 
cells/cm2 and 125000 cells/cm2 for calcium imaging/immunofluorescence and RNA 
extraction, respectively. At day 20, B27 w/o Vitamin A in the basal neuronal medium 
was replaced with B27 with Vitamin A and cells were every few days as needed by 
changing half of the media.  
2.2.3.2. Cortical interneurons 
For cortical interneuron differentiation, neuronal conversion was performed using basal 
neuronal media supplemented with 10μM SB431542, 100nM LDN, and 2μMXAV939 
(Tocris) until day 9. From day 10 to day 18, 200ng/ml of Sonic Hedgehog (SHH, R&D) 
and 1μM purmorphamine (STEMCELLS) were added to the basal neuronal media. 
During the second passage, cells were split at a ratio of 1:5. From day 20, the media was 
supplemented with 10ng/ml of BDNF (PeproTech) and 10ng/ml of GDNF (PeproTech). 
2.2.3.3. MSNs (Dr Marija Fjodorova) 
For MSN differentiation, the neuronal conversion was performed in the same way as for 
cortical projection neurons. SB and LDN were stopped and basal neuronal media was 
supplemented with 25ng/ml of Activin A from day 10 onwards. During the second 
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passage, cells were split at a ratio of 1:1 and BDNF and GDNF were added at the same 
concentration as in cortical interneuron differentiation. 
2.2.3.4. Dopaminergic neurons (Dr Marija Fjodorova) 
Finally, for dopaminergic neuron differentiation, neuronal conversion was performed 
with 10μM SB431542 and 100nM LDN from day 0. From day 3 to 7, neuronal conversion 
media was supplemented with 1μM PD0325901 (Sigma). At day 7, LDN, SB, and PD 
were removed and 200ng/ml of SHH and 1μM purmorphamine were added to the basal 
neuronal media until day 16. During the first passage at day 9, 100ng/ml of FGF8 was 
also added to the neuronal media until day 16. Following the second passage at day 20, 
BDNF and GDNF were added to the basal neuronal media at the same concentration as 
in the cortical interneuron differentiation. 
 
2.2.4. Human primary astrocyte culture 
Human primary fibroblasts (Lonza) were plated onto 75ml flask without coating. Primary 
medium was prepared with 50ml of neurobasal supplemented with 10% FCS, 1ml of B-
27, 1:500 Mycozap, and 2mM L-glutamine.  
Astrocytes were passaged once confluent at a ratio of 1:3. Cells were incubated in Trypsin 
for 5 to 10 minutes followed by the inactivation of the enzyme with a double volume of 
media. Cells were gently triturated and dispensed accordingly. 
 
2.3. Gene expression analysis 
2.3.1. RNA isolation and RT-PCR from cell culture 
Total RNA was isolated from cultured cells according to the protocol supplied with 
TRIzol reagent (Invitrogen, Life Technologies, Carlsbad, CA).  
Concentration and purity of RNA samples were determined using a spectrophotometer 
(Eppendorf) which scans in the ultraviolet (UV). The absorbance ratio 260/280 was 
measured, a value above 2.0 was considered as pure. 
To prevent DNA contamination, RNA samples were treated with DNase, PerfeCTa 
DNase I (Quanta bioscience). The reaction was designed as follow: 
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RNA template 1µg 
10X reaction buffer 1µl 
PerfeCta® DNase I (2U/ul) 1µl 
RNase/DNase free water variable 
Total Volume (µl) 10µl 
 
Reagents were combined in 0.2ml tubes sitting on ice. Each reaction was gently vortexed 
followed by a centrifugation to collect the solution at the bottom of the reaction tube. 
Samples were incubated at 37°C for 30minutes, then 1µl of 10X Stop buffer was added 
to each sample. Reactions were gently mixed and then centrifuged to collect samples at 
the bottom of the tube. Samples were incubated 10 minutes at 65°C. The entire reaction 
volume was then used as a template for the first-strand cDNA synthesis. 
Total RNA was reverse transcribed with the qScript cDNA superMix (Quanta 
Bioscience). The reaction was performed as follow: 
 
qScript cDNA Supermix 4µl 
RNA template 2µl 
RNase/DNase free water 14µl 
Total Volume (µl) 20 
 
Reagents were added to 0.2ml tubes sitting on ice. The reactions were vortexed and 
subsequently centrifuged in order to collect the solution at the bottom of the tube. Tubes 
were placed in a thermocycler, which was set up as follow:  
 
5 minutes 25°C 
30 minutes 42°C 
5 minutes 85°C 
Hold 4°C  
 
Samples were then kept at -20°C until processed for RT-PCR. 
 
2.3.2. Pre-amplification 
Prior to gene expression analysis, cDNA samples from the reverse transcription were pre-
amplified in order to obtain optimal cDNA concentrations for gene expression.  
In a 0.2ml tube, 1µl of each 100µM stock primer was added. Final volume was adjusted 
to 200 µl with the DNA Suspension Buffer (10 mM Tris, pH 8.0, 0.1 mM EDTA; 
TEKnova, PN T0221), a full list of primers is presented in Table 2-1. When possible, 
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primers were designed to have a PCR product not exceeding 200bp. To prepare the 
reaction solution, reagents were added to a 1.5ml Eppendorf tube together with the mix 
of primers as presented below.  
 
Component Vol per reaction (µl) 
Vol for 96 Reactions 
w/Overage (µl) 
Preamp Master Mix 
(Fluidigm PN 100-5580) 1 105.6 
Pooled Primers (500nM) 0.5 52.8 
DNase free water 2.25 237.6 
cDNA 1.25  
TOTAL Volume 5 - 
 
A 96-well plate was filled in by dispersing 3.75µl of the premix. Then 1.25µl of cDNA 
was added into individual wells. Samples were vortexed and centrifuged at 1000g for a 
minute. The pre-amplification reactions were loaded into a thermocycler using 
parameters presented below: 
 
Cycles Temperature Time 
Hold 95°C 2 min 
10 
95°C 15 secs 
60°C 4 min 
Hold 4°C ∞ 
 
Following this, samples required incubation with exonuclease I (New England Biolabs 
PN M0293S) to remove unincorporated primers. In total, 2µl of diluted Exonuclease I at 
(4U/ µl) were added to each reaction and incubated at 37°C for 30 minutes followed by 
15 minutes at 80°C. The final product was diluted 1:5 in TE buffer. 
 
Table 2-1 List of primers 
     
GAPDH F: acgaccccttcattgacctcaact R: atatttctcgtggttcacacccat B-ACTIN 
F: tcaccaccacggccgagcg 
R: tctccttctgcatcctgtcg 
MASH1 F: gtcctgtcgcccaccatctc R: ccctcccaacgccactgac NESTIN 
F: agcaggagaaacagggcctac 
R: ctctggggtcctagggaattg 
NGN2 F: tcaagaagacccgtagactgaagg 
R: gtgagtgcccagatgtagttg 
OTX2 F: tgccaaaaagaagacatctcca 
R: aagctgggctccagatagacac 
Pre-Mix 
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TUJ1 F: acctcaaccacctggtatcg R: tgctgttcttgctctggatg EMX1 
F: accggaggacaaagtacaaac 
R: tagtcattggaggtgacatcg 
FOXG1 F: tggcccatgtcgcccttcct R: gccgacgtggtgccgttgta EMX2 
F: gcttctaaggctggaacacg 
R: ccagcttctgccttttgaac 
LDB1 F: cgatgtgaagatgtcagtgggctg 
R: atccctatccagcatggtgcc 
GSX2 F: tcactagcacgcaactcctg 
R: ttttcacctgcttctccgac 
NKX2.1 F: tgtgcccagagtgaagtttg R: tgtgcccagagtgaagtttg NKX2.2 
F: tgcctctccttctgaaccttgg 
R: gcgaaatctgccaccagttg 
NKX6.1 F: acacgagacccactttttccg R: tgctggacttgtgcttcttcaa PAX6 
F: aataacctgcctatgcaaccc 
R: aacttgaactggaactgacacac 
CALRET F: ccttacctgcacctggccga R: ccagagcctttccttgccttc FOXP2 
F: aatgtgggagccatacgaag 
R: gcctgccttatgagagttgc 
REELIN F: atgtggaggtcgtcctagtaagc 
R: ggaaagtggtgtacactcgg 
SATB2 F: caacgcaactaataatcatctccc 
R: gagaaagggctgagaacccg 
EOMES F: caccgccaccaaactgagat R: cgaacacattgtagtgggcag TBR1 
F: agcagcaagatcaaaagtgagc 
R: atccacagaccccctcactag 
VGLUT1 F: gaaactcatgaaccccctca R: gggagatgagcagcaggtag VGLUT2 
F: attccatcagcagccagagt 
R: ttgctccatatcccatgaca 
BRN4 F: taactagtaggggatcctcaccg 
R: tggaactgagaatgctgtagg 
CTIP2 F: ctccgagctcaggaaagtgtc 
R: ctccgagctcaggaaagtgtc 
EBF1 F: aatgtaagcaaggtggacgc R: tcaaggtctaagccggacac HELIOS 
F: acctcaggacccattctgtg 
R: gcaggtctctcaaaaggcac 
ISL1 F: aagcgcaggaagagagactg R: ccaagagacccaggatttca NOLZ1 
F: acattttgcaccccgagtac 
R: ggagtacggcttgaaactcg 
ARPP21 F: ggaagctggttgacgatgtgtc 
R: ggcttctgtcgttctacgcc 
CALB F: atcaggacggcaatggatac 
R: taagagcaagatccgttcgg 
DARPP32 F: ggtatttttatccgtgcgcgaac R: cttcctcctctggtgaggagtg CHRM4 
F: acgaacgatctttgccattc 
R: tgttgacgtagcagagccag 
DRD1 F: ttgtcatctccttggctgtg R: aggccacccagatgttacag PENK 
F: gctgtccaaaccagagcttc 
R: tctggctccatgggataaag 
CRABP1 F: acttatcctgacgtttggcg R: tattggtaggggaaaagggc LHX6 
F: acagatctacgccagcgact 
R: catggtgtcgtagtggatgc 
LHX8 F: ggaaacgcttcccctatttc 
R: tgcgaccaagagtctgtacg 
NPY F: cgctgcgacactacatcaac 
R: cagggtcttcaagccgagtt 
ZCCHC12 F: aattctgtgcagctgattgc R: caggggacgaactctgaaac DGCR6 
F: ggagttgcccagctcattcc 
R: cgatgctcgttctgtaggc 
PRODH F: ctcacagcactggggagac R: ttggtgaaagaagcacctcca DGCR2 
F: ccaacagtaccgcaaggac 
R: ggccatggagtcaaacagac 
DGCR14 F: tatatcgagggcctccagacg 
R: gcatccgttccaagtctcca 
TSSK2 F: ggtaaggcagtgctgtggaa 
R: gctgtgtccttggtgtggta 
GSC2 F: tgcagaaccagtatcctgacg R: ttcttgaaccagacctccacg SLC25A1 
F: cgcacaaataccggaacacg 
R: gtgcccttgtagaatgccttg 
CLTCL1 F: ttcttcagcaggggcgtaag R: ttgcccgaaggtacacactc MRPL40 
F: gactagcgggcttctgggaa 
R: agacaacaatgacgctcgct 
HIRA F: cagtagtgggtctgcggaag 
R: tgtcgagctgttcctgacac 
C22ORF39 F: caccactactacgtccacgg 
R: tctcacagagggattgctgg 
UFD1L F: aaaggttgaagaggatgaagctg R: ccctgtcagtgccagtaactaa CDC45 
F: tgggccatcgttggactaa 
R: caggacaccaacatcagtcac 
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CLDN5 F: tctgctggttcgccaaca R: agctcgtacttctgcgacac SEPT5 
F: aggacttcaagcagcaggac 
R: caccgtgttgctgcctataac 
GP1BB F: accacgtgggacagaactc R: tttggaagggagacgcagca TBX1 
F: tcgacaagctcaagctgac 
R: gctggtatctgtgcatggaa 
GNB1L F: gattcgcgtagcctcaggtaa 
R: gtgcctcggaggacaaactg 
C22ORF29 F: ttcgcgtagcctcagattgc 
R: gacagggatggctgaacagg 
TXNRD2 F: gccatagcaccttgcatctc R: cagggaaggcgaggatgatt ARVCF 
F: ggagtggttccaccaaggaaagaa 
R: ggtgttgaagttccggctctc 
COMT F: gtcttcctcgaccactggaa R: agtagcactgtccccttcc C22ORF25 
F: aacgcgtacaggctcatctt 
R: gctgcaggtagttggtgagt 
DGCR8 F: ctgggctgttgtctccatatca R: ttgatagacgtgtcacccatcc TRMT2A 
F: catccccgaagccaccaa 
R: tctgggtcgtatgccgagta 
RANBP1 F: gaccctcagtttgagccaata 
R: ctcagaggcaaatcggaaca 
ZDHHC8 F: acgtggatgtgcgaggtatc 
R: agtggtggtcaaagtcctct 
ZDHHC8-F F: catggaccctggtgttttcc R: cgcacatccacgttcttgta ZDHHC8-I 
F: cagcgtctgtgacaactgtgta 
R: cgatgcagttgttgaccca 
RTN4R F: gcccaacccctacgatgaa R: accttgggctcattgtagca SHANK1 
F: ggctcctacgacagctttga 
R: gtaatcgctccctgggccaat 
NANOG F: gcttgccttgctttgaagca 
R: ttcttgactgggaccttgtc 
OCT4 F: cgaccatctgccgctttgag 
R: ccccctgtcccccattccta 
GLUN1 F: acaagagcatccacctgagc R: ttctctgccttggactcacg GLUN2A 
F: cccaagagcctcatcacgca 
R: agacgtcggatccttgtcagc 
GLUN2B F: tctgaccggaagatccaggg R: tccatgatgttgagcattacgg GAD1 
F: cgtcttcgaccccatcttcgt 
R: cgcagatcttgagccccagtt 
CUX1 F: cttgaaagggcaaaccagag 
R: acctctatggcctgctccac 
PALM F: ctgcagcacctgaagtcca 
R: cgctccagcacctcaatttc 
GLI1 F: tgaggcccttcaaagccc R: gtatgacttccggcacccttc PV 
F: aaagagtgcggatgatgtgaag 
R: accccaattttgccgtccc 
TH F: tgtgaaggtgtttgagacgtttg R: tcgaggcgcacgaagtact SST 
F: gctgctgtctgaacccaac 
R: cgttctcggggtgccatag 
PSD95 F: cacaacctcttattcccagcac R: catggctgtggggtagtcg   
 
2.3.3. Gene expression using Biomark HD 
In a 0.2ml tube, the SsoFastTM EvaGreen® and 20X DNA binding dye (sample pre-mix) 
were combined with each sample as specified in the table below. In brief, the master mix 
of the sample pre-mix was vortexed and centrifuged at 1000x for 10 seconds. A total of 
3.3μl of pre-mix was added into individual tubes together with 2.7μl of the final product 
of pre-amplification. To assure correct homogenisation, samples were mixed then 
centrifuged at 1000g for at least 30 seconds. 
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Component Volume per inlet 
with overage (μl) 
Vol for 96.96 IFC 
overage 
2X SsoFast EvaGreen 
supermix with low ROX 3 360 
20X DNA binding Dye 0.3 36 
Pre-amplified cDNA 2.7  
TOTAL 6 - 
 
In a 0.2ml tubes, the forward and reverse primers at 100μM were combined and mixed as 
follows: 
 
Component Vol per inlet 
with overage (μl) 
Vol for 50 μl 
Stock (μl) 
2X Assay Loading Reagent (PN 100-
761) 3.0 25 
1X DNA TE Buffer 2.7 22.5 
100μM combined primers 0.3 2.5 
TOTAL 6.0 50 
 
Gene expression was carried out using the 96.96 IFC (BMK-M-96.96). Each IFC contains 
two accumulators that need to be filled in with a viscous fluid provided in a syringe. They 
were then placed into the Controller HX (Fluidigm) and the program Prime (136x) was 
run. Samples and primers were then loaded into their respective inlets on the IFC. Once 
performed, the IFC was placed back into the Controller HX and the program load mix 
(136x) was run. Then the IFC was inserted into the Biomark HD and was run using the 
program GE 96x96 PCR+Melt v2. 
Data were collected with the software Biomark HD Data Collection (Fluidigm) and then 
processed with the Real time PCR Analysis software (Fluidigm). Once the software 
opened, gene expression data were loaded and a test report was generated. This test 
summarized the name of the chip, it also mentioned the program used for the real-time 
PCR and finally a screenshot of a heatmap with Ct values was generated. Each sample 
and primer were then manually annotated according to their position within the IFC. The 
quality threshold was set up as recommended by the company at 0.65. Although value 
below 0.65 are considered to have failed they were individually checked to determine 
whether or not the sample failed. Data were exported into an excel file in order to be 
analysed.  
Sample 
Pre-Mix 
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All qPCR data presented in this thesis are the result of one experiment with n = 3 or 2 
biological replicates for cortical interneurons, glutamatergic neurons and medium spiny 
neurons, dopaminergic neurons respectively. Data were normalised to the reference gene 
β-ACTIN – and relative mRNA expression was compared to control basal conditions 
using the 2-ΔΔ-CT method.  
 
2.4. Genome Editing 
2.4.1. DNA extraction 
DNA was extracted from cultured cells with a solution of lysis buffer containing; 10nM 
Tris, pH8.0; 50mM EDTA; 100mM NaCl; 0.5% SDS. A solution of proteinase K at 
20mg/ml stock was diluted 1:100 in lysis buffer. Once the culture media was removed, 
cells were washed with DPBS. A volume of 500μl of lysis buffer was added into the well 
and left to incubate overnight at 37°C. The next day, the solution was retrieved into a 
1.5ml tube together with an equal volume of 100% isopropanol. The solution was briefly 
vortexed and centrifuged at 12,000g for 20 minutes at 4°C. The supernatant was aspirated 
and the white pellet was resuspended in a solution of 70% ethanol. Again, the supernatant 
was removed after centrifugation, the pellet was air dried for 10 minutes and dissolved in 
50μl of ddH2O (double distilled water). 
 
2.4.2. Estimating nucleic acid concentration 
DNA concentration was estimated with the spectrophotometer using the appropriate 
program. The optical density was taken at 260nm, the ratio 260/280 was used to estimate 
the purity of the sample. A ratio between 1.8 and 2.0 was being considered as pure. 
 
2.4.3. Detection of nucleic acids 
The polymerase chain reaction (PCR) reaction was used in order to amplify specific DNA 
fragment. Primers were designed to match specific DNA sequence. Using a Taq 
polymerase I, the DNA fragment between a pair of primers was amplified. 
PCR reaction was performed in a PCR reaction tube using the MyTaq™ DNA polymerase 
(BIO-21107) as described below: 
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PCR reaction set-up  
5x MyTaq Reaction Buffer 10μl 
Template 200ng 
Primers 20μM each 1μl 
MyTaq DNA polymerase 1μl 
ddH2O Up to 50μl 
 
Samples were then transferred into a thermocycler and processed according to the 
following protocol: 
 
PCR cycling 
conditions    
Step Temperature Time Cycles 
Initial denaturation 95°C 1min 1 
Denaturation 95°C 15s 
5 Annealing 60°C ramp down 
-1°C/cycle 
15s 
Extension 72°C 10s 
Denaturation 95°C 15s 
25 
Annealing 55°C 15s 
Extension 72°C 10minutes - 
Hold 4°C ∞ - 
 
2.4.4. Agarose gel electrophoresis 
Visualization of PCR fragments was performed using agarose gel electrophoresis. A 
range between 1 to 5μg of agarose (UltraPURE, Gibco) was dissolved in 1x TAE buffer. 
Once melted, Safeview (G108, ABM) 1/10000 was added to allow the visualization of 
nucleic acids when excited at 470nm. Electrophoresis was performed in 1x TAE solution 
with a voltage ranging from 60 to 100 volts until desired separation of different amplicons 
was achieved, usually 1h. DNA was visualized using a transilluminator and pictures were 
acquired for further analysis. 
 
2.4.5. Cloning  
2.4.5.1. Oligo annealing 
Different gRNAs were designed using the CRISPR MIT website from the Zhang lab. A 
list with the resulting gRNAs is presented below. The first two gRNA and two last were 
targeting the exon 3 and 4 respectively of the ZDHHC8. 
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gRNAs sequence (3’5’) PAM sequence 
CGTTCTTGTACAGCGGAGCC CGG 
CGGGCGGTAGAAGTGGCACG TGG 
CCCGATGCAGTTGTTGACCC AGG 
CGTGGTTCAGCACGTAGACC AGG 
 
Below is presented the DNA sequence which were targeted by our different gRNA 
together with the primers used to check for INDELs and the set of primer to evaluate the 
mRNA level of ZDHHC8. The intronic and exonic sequence were respectively 
represented in lower case and upper case/bold. Both sequence highlighted in grey 
represent the pair of primers used to check for INDELs located in intron 2 and 4. The 
sequence highlighted in green are representing the different gRNAs with their PAM 
sequence in red. Finally, the sequence in yellow represents the primers used to assess the 
mRNA level of ZDHHC8. It was noteworthy that the third gRNA and the reverse primer 
were partly sharing the same sequence. 
 
 
 
The complementary sequence of each gRNAs was synthetized together with the specific 
overhangs corresponding to the BbsI restriction enzyme thus allowing their cloning 
within the host plasmid. The nucleotides sequence is presented in the table below with in 
red the overhangs. In addition, two guanine bases were added, in green. The first guanine 
was necessary for the U6 promoter, while the second guanine was demonstrated to reduce 
the off-target effect.  
 
Target 
Exon 
Forward 5’ 3’ Reverse 5’ 3’ 
Exon 3 CACCGGCGGGCGGTAGAAGTGGCACG AAACCGTGCCACTTCTACCGCCCGCC 
Exon 3 CACCGGCGTTCTTGTACAGCGGAGCC AAACGGCTCCGCTGTACAAGAACGCC 
Exon 4 CACCGGCCCGATGCAGTTGTTGACCC AAACGGGTCAACAACTGCATCGGGCC 
Exon 4 CACCGGCGTGGTTCAGCACGTAGACC AAACGGTCTACGTGCTGAACCACGCC 
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Each pair of oligos were annealed to form a dimer. In a 0.2ml tube, 1μl of each oligo at 
100μM, 1μl of 10X T4 Ligation Buffer (NEB), 6.5μl of ddH2O and 0.5μl of T4 PNK 
(NEB) were added and incubated in a thermocycler with the protocol presented below. 
 
Temperature Time 
37°C 30 min 
95°C 5min 
95°C ramp down to 25°C at 5°C/min - 
 
2.4.5.2. Multiplex CRISPR/Cas9 Construction 
Two steps were necessary for the construction of the all-in-one multiplex CRISPR/Cas9. 
The CRISPR kit used to generate the multiplex CRISPR/Cas9 vectors(Sakuma et al. 
2014) was a gift from Takashi Yamamoto (Addgene kit # 1000000054). The first step 
involved the cloning of the annealed oligos into four different plasmids, one pX330 
Ampicillin (pX330A 1-4) resistant plasmid and three pX330 (pX330S 2, 3 and 4) resistant 
to spectinomycin.  
Ligation of the oligonucleotides was performed in a 0.2ml PCR tubes. In four tubes, we 
premixed 0.2µl of 10X T4 DNA ligase buffer (NEB), 0.1µl of BbsI (NEB), 0.8µl of Quick 
ligase (NEB) and 0.8µl of ddH20. Then 0.3µl of the circular plasmid at 25ng/µl together 
with 0.5µl of 10µM of annealed oligonucleotides were added into their respective tubes. 
The tubes were added to a thermocycler and 3 cycles at 37°C for 5minutes and 16°C for 
10 minutes were performed and followed by an additional BbsI digestion at 37°C for an 
hour and inactivation at 80°C for 5 minutes.  
Digestion by BbsI results to the appearance of sticky ends allowing the integration of our 
different gRNAs therefore our gRNAs were generated with the specific overhang 
sequence allowing their specific integration into the host plasmid A schematic of this 
process is presented below with the example of the first gRNA. The gRNA sequence with 
the specific overhangs is presented at the top. The bottom sequence corresponds to the 
region where the BbsI enzyme is cutting with the letter in red corresponding to the sticky 
end sequence. Once BbsI is cutting, the fragment will be removed therefore allowing the 
integration of our donor sequence. Interestingly, due to the specificity sequence of the 
overhangs, there is a unique orientation in which the donor plasmids can be ligated. 
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It was noteworthy that once integrated, the BbsI recognition site isn’t present anymore 
therefore preventing it to be cut again by the enzyme. As a result, the last step of the 
protocol which consisted of the additional digestion was used to linearize all remaining 
plasmids that did not contain the donor plasmid. As only circular plasmid can be 
introduced into bacterial cells it increased the likelihood of obtaining a positive clone. 
 
 
Figure 2-1 Cloning map of the gRNA into the recipient plasmid. The gRNA sequence on top in black, 
contain the sequence of the overhangs corresponding to the BbsI restriction enzyme. Once the BbsI enzyme 
cut the plasmid, we can observe that the gRNA is able to be ligated within the plasmid. Furthermore, it was 
noteworthy that the BbsI sequence disappeared once ligated into the recipient plasmid. 
 
The second step of the multiplex CRISPR/Cas9 consisted of golden gate reaction which 
was responsible of cutting the fragment of interest and inserting them into one recipient 
plasmid using the BsaI enzyme. Once cutting, the enzyme induces specific overhangs 
sequence which are different for each plasmid (Figure 2-2). Therefore, it ensures the 
specificity of insertion. The golden gate reaction was performed as follow, in one tube, a 
solution was prepared with 100ng/µl of each spectinomycin plasmid, 50ng/µl of the 
ampicillin plasmid together with 2µl of 10X T4 DNA ligase buffer, 1µl of BsaI enzyme 
and 1µl of quick ligase. The reaction was then run using a thermocycler with the following 
parameters. 
 
Cycle Temperature Time 
25 37℃ 5 16℃ 10 
Hold 4℃ ∞ 
 
Figure 2-2 below allows the visualisation of the cloning process during the step 2. 
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2.4.5.3. Bacterial Transformation 
Bacterial transformation which corresponds to the insertion of exogenous genetic material 
into bacterial cells was performed as follows: 1μl of each reaction were transferred to a 
corresponding vial of competent cells 5-alpha F'Iq Competent E. coli (C2292H, NEB) 
and carefully flicked to mix the bacteria with DNA. The vials were placed on ice for 30 
minutes. A water bath was set up at 42°C and vials were heat shocked for exactly 30 
seconds and placed on ice for 5 minutes. A volume of 950μl of SOC media provided by 
the manufacturer was added to each vial. They were further incubated for 1 hour at 37°C 
under constant agitation at 200 rotations per minutes (rpm). In the meantime, the agarose 
plates were warmed at 37°C to avoid condensation. Prior dispersion onto the agar plate, 
the vials were flicked thoroughly as well as inverted. Two different volumes, usually 50 
and 75μl, were spread onto the plates and incubated overnight at 37°C. 
Bacterial colonies were manually picked and transferred to a bacterial tube with 3ml of 
LB media and incubated overnight on the shaker at 37°C and 200rpm.  
 
Figure 2-2 Second step of the generation of the all-in-one multiplex CRISPR/Cas9.The reaction 
involves the cutting of each plasmid by BsaI which generate the specific overhangs sequence allowing 
their ligation within the plasmid containing the gRNA 1. Digestion by BsaI generates fragment of 445bp 
which contained the U6 promoter, the gRNA as well as the gRNA scaffold. 
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2.4.5.4. Genomic DNA extraction 
2.4.5.4.1. Miniprep 
From the previous step, 1.5ml of the bacterial solution was transferred into a 2ml 
Eppendorf tube and centrifuged at 12000g for a minute. The supernatant was removed 
and replaced by 200µl of solution A (25mM Tris HCl, pH8, 10mM EDTA) which was 
previously prepared by adding 3µl of RNAse A per ml. In addition, 200µl of lysis buffer 
(200mM NaOH, 1% SDS) was incubated for no longer than 5 minutes. To neutralise the 
lysis buffer, 240µl of solution K (5M potassium acetate, pH5.5) was added and mixed 
gently by inverting 5-6 times. The bacterial solution was further incubated at room 
temperature for 3 minutes. The bacterial solution was centrifuged at 12000g for 2 minutes 
allowing the protein and debris to pellet. The supernatant was carefully collected into a 
1.5ml Eppendorf tube and 400µl of 100% isopropanol were added to the tubes which 
were subsequently vortexed in order to precipitate the DNA and left to incubate for a 
minute at room temperature. The DNA was pelleted by centrifugation at 14000g for a 
minute. Supernatant was immediately removed and replaced by 1ml of 70% ethanol and 
vortexed to clean the DNA pellet. Tubes were centrifuged at 14000g for a minute, the 
supernatant was removed and centrifuged a second time to remove the remaining ethanol. 
Tubes were air dried for 10minutes. Finally, 50µl of ddH2O was added to resuspend the 
DNA.  
2.4.5.4.2. Maxiprep 
In order to perform a Maxiprep, 150ml of bacterial solution was incubated overnight at 
37°C under continuous agitation. DNA extraction was performed using the HiSpeed 
Plasmids Kit (Qiagen, 12662) following the instructions provided by the manufacturer.  
2.4.5.4.3. Plasmid Digestion 
Plasmid digestion was performed using the appropriate enzymes and buffers which was 
suggested by the manufacturer. The usual protocol is described below and particular 
restriction enzymes are stated in relevant results chapters. 
 
NEB digestion Reaction Volume (µl) 
Buffer 10X 5µl 
DNA template 1µg 
Restriction enzyme 0.5µl 
ddH2O Up to 50µl 
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The solution was mixed and centrifuged to collect the solution at the bottom of the tube. 
Tubes were run using a thermocycler for 1h at 37°C. The digestion product was loaded 
to a 1% agarose gel and run for 1h at 80V.  
2.4.5.4.4. Nucleofection 
In order to integrate the all in one CRISPR/Cas9 complex, electroporation was performed 
using the Amaxa NucleoFector™ system (Lonza). This system was designed for the 
transfection of primary cells. It consists of the application of an electric pulse generating 
momentary pores in cell membrane thereby allowing the integration of an exogenous 
plasmid. 
Prior to nucleofection, cells were harvested onto another well in order for them to be in 
their exponential growth phase. This step increases the number of cells surviving the 
nucleofection process.  
An aliquot with 3.5µg of a neomycin resistant plasmid was mixed with 1.5µg of the 
multiplex CRISPR/Cas9 complex. A volume of 68µl of the P3 Primary cell 4D- 
nucleofector® X solution was mixed with 12µl of supplement. This solution was mixed 
with the plasmids and left in the incubator at 37°C. 
Cells were harvested as described above (chapter 2.2.1). The cell suspension was 
centrifuged at 1150rpm for 3 minutes. The supernatant was discarded while the pellet was 
resuspended with the pre-warmed nucleofection solution and passed through a cells 
scrapper to obtain a quasi-single cell solution. The solution was added to the 
Nucleocuvette® and quickly processed in the Nucleofector using the CB-150 program. 
Cell suspension was divided into 6 wells of a 6-well plate in E8 medium supplemented 
with 1/100 of RevitaCell (Life technologies). 
2.4.5.4.5. pGEM-T easy and sequencing 
PCR product from the screening of positive clones were cleaned using the PCR 
Purification Kit (QIAquick, Qiagen) following the manufacturer protocol. Clean PCR 
products were ligated into the pGEM®-T Easy vector (Promega). This plasmid contains 
a 3’-T overhangs at the insertion site which greatly improves the ligation efficiency. Due 
to the presence of a restriction site and the RNA promoter T7 and SP6 it can respectively 
be digested or amplified. Figure 2-3 represents a map of the vector with all the different 
enzymes that can be used to screen for insert or for sequencing. 
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The pGEM-T-easy vector was used firstly to visualize single allele amplicon secondly to 
send those selected plasmids for sequencing. 
Several plasmids for each clone were sent for sequencing. The T7 promoter was used to 
amplify the different ligated PCR products. 
 
 
2.5. Immunocytochemical staining 
Cells in culture were washed once with PBS and subsequently fixed in a solution of 3.7% 
PFA for up to 15 minutes at room temperature. After two washes in PBS, fixed cells were 
incubated in PBS-NH4Cl to quench the remaining aldehyde residues for 20 minutes. Cells 
were stored for up to three weeks at 4°C or stained immediately after the quench. For 
nuclear stains, cells further underwent 5 minutes of ascending and descending methanol 
washes in PBS (33%, 50%, 66% at 4°C, then at -20°C in 100% methanol). Fixed cells 
were permeabilized in a solution of PBS-T (PBS + 0.3% Triton-X100, Sigma) for 4 
minutes at room temperature. The cells were incubated overnight at 4°C in PBS with 5% 
donkey serum (Gentaur) in which the primary antibodies were added. The following day, 
the cells were washed three times for 10 minutes. Secondary antibodies raised against 
species of the primary antibody were then added to PBS (1/200, Alexa Fluor 488, 594, 
Figure 2-3 Map of the pGEM-T Easy vector. Several enzymes can be used to screen for fragment 
insertion. To determine whether or PCR product were inserted, we digested the plasmid with EcoRI. For 
sequencing, fragments were amplified using the T7 promoter. 
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647, Life technologies) and incubated for 40 minutes at room temperature under constant 
agitation. Cells were counterstained with DAPI (1/3000, Life technologies) in PBS for 5 
minutes at room temperature followed by three 10-minute PBS washes. Either the stained 
cells were covered in the culture plate with a coverslip or coverslips were transferred onto 
a glass slide (VWR) and mount respectively with a 20µl drop of DAKO (Life 
technologies). A list of primary and secondary antibodies is presented in Table 2-2.  
 
Table 2-2 List of primary antibodies used for immunostaining 
Antigen Species Supplier Code Dilution 
CTIP2 rat Abcam ab18465 1/500 
FOXA2 goat Santa cruz Sc6554 1/200 
FOXG1 rabbit Abcam  1/250 
KI67 mouse BD bioscience 550609 1/200 
LMX1A Guinea Pig Custom made  1/1000 
MAP2 rabbit Millipore AB5622 1/1000 
N-CADHERIN mouse Invitrogen 18-0224 1/1000 
NKX2.1 rabbit Abcam Ab40880 1/1000 
OCT4 goat Santa cruz Sc8628 1/500 
PAX6 mouse DSHB  1/1000 
PSD-95 mouse Neuromab  1/50 
SSEA3 rat Chemicon MAB4303 1/500 
TRA1-81 mouse Chemicon MAB4381 1/500 
 
Cells were imaged on a Leica DMI6000 inverted fluorescence microscope. A stack of 
images was acquired to obtain information from all planes. For quantification, we used a 
10x objective while for synaptic proteins a 100x oil immersion objective was used. 
Images were post processed in ICY (open source software for bioimage informatics). One 
slice from each stack was extracted for each channel then processed using histogram 
equalization, a plugin in ICY which allow to obtain an equal histogram. This step is 
crucial for the subsequent quantification performed in CellProfiler (Cell image analysis 
software). To count the nuclear staining, CellProfiler was setup on DAPI then the marker 
of interest. 
 
2.6. Motility Assay 
Motility assay was performed on neurons plated on glass coverslip. The experiment was 
performed at day 20 with excitatory progenitor cells. The coverslip was transferred into 
59 
 
a recording chamber filled with neuronal media. The chamber was temperature, CO2 and 
humidity controlled (Ibidi). The recording chamber was placed under a ZEISS Axio 
Observer Z1 microscope with a 10x objective. Five to eight random fields of view were 
selected on the same coverslip. Pictures were acquired every 5 minutes for 12 hours. The 
recording chamber was setup at 37°C, with 90% humidity and 5% CO2.  
The images were analysed using a manual tracking plugin in Fiji. Data were then 
transferred to excel and analysed. 
 
2.7. Calcium Imaging 
In order to accelerate neuronal maturation of our cortical excitatory projection neurons, 
at day 20 - 26 of differentiation, basal neuronal media was supplemented with β-secretase 
inhibitors, 10μM DAPT (Sigma) and 2μM PD0332991 (Selleckchem) to synchronise cell 
cycles and push progenitors to a post-mitotic stage to mature. After this treatment, half of 
media was replaced with a mix (at 1:1 ratio) of the basal neuronal media and astrocyte-
conditioned medium (ACM). At the same time, neurons were transferred to an incubator 
monitored at 2% oxygen. Until the end of the differentiation, the media was replaced once 
a week. 
Neurons were loaded with 5µM Fluo-4AM (Life technologies), 0.02% Pluronic F-127 
(20% in DMSO, Life technologies) and 0.01% Cremophor EL (10% in DMSO, Sigma) 
and incubated at 37°C in fresh media for 30 minutes. Neurons were quickly washed twice 
and transferred into a solution of artificial cerebrospinal fluid (aCSF), which contained 
(in mM): 142 NaCl, 5 KCl, 2.5 MgCl2, 1 CaCl2, 30 D-glucose, 10 2-[4-(2-hydroxyethyl) 
piperazin-1-yl] ethanesulfonic acid (HEPES) (Sigma), pH 7.4. Neurons were further 
incubated in the aCSF for 30 minutes at 37°C. Prior to recordings, the aCSF media was 
replaced with a fresh recording solution. 
Calcium activity was acquired using an LED system (Rapp OptoElectronic and 
Lumencor) at 10Hz for 10 minutes with a final resolution of 1024*1024 pixel. From each 
time frame, we extracted random regions of interest of 308*308 pixels. The segmentation 
was performed using NeuroCa, standalone MATLAB package(Janget al. 2015) with the 
following parameters: the type of raw image, TIF; the image size, 308*308; the radius, 2-
7; sensitivity, 0.9 and the frame rate at 10Hz. The segmentation files were retrieved and 
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run in FluoroSNNAP, a MATLAB script for the analysis of calcium activity(Patel et al. 
2015). 
The analysis generates a summary text file with values corresponding to the amplitude 
(ΔF/F0), the inter-spike-interval (ISI), the number of events, the rise and fall time of the 
spikes. All cells exhibiting no events were discarded from the analysis. 
 
2.8. RNA sequencing 
2.8.1. Sample preparation and sequencing 
Heterozygous cell line for ZDHHC8 and its isogenic control (iCas9?) as well as an iPSC 
line (one from each) from a 22q11.2 carriers and a healthy individual were used for this 
experiment. Cells were differentiated into cortical excitatory projection neurons. 
At day 15, RNA samples were extracted by pooling two wells together in order to reduce 
the variability of the samples. In total, we extracted six RNA samples per line using the 
mirVana™ miRNA Isolation Kit following the protocol provided by the manufacturer. 
The concentration and the purity of each sample were determined using the 
spectrophotometer. 
To accurately assess the purity of our RNA samples, they were run on a bioanalyser (CBS 
Cardiff University) which evaluates the integrity of the 28S and 18S ratio using the 
Agilent RNA 6000 Nano Kit (Agilent). RNA samples were quantified again using the 
Qubit RNA High Sensitivity Kit (Life technologies). To extract only the mRNA from the 
total RNA, the KAPA mRNA HyperPrep Kit was used and aimed to capture the poly(A) 
RNA. The protocol was followed according to the manufacturer recommendation and 
using a total of 1µg of RNA.  
Prior to RNA sequencing, the library preparation was quantified using the Qubit DNA 
high sensitivity kit (Life technologies). The clustering and sequencing was carried out as 
per standard Illumina protocols, with 2 times 75bp paired-end reads on HiSeq 4000.  
Except for the neuronal differentiation and RNA extraction, the sample preparation and 
sequencing were performed by Joanne Morgan. 
2.8.2. RNA sequencing analysis 
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Prior to alignment of the reads, data were processed with the Trimmotic software to 
remove the adaptor sequences and also base pairs with a Phred lower than 30 (Bolger et 
al. 2014). FastQC was performed before and after the trimming as a quality control. 
The RNAs-seq reads alignment was performed by Daniel Cabezas De la Fuente in our 
laboratory using a script developed by Dr Robert Andrews and Daniel Cabezas De la 
Fuente. Data were aligned to the reference genome hg38 with the STAR aligner software 
(Dobin et al. 2013). 
The average read depth for present samples is summarised in table 2-3 below 
 
Table 2-3. Read depth of the RNA-seq experiment 
Samples Read depth in millions reads 
Cas9 (Control) 42.82 
541 (ZDHHC8+/-) 47.13 
900 Control  43.32 
E11 (22q11.2) 46.83 
 
After alignment, the RNA-seq data were processed in R using a script developed and 
tested by Daniel Cabezas De la Fuenta and Dr Robert Andrews. The script used the 
DEseq2 package from the Bioconductor(Love et al. 2014). 
 
2.9. Statistical analysis 
For cell counting analysis, the proportion of cells was calculated using different field of 
view from one experiment. Normality of the data was first examined. If data passed 
normality test, we performed a parametric t-test, unpaired t test. Conversely if they did 
not pass normality, we performed a nonparametric t-test, Mann-Whitney test. Statistical 
analysis was performed using Prism Graphpad. 
Similarly, for motility assay and calcium imaging, data were first checked for normality 
and statistical analysis was performed accordingly. 
For gene expression data, a one-way and a two-way ANOVA was conducted to test for 
significant differences in our samples with a post-hoc Bonferroni correction for multiple 
pairwise comparisons. 
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3. Temporal and spatial expression of the 22q11.2 genes 
during neuronal differentiation of hESCs. 
 
3.1. Introduction 
The 22q11.2DS is a highly penetrant mutation that affects 1/4000 live births making it 
the most common microdeletion in humans (Karayiorgou et al. 2010). Most deletions are 
either 3Mb or 1.5Mb, which encompass around 60 genes and 28 genes, respectively 
(Williams 2011). 90% of the 22q11.2 deletion cases arise by de novo mutation while 10% 
are inherited in an autosomal dominant fashion (Ellegood et al. 2014). Patients with 
22q11.2DS are more likely to develop psychiatric disorders than the general population 
(Schreiner et al. 2013). Recent evidences have also linked 22q11.2DS with Parkinson’s 
disease (Dufournet et al. 2017; Retnakaran et al. 2010). Although most patients 
commonly carry a 3Mb deletion, it has been demonstrated that the 1.5Mb deletion was 
responsible for the underlying pathologies, hence many studies are focusing on this 
specific region (Jonas et al 2014). 
Whereas most studies on 22q11.2DS focused on the role of selected genes such as Dgcr8, 
Tbx1, Comt or Prodh in mouse model, the study from Maynard et al. 2003 investigated 
the expression profiling of all 22q11.2 genes in WT mouse. Thus, the group addressed 
whether genes within the 1.5Mb deletion were temporally and spatially expressed during 
mouse embryonic development and adulthood. Samples from either mouse brain or other 
organs extracted at different time points were screened against genes from the 22q11.2 
small deletion. The study identified six genes that were primarily located in neurons 
including forebrain regions which are known to be altered in schizophrenia. Amongst the 
twenty-two genes tested, twelve exhibited a similar expression across the different time 
points from embryonic stage to adulthood. Tmvcf, also known as Cldn5, displayed an 
expression pattern that increased over time. Conversely, Cdc45l (Cdc45) exhibited a brain 
expression profile that peaked at E12 and E14. The PCR result of Prodh2 (Prodh) was 
negative in brains at embryonic stage but increased postnatally and declined in the adult. 
Tbx1 and Wdvcf (Gnb1l) exhibited expression in other tissues but not in the brain. Three 
genes: Gscl (also known as Gsc2), Gpibb (Gp1bb) and Stk22b (Tssk2) were found not 
expressed. Finally, authors examined the expression of a subset of these genes in human 
fetal brain, different adult brain regions and several other human tissues with similar 
observations to that in mice (Maynard et al. 2003).  
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Although studies have already shed light on the expression profiling and brain region 
specific expression of genes in the 1.5Mb deletion, the data presented lacked temporal 
and spatial resolution. Furthermore, microdissected brain tissue does not allow to assess 
differentially expressed genes in specific neuronal populations.  
Neurons derived from hESCs offer a unique opportunity to understand the expression of 
these genes during human neural development. It is currently possible to differentiate 
hESCs into the major neuronal lineages present in the brain allowing the examination of 
the spatial and temporal expression profile of the genes present in the 1.5Mb deletion.  
 
Aims 
The aims of this chapter were to determine the temporal and cell-type specific expression 
of twenty-eight genes located in the 1.5Mb deletion. Due to the transcript similarity 
between DGCR6 and DGCR6L, only DGCR6 was studied. The specific objectives are: 
1. To differentiate hESCs into glutamatergic cortical neurons, GABAergic cortical 
interneurons, medium spiny neurons (MSN) and dopaminergic neurons and to 
extract RNA samples at different time points. 
2. To investigate the temporal expression profile and determine whether any genes 
exhibit a cell type specific expression using a high-throughput Biomark HD PCR 
machine. 
 
3.2. Results 
The hESCs iCas9 and H7 were differentiated using previously establish protocols into 
cortical excitatory projection neurons (Espuny-Camacho et al. 2013) , GABAergic MSN 
(Arber et al. 2015), cortical interneurons (Maroof et al. 2013) and midbrain dopaminergic 
neurons (Jaeger et al. 2011). All protocols were based on dual SMAD inhibition that 
block BMP signalling. The newly derived naïve neuroepithelial cells, largely of forebrain 
characteristics by default, can then be directed towards specific regional fate by 
appropriate morphogens. For example, SHH and/or SHH agonist purmorphamine are 
normally applied to ventralize forebrain progenitors into medial ganglionic fate for 
generating cortical interneurons. Instead addition of activin A is necessary to the 
differentiation into LGE progenitors that gives rise to MSNs. Finally, a MEK blocker 
PD0325901, SHH and FGF8 were used for generating midbrain dopaminergic neurons. 
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All different protocols are presented in the schematic timeline in Figure 3-1 moreover, 
details of the concentration for each compound are presented in 2.2.3. 
 
 
 
RT-PCRs were performed on 3 or 2 biological samples from one experiment using the 
qScript cDNA superMix as explained in chapter 2 and processed using the Biomark HD 
to assess the variation level of these different genes. To identify potential regulated 
expression, all data were firstly normalized to the housekeeping gene β-actin and 
compared to one common reference usually time point at day 0 when possible.  
 
3.2.1. Neuronal Subtype differentiation from hESC 
3.2.1.1. Glutamatergic neuron differentiation 
To verify glutamatergic fate induction, cultures at day 15 were stained with antibody 
against FOXG1, a transcription factor expressed exclusively in the developing 
telencephalon. The majority of cells were positive for FOXG1 (Figure 3-2A), suggesting 
highly efficient induction of glutamatergic precursors. VGLUT1 (SLC17A7), PSD-95 
Figure 3-1 Schematic timeline of the four differentiation protocols. A, cortical excitatory projection 
neurons differentiation. B, cortical interneurons. C, MSN. D, dopaminergic neurons. Time points for RNA 
extraction are also represented in blue.  
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(DLG4) and GRIN1 (GLUN1) are proteins essential for excitatory synapses and hence 
can be used as markers for mature neurons (Figure 3-2B). As neurons matured 
morphologically from day 30 to 80, an increase in transcript levels of these marker genes 
was observed. Furthermore, we observed that during the course of differentiation the 
expression of these genes were significantly higher when compared to day 30 for GRIN1 
and SLC17A7 and day 0 for DLG4. 
In keeping with the RT-PCR observation, immunofluorescence staining confirmed the 
expression of the postsynaptic protein PSD-95 and microtubule associated protein 2 
(MAP2) in neuronal processes (Figure 3-2C). 
Together these data support the generation of glutamatergic neurons derived from hESCs. 
 
 
 
 
Figure 3-2 Glutamatergic precursors and mature neurons Legend on the next page.  
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3.2.1.2. Cortical Interneuron differentiation 
Cortical interneuron differentiation was characterized at day 20 by immunostaining for 
NKX2.1, a transcription factor expressed in medial ganglionic eminence (MGE), a region 
in the ventral forebrain that gives rise to major types of cortical interneurons. As 
illustrated in Figure 3-3A, a large proportion of cells were NKX2.1 positive. To further 
characterize those cells, the expression of key transcripts was analysed by RT-PCR 
(Figure 3-3B). LHX6 is a transcription factor responsible for the tangential migration of 
MGE cells towards the cortex (Alifragis et al. 2004). An increase of this crucial gene 
could be detected from day 30. SST and PV are two major classes of inhibitory 
interneurons, generation of which was confirmed by increased expression of these two 
genes in the present experiment.  
For this experiment, day 30 interneurons progenitors were provided by Maria Cruz Santos 
and re-plated onto poly-D-lysine laminin and kept in neuronal media until day 80. RNA 
samples were extracted every 10 days from day 30. Pictures presented below are a 
courtesy of Maria Cruz Santos. The above data together suggests an efficient conversion 
of hESCs into cortical interneurons. 
 
Figure 3-2 Glutamatergic precursors and mature neurons A, immunofluorescence of glutamatergic 
neurons precursors at day 15 for FOXG1 (red) with DAPI counter staining, scale bar 50µm. B, Temporal 
expression profiling of mature neurons markers, GRIN1, SLC17A7 and DLG4. Data were normalized 
against the housekeeping gene β-actin. Data were then compared to day 30 for GRIN1 and SLC17A7 while 
DLG4 was compared to day 0. The levels of all three transcripts increased over time suggesting a 
differentiation of the precursors into mature neurons. Error bars represent mean+/-SEM with n = 3 
biological replicates. Statistical analysis was performed on ΔCT value with a one-way ANOVA with 
Bonferroni post-hoc, **P<0.01, ***P<0.001 ****P<0.0001. C, immunofluorescence of glutamatergic 
neurons at day 60 stained for PSD-95 (green), MAP2 (red) and DAPI (blue). Arrowhead are pointing 
towards PSD-95 puncta localized on a dendrite. Pictures were acquired with an upright Leica Microscope 
with a 100x immersion objective, scale bar 1µm.  
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3.2.1.3. Dopaminergic neuron differentiation 
Immunofluorescence using FOXA2 and LMX1A antibodies was performed at day 20 
(Figure 3-4). Together, these early markers are key determinants for dopaminergic neuron 
identity. As illustrated in Figure 3-4A, an important proportion of cells were positive for 
both FOXA2 and LMXA1 suggesting an appropriate regionalisation towards a 
dopaminergic fate. While maturing, these neurons express the enzyme tyrosine 
hydroxylase (TH), responsible for the conversion of tyrosine into L-DOPA, a precursor 
of the neurotransmitter dopamine. This gene started to be expressed from day 20 and 
increased 11-fold at day 50 when compared to day 20 (Figure 3-4B). 
RNA samples and immunofluorescences were a courtesy of Dr Marija Fjodorova. 
 
Figure 3-3 Cortical Interneuron differentiation. A, Immunofluorescence of interneuron precursors at 
day 20 with DAPI (green) and NKX2.1 (red) a marker of the MGE. An image was acquired using a Leica 
inverted microscope with a 10x objective. B, Temporal expression profiling of mature interneuron markers. 
The expression of LHX6, SST and PV were normalized to the housekeeping gene β-actin. Due to high Ct 
value prior day 30, the relative mRNA levels for LHX6 and PV were compared to day 30. Conversely, 
relative mRNA level for SST was compared to day 0. The expression of LHX6, SST and PV increased over 
the course of the differentiation suggesting a neuronal maturation. Error bars represent mean+/-SEM with 
n = 3 biological replicates from one experiment. Statistical analysis was performed on ΔCT value with a 
one-way ANOVA with Bonferroni post-hoc, *P<0.05, **P<0.01, ****P<0.0001. 
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3.2.1.4. MSN differentiation 
GABAergic medium spiny projection neurons were characterized at day 20 using an 
antibody against CTIP2 (BCL11B) protein, a transcription factor known to be expressed 
by striatal progenitors in the LGE. A high proportion of cells positive for CTIP2 could be 
observed in day 20 cell cultures (Figure 3-5). While this protein is also expressed by 
glutamatergic neurons, CTIP2 and the transcription factor GSX2 are two genes which can 
be used to assess the cellular identity of the LGE. Indeed, a peak of expression of GSX2 
was detected at day 20 corresponding to the progenitor stage. CTIP2 expression increased 
over the course of differentiation. During development, these progenitors are 
morphologically and physiologically maturing thus marker like DRD1 can be used to 
evaluate the maturation stage. Dopamine receptors D1 are expressed by mature neurons 
from the direct pathway and an increase in expression of this gene was observed over the 
course of differentiation. 
RNA samples and immunofluorescence were a courtesy of Dr Marija Fjodorova. 
 
Figure 3-4 Dopaminergic neuron differentiation. A, Immunofluorescence of dopaminergic precursors at 
day 20 with DAPI (blue), FOXA2 (red) and LMX1A (green). Images were acquired using a Leica inverted 
microscope with a 20x objective, scale bar = 50µm. B, Temporal expression profiling of gene expressed by 
dopaminergic neurons. The expression of TH was normalized to the housekeeping gene β-actin and mRNA 
expression level was compared to day 20. Error bars represent mean+/-SEM. No statistical analysis was 
performed due to sample size. 
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Taken together, these data demonstrate that four different neuronal precursor populations 
were properly differentiated from hESCs stage. Given the high proportion of relevant 
progenitor markers, cells were directed to mature glutamatergic, cortical GABAergic, 
striatal medium spiny and midbrain dopamine neurons. 
 
3.2.2. Temporal expression of the 22q11 genes 
First, genes were categorized according to their Ct value from high to low and not 
expressed. These data are presented in table 3-1 and an average Ct value of all cell 
lineages for each gene is shown. 
 
 
 
 
Figure 3-5 Medium Spiny Neuron differentiation. A, Immunofluorescence of MSN precursors at day 20 
with DAPI (green) and CTIP2 (red) a marker of the LGE. Images were acquired using a Leica inverted 
microscope with a 40x objective, scale bar = 50µm. B, Temporal expression profiling of genes expressed 
by MSN. The expression of GSX2, CTIP2 and DRD1 was first normalized to the housekeeping gene β-
actin. Relative mRNA levels for GSX2 was compared to day 12 while it was compared to day 0 for CTIP2 
and DRD1. Error bars represent mean+/-SEM with n = 2 biological replicates from one experiment. 
Statistical analysis was attempted on the ΔCT value with a one-way ANOVA with Bonferroni post-hoc, 
*P<0.05, ***P<0.001, ****P<0.0001. 
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Table 3-1 Average Ct value across cell lineages 
Ct < 15 15 ≤ Ct ≤ 22 Ct > 22 
DGCR6, DGCR2, 
DGCR14, SLC25A1, 
CLTCL1, HIRA, 
MRPL40, CDC45, 
SEPT5, C22ORF29, 
COMT, C22ORF25, 
DGCR8, TRMT2A, 
RANBP1,   ZDHHC8 
PRODH, TSSK2, 
UFD1L, CLDN5, 
GP1BB, TBX1, 
ARVCF,    RTN4R 
GSC2, C22ORF39, 
GNB1L,     TXNRD2 
 
Amongst the 28 genes in the 1.5Mb deletion, four had a Ct value higher than 22, eight 
had a Ct value between 15 and 22, while sixteen genes had a Ct value below 15.  
According to the manufacturer, when samples are processed on the Biomark HD, due to 
the high sensibility of the equipment, they advised to discard genes with a Ct value of 22 
and above. Thereby, in our experiment genes with a Ct value of 22 and above were also 
discarded.  
Subsequent analysis investigated whether these genes exhibited a temporal expression 
profile and the twenty-four genes were grouped into three categories: early expression, 
later expression and constitutive expression.  
3.2.2.1. Early expression 
The expression of four genes, HIRA, CDC45, RANBP1 and UFD1L showed a higher level 
at early stage of differentiation compared to the later stages (Figure 3-6). These genes are 
thought to regulate the cell cycle (Meechan et al. 2009). Hira is only weakly present in 
the mouse developing cortex; however, this gene is considered to be an important 
candidate responsible for the pathophysiology of 22q11.2DS (Maynard et al. 2003). 
Cdc45 has been shown to be expressed in the VZ and SVZ of the mouse developing brain 
and is essential for the initiation of DNA replication (Maynard et al. 2003). Likewise, 
Ranbp1 is also highly expressed in the VZ/SVZ where it controls the nucleocytoplasmic 
transport of proteins and nucleic acids (Maynard et al. 2003). Finally, Ufd1l has 
demonstrated to be restricted to the intermediate zone of the mouse developing cortex 
(Maynard et al. 2003). 
Because we did not collect RNA samples prior day 30 in cortical differentiations, data 
were plotted on two different graphs. The first one displayed dopaminergic and MSN 
while the other displayed glutamatergic and cortical interneurons. The relative expression 
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of CDC45 and RANBP1 were significantly higher at day 10 and 20 in MSN and 
dopaminergic differentiation cultures. Although, it appeared that the relative expression 
of HIRA at day 10 and day 10-20 in MSN and dopaminergic neurons respectively was 
higher, data failed to reach significance. Similar result was obtained for UFD1L although 
the expression was higher in dopaminergic cultures than MSN.  
The level of HIRA, CDC45 and RANBP1 transcript showed little change in the time 
windows analysed. The Ct value for these RT-QPCRs were low in both the cortical 
glutamatergic and interneurons samples, suggesting a high level of expression of these 
genes in these cells. However, UFD1L expression appeared to increase in cortical 
interneurons and decrease in glutamatergic cells as the cultures matured. 
Table 3-2 below presents the results of the two-way ANOVA to compare the expression 
between the different cell type. Only significant data were displayed. 
 
Table 3-2 Results of two-way ANOVA that compare difference between cell lineages 
Gene Day Cell types Significance 
HIRA 40 Cortical Interneurons vs Dopaminergic * 
CDC45 
30 
Cortical interneurons vs Glutamatergic 
* 
40 **** 
50 **** 
60 **** 
80 ** 
30 
Cortical interneurons vs Dopaminergic 
*** 
40 **** 
50 **** 
50 Glutamatergic vs Dopaminergic ** 
40 Cortical interneurons vs MSN *** 
20 Dopaminergic vs MSN ** 
RANBP1 20 Dopaminergic vs MSN ** 
UFD1L 
30 
Cortical interneurons 
** 
40 * 
70 **** 
80 **** 
30 Cortical interneurons vs Dopaminergic * 
30 Glutamatergic vs Dopaminergic 
 
**** 
40 **** 
40 Glutamatergic vs MSN *** 
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3.2.2.2. Late expression  
SEPT5, GP1BB, DGCR6 and ARVCF are four genes which displayed a later stage 
expression pattern (Figure 3-7). Sept5 has been shown to be involved in the process of 
Figure 3-6 Expression profile of a subset of the 22q11.2 genes displaying an early expression pattern.
A small subset of four genes in the 22q11.2 genes displayed an early expression profile. Cortical 
interneurons (black), glutamatergic neurons (red), dopaminergic neurons (green) and MSN (blue). Data 
were normalised to the housekeeping gene β-actin and compared to day 0. Error bars represent mean+/-
SEM. The data presented correspond to one experiment with n = 3 biological replicates for cortical 
interneurons, glutamatergic neurons and n = 2 for dopaminergic and medium spiny neurons. Error bars 
represent +/-SEM. Statistical analysis was performed on the ΔCT value with a one-way ANOVA with 
Bonferroni post-hoc to compared within cell lineage the expression of each time point to day 0 with * 
(cortical interneurons), # (glutamatergic neurons), ¬ (dopaminergic neurons) and ~ (medium spiny 
neurons). *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001. 
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exocytosis and cell division (Choi et al. 2003), while Gp1bb has a role in the formation 
of the platelet plugs (Kunishima et al. 2013). Dgcr6 is part of the family of the DiGeorge 
syndrome Critical Region regrouping genes implicated in DiGeorge Syndrome. Dgcr6 is 
suggested to play a role in neural crest migration (Hierck et al. 2004), finally Arvcf was 
shown to be involved in protein-protein interaction at adherens junction (Ulfig et al. 
2004). 
Due to high Ct value, data for GP1BB were normalized from day 16 for MSN and 
dopaminergic neurons whereas cortical interneurons and glutamatergic neurons were 
normalized from day 30. ARVCF was normalized at day 8 for dopaminergic neurons. 
Thus, comparison between these two groups was not possible. 
As shown in Figure 3-7, transcript levels of this group increased over the course of 
neuronal maturation in all four differentiation cultures. All genes in this group showed 
their highest expression at the end of differentiation for most of the cell lineages, with the 
exception of DGCR6, which peaked at day 30 in dopaminergic neuron cultures.  
Although the expression profile of GP1BB in glutamatergic and cortical interneurons was 
not obvious, an increase from day 30 to 80 was observed. A 4-fold change increase was 
observed in glutamatergic neurons while it was 2-fold in cortical interneurons. 
Similarly to the early expression profiling, statistical analysis was performed on our data 
in order to determine whether different existed between the different cell type at a given 
time point. These data are presented in table 3.3. 
 
Table 3-3 Results of two-way ANOVA that compare difference between cell lineages. 
Gene Day Cell type Significance 
SEPT5 
40 
Cortical interneurons vs Glutamatergic 
*** 
60 * 
70 *** 
80 **** 
30 Cortical interneurons vs Dopaminergic ** 40 ** 
40 Glutamatergic vs MSN ** 
20 Dopaminergic vs MSN ** 
DGCR6 
80 Cortical interneurons vs Glutamatergic ** 
30 Cortical interneurons vs Dopaminergic **** 40 ** 
30 Glutamatergic vs Dopaminergic **** 40 **** 
40 Glutamatergic vs MSN *** 
40 Dopaminergic vs MSN ** 
ARVCF 
30 Cortical interneurons vs Dopaminergic  * 
30 Glutamatergic vs Dopaminergic *** 
20 Dopaminergic vs MSN * 
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Figure 3-7 Expression profile of a subset of the 22q11.2 genes displaying a later expression pattern.
Four of the 22q11.2 genes displayed an expression profile that increased along the course of differentiation. 
Black, red, green and blue lines represent cortical interneurons, glutamatergic neurons, dopaminergic 
neurons and MSNs, respectively. Data were normalised to the housekeeping gene β-actin and compared to 
day 0 for SEPT5, DGCR6 and ARVCF while GP1BB was compared to day 16 for dopaminergic, MSN and 
day 30 for cortical interneurons and glutamatergic neurons. The data presented correspond to one 
experiment with n = 3 biological replicates for cortical interneurons, glutamatergic neurons and n = 2 for 
dopaminergic and medium spiny neurons. Error bars represent +/-SEM. Statistical analysis was performed 
on the ΔCT value with a one-way ANOVA with Bonferroni post-hoc to compared within cell lineage the 
expression of each time point to day 0 with * (cortical interneurons), # (glutamatergic neurons), ¬ 
(dopaminergic neurons) and ~ (medium spiny neurons). *P<0.05, **P<0.01, ***P<0.001 and 
****P<0.0001. 
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3.2.2.3. Genes with no apparent temporal profile 
The profiles of PRODH, DGCR2, TSSK2, TBX1 and COMT did not exhibit an obvious 
trend. (Figure 3-8). 
PRODH expression decreased during the course of MSN and dopaminergic neuron 
differentiation when compared to day 0. On the other hand, the transcript level remained 
constant at all the time points analysed for the two cortical cultures. However, the average 
Ct value was 16 suggesting that the transcript was present in enough quantity to be 
detected in these samples. COMT followed a similar pattern to that of PRODH except a 
very small increase during glutamatergic differentiation at day 80. DGCR2 encodes for 
an activity dependent adhesion protein (Kajiwara et al. 1996). As shown in Figure 3-8, 
the expression level of DGCR2 increased slightly in all four differentiation paradigms. 
TSSK2 is part of a family of serine threonine kinase that is mostly expressed in testis (Hao 
et al. 2004). Surprisingly, as illustrated in Figure 3-8, TSSK2 expression was detected in 
all four lineages. The Ct value was classified as high with an average Ct of 16 across the 
different neuronal populations. The expression profile rose in dopaminergic neurons from 
day 0 until day 10 then remained steady. In MSNs, the expression kept increasing until 
day 50. A similar pattern was observed in cortical interneurons where the transcript levels 
increased from day 30 to 80. However, during glutamatergic differentiation, TSSK2 
expression appeared to drop first before it increased again from day 50 to 80.  
Table 3-4 below is the result of the statistical analysis which aimed to compare difference 
between cell lineages at a given time point. 
 
 
Table 3-4 Results of two-way ANOVA that compare difference between cell lineages 
Gene Day Cell type Significance 
DGCR2 40 Cortical interneurons vs Glutamatergic ** 40 Cortical interneurons vs Dopaminergic * 
PRODH 
30 
Cortical interneurons vs Glutamatergic 
**** 
40 **** 
50 **** 
60 **** 
70 **** 
80 **** 
30 Cortical interneurons vs Dopaminergic *** 50 **** 
40 Glutamatergic vs Dopaminergic ** 50 * 
40 Cortical interneurons vs MSN *** 
20 Dopaminergic vs MSN ** 40 * 
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COMT 
30 
Cortical interneurons vs Glutamatergic 
**** 
40 **** 
50 **** 
60 **** 
70 **** 
80 **** 
30 Cortical interneurons vs Dopaminergic **** 40 ** 
30 
Glutamatergic vs Dopaminergic 
** 
40 **** 
50 **** 
40 Cortical interneurons vs MSN **** 
20 Dopaminergic vs MSN * 
TSSK2 
30 Cortical interneurons vs Glutamatergic ** 70 * 
40 Cortical interneurons vs Dopaminergic * 
30 Glutamatergic vs Dopaminergic ** 50 * 
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3.2.3.  Subtype specific expression 
In addition to temporally regulated expression, it is particularly interesting to investigate 
whether any of the 22q11 genes show a cell type-specific expression. Therefore, the data 
was next analysed from this perspective. 
Figure 3-8 22q11.2 genes with no apparent expression profile. Five genes showed no apparent temporal 
profile. In black, red, green and blue are represented the cortical interneurons, glutamatergic neurons, 
dopaminergic neurons and MSN respectively. Data were normalised to the housekeeping gene β-actin and 
compared to day 0. The data presented correspond to one experiment with n = 3 biological replicates for 
cortical interneurons, glutamatergic neurons and n = 2 for dopaminergic and medium spiny neurons. Error 
bars represent +/-SEM. Statistical analysis was performed on the ΔCT value with a one-way ANOVA with 
Bonferroni post-hoc to compared within cell lineage the expression of each time point to day 0 with * 
(cortical interneurons), # (glutamatergic neurons), ¬ (dopaminergic neurons) and ~ (medium spiny 
neurons). *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001. 
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As shown in Figure 3-9, ten genes were identified as being preferentially expressed in a 
specific cell lineage. This group including DGCR6, CLTCL1, MRPL40, CLDN5, TBX1, 
C22ORF29, C22ORF25, DGCR8, ZDHHC8 and RTN4R were selected due to their 
expression profile that suggested an enrichment in dopaminergic neurons. Similar to the 
data presented earlier, the classification was based on first a visual assessment, then 
confirmed by statistical analysis. Reported functions of these genes are summarized in 
table 3.-5. 
 
Table 3-5 Function of the gene exhibiting cell type specific expression 
Gene Function 
DGCR6 Suggested to play a role in neural crest migration 
CLTCL1 Encodes for CH22 protein thought to be involved in intracellular endosomal trafficking 
MRPL40 Implicated in mitochondrial translation 
CLDN5 Plays a role in tight junction at the blood brain barrier 
TBX1 Transcriptional regulator involved in developing process 
C22ORF29 May induce apoptosis in a BH3 domain 
C22ORF25 Predicted to play roles in secretory protein in the endoplasmic reticulum 
DGCR8 Component of the microprocessor complex that is required to process micro RNA 
ZDHHC8 Palmitoyltransferase responsible of posttranslational modification 
RTN4R Mediates axonal growth inhibition, may be involved in axonal regeneration 
 
In order to directly compare the relative level of expression, data of all four cell types 
from day 20 (committed neuronal progenitors) to 50 (neurons) were included in Figure 
3-9.  
DGCR6 was already described above as a late expression gene, and indeed its transcript 
levels increased in cortical interneurons and glutamatergic neurons from day 40 onward. 
In addition, this gene demonstrated preferential expression in dopaminergic neurons at 
days 30 and 40. TBX1 exhibited a peak of expression in dopaminergic neurons at day 30 
and although it decreased thereafter, the fold change was still higher in these cultures 
compared to the other cell lineages. CLTCL1, MRPL40, CLDN5, C22ORF29, 
C22ORF25, DGCR8, ZDHHC8 exhibited a constant expression in MSN, cortical 
glutamatergic and interneurons while peaking at day 30 in dopaminergic neurons. RTN4R 
followed a similar pattern of expression to the aforementioned group of genes in 
dopaminergic neurons, while its expression in the other lineages exhibited only a slight 
increase at day 50. Such enrichment of these particular genes in dopaminergic neurons 
may suggest that at this stage they are more important for the development of this specific 
category of neurons. 
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The result of the statistical analysis which aimed to compare whether we had different in 
expression between cell lineage at a given time point is presented below in table 3-6. Only 
significant data were presented. 
 
Table 3-6 Results of two-way ANOVA that compare difference between cell lineages 
Gene Day Cell Type Significance 
DGCR6 
30 Cortical interneurons vs Dopaminergic **** 40 ** 
30 Glutamatergic vs Dopaminergic **** 40 **** 
40 Dopaminergic vs MSN ** 
CLCTL1 
30 Cortical Interneurons vs Dopaminergic  * 40 ** 
30 
Glutamatergic vs Dopaminergic 
**** 
40 ** 
50 *** 
20 Dopaminergic vs MSN ** 40 **** 
MRPL40 
30 Cortical interneurons vs Dopaminergic ** 
30 Glutamatergic vs Dopaminergic **** 
20 Dopaminergic vs MSN ** 
CLDN5 
30 
Cortical interneurons vs Dopaminergic 
**** 
40 **** 
50 **** 
30 
Glutamatergic vs Dopaminergic 
**** 
40 **** 
50 **** 
20 Dopaminergic vs MSN **** 40 *** 
TBX1 30 Glutamatergic vs Dopaminergic * 
C22orf29 
30 Cortical interneurons vs Dopaminergic *** 40 ** 
30 Glutamatergic vs Dopaminergic **** 40 **** 
C22orf25 
30 Cortical interneurons vs Dopaminergic ** 
30 Glutamatergic vs Dopaminergic ** 50 ** 
DGCR8 
30 Glutamatergic vs Dopaminergic * 50 *** 
50 Cortical interneurons vs Dopaminergic * 
ZDHHC8 30 Cortical interneurons vs Dopaminergic * 30 Glutamatergic vs Dopaminergic *** 
RTN4R 
30 Cortical interneurons vs Dopaminergic **** 40 *** 
30 Glutamatergic vs Dopaminergic **** 40 **** 
20 Dopaminergic vs MSN * 40 **** 
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Finally, table 3-7 shows a summary of above analyses, specifying at what stage of 
differentiation 22q11.2DS genes were expressed and whether they were enriched in a 
specific neuronal population. 
 
Figure 3-9 22q11.2 gene exhibiting dopaminergic enrichment. In black, red, green and blue are represented 
cortical interneurons, glutamatergic neurons, dopaminergic neurons and MSNs, respectively. Error bars 
represent +/-SEM Statistical analysis was performed on the ΔCT value with a two-way ANOVA with 
Bonferroni post-hoc to compared at a given time point between cell lineage, data are presented in table 10. 
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Table 3-7 Summary of the findings on the expression of 22q11.2DS gene expression. Genes were 
classified according to their order in the genome. 
GENE 
LIST 
Temporal profile Cell type specific expression 
Early Late 
DGCR6  X Dopaminergic neurons 
TSSK2    
CLTCL1   Dopaminergic neurons 
MRPL40   Dopaminergic neurons 
HIRA X   
UFD1L X   
CDC45 X   
CLDN5   Dopaminergic neurons 
SEPT5    
GP1BB  X  
TBX1   Dopaminergic neurons 
C22orf29   Dopaminergic neurons 
ARVCF    
C22orf25   Dopaminergic neurons 
DGCR8   Dopaminergic neurons 
RANBP1 X   
ZDHHC8   Dopaminergic neurons 
RTN4R   Dopaminergic neurons 
 
3.3. Discussion 
Previous studies in mouse brain have suggested that some of the 22q11 genes exhibited a 
temporally regulated expression fashion. However, little is known about the cellular 
identity in which specific 22q11 genes are expressed, particularly in human neurons.  
This chapter investigated the temporal expression profile of the genes located in the 
1.5Mb deletion of the 22q11.2DS and identified genes whose expression was enriched in 
a specific neuronal population. Over the twenty-eight genes present in this region, twenty-
two displayed identifiable expression features. Present data suggest that HIRA, CDC45, 
RANBP1 and UFD1L, are expressed early during hESCs neuroectodermal differentiation. 
Conversely, DGCR6, SEPT5, GP1BB and ARVCF are expressed later during neuronal 
development. Interestingly, DGCR6, CLTCL1, MRPL40, CLDN5, TBX1, C22ORF29, 
C22ORF25, DGCR8, ZDHHC8 and RTN4R showed preferential (or enriched) expression 
in dopaminergic neurons.  
Variation in the expression of PRODH and COMT has been shown to cause brain 
abnormalities and increases vulnerability to schizophrenia (Zinkstok et al. 2008). 
Furthermore, due to their implication in neuronal physiology, these two genes were 
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intensively studied. PRODH is a mitochondrial protein responsible for the first step of the 
proline catabolism that is subsequently converted into glutamate (Willis et al. 2008). 
COMT is an enzyme that degrades catecholamines like dopamine or norepinephrine 
(Craddock et al. 2006). However, as presented in the current study, expression of COMT 
and PRODH did not show convincing results. Except in dopaminergic neurons where 
levels of COMT decreased, it remained constant in other neuronal populations. 
Furthermore, PRODH expression was similar to that of COMT in glutamatergic and 
cortical interneurons while it decreased in MSN and dopaminergic neurons. Despite the 
level of maturity of neurons in this study, they still may not be mature enough at these 
stages for these two specific genes to be expressed. It was demonstrated that PRODH as 
well as COMT showed enrichment in adolescent brain but not in embryonic brain 
supporting their role later in life (Lin et al. 2016). 
Previous studies using mouse model of 22q11.2DS identified genes in the 1.5Mb deletion 
which have crucial role in early stages of brain development, namely, Cdc45, Hira, 
Ranbp1, Ufd1l (Meechan et al. 2015; Meechan et al. 2009). Thus, present experiment 
was in accordance with these previous findings as the same genes were identified as 
having their peak of expression early in the process of differentiation. 
The role of RANBP1 at the first stage of neuronal differentiation is coherent with a recent 
study which revealed that Ranbp1 homozygous mice showed cortical growth alteration 
(Paronett et al. 2015). Authors discovered that it was due to a disruption of the basal 
progenitors which in turn are responsible for the generation of the layer 2/3 projection 
neurons (Paronett et al. 2015).  
Due to the function of Ranbp1 early in cortical neurogenesis, it is very likely that despite 
the absence of RNA samples before day 30 in glutamatergic and cortical interneurons, 
one should expect to observe a similar profile to that observed in dopaminergic and MSN 
differentiation.  
Moreover, individual homozygous knock-out of these four genes, Cdc45, Ranbp1, Ufd1l 
and Hira was demonstrated to be lethal, emphasizing their importance during 
development (Meechan et al. 2015).  
With novel tools available for gene editing, such as CRIPSR/Cas9, it would be interesting 
to generate hESCs lines deficient for these genes in order to study their role over the 
course of human neuronal differentiation. 
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Tssk2 and Gp1bb are two genes whose expression was not detected in the mouse brain in 
previous studies (Maynard et al. 2003). Tssk2 was shown to be mainly expressed in testis 
while the Gp1bb has been associated with platelet adhesion. However, present findings 
suggest that these two genes might be expressed in the brain. Indeed, GP1BB exhibited a 
profile of expression that increased along the course of differentiation in all four neuronal 
populations. TSSK2 transcripts were also observed in all four neuronal lineages whereas 
this gene was previously shown to be absent or only weakly expressed in the brain (Li et 
al. 2011). To conclude, current data demonstrated the presence of two novels genes in 
differentiating human neurons, GP1BB and TSSK2. While the function of TSSK2 in the 
brain is still largely unknown, present study suggested that this gene may have a function 
in mature neurons. On the other hand, as GP1BB is important for platelet formation which 
involves secretion of granules, a recent study from Goubau et al. identified common 
molecular mechanism between granule trafficking in platelets and neurons (Goubau et al. 
2013) . Thus, it would be interesting to study the role of GP1BB in mature neurons to 
identify whether it has a role in neuronal trafficking. 
All genes that were classified as being expressed later during development in current 
analysis have been implicated in neuronal physiology. Septin5 has been shown to be 
expressed exclusively in non-dividing cells and its role in neurons has been linked to 
vesicular exocytosis, an important process in neurons. Dgcr6 has been found to interact 
with GABAB1, a metabotropic receptor subunit part of the GABAB metabotropic receptor 
(Zunner et al. 2010). On the other hand, Arvcf has been suggested to be expressed in the 
MGE during development. 
Thus, it can be concluded that the increase of expression of these different genes is 
consistent with neuronal maturation. During this process, vesicle exocytosis increases, 
more receptors are either secreted or sent to synapses and neurons in turn are making 
more connections giving rise to the network complexity. 
Present analysis discovered that a subset of 10 genes from the 1.5Mb deletion exhibited 
an enrichment in dopaminergic neurons when compared to other neuronal populations. 
Although these results have not been replicated yet, it is the first time that a study revealed 
an enrichment of these genes in a specific neuronal population.  
Dopaminergic alteration is known to be implicated in the occurrence of both Parkinson’s 
disease and schizophrenia. Indeed, dopaminergic neurons were observed to be involved 
in cognitive deficits in individuals with schizophrenia. This alteration of dopamine 
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transmission occurs primarily in the mesolimbic brain area, but also in the amygdala and 
prefrontal cortex. On the other hand, Parkinson’s disease occurs due to a loss of dopamine 
neurons from the substantia nigra pars compacta. It would thus be interesting to 
investigate the function of these genes in dopaminergic neurons. 
In addition to the study presented in this chapter and due to the availability in our institute 
of iPSCs derived from individuals carrying a 22q11.2 mutation, it would be interesting to 
perform a similar experiment than the one presented in this chapter. This study would aim 
to investigate whether hemizygous deletion of the 22q11.2 genes alter their temporal 
profile but also determine if we would obtain similar genes enrichment than the one 
observed in the control experiment. This experiment therefore might explain the 
appearance of the subsequent neurological alteration observed in patients with 
22q11.2DS. 
Finally, our experiments revealed limitations regarding neurons differentiation. Indeed, 
genes such as COMT or PRODH are usually expressed in adolescent neurons. However, 
neurons derived stem cells in vitro never mature past the second trimester. Therefore, 
progress would be necessary to obtain neurons in vitro that would mimic older neurons 
in human. Recently a new media was developed by Telezhkin et al. 2016, named the 
synaptoJuice (Telezhkin et al. 2016). This media consists of different steps and different 
media composition during the course of the differentiation. Authors demonstrated that it 
improves the maturation of hESCs derived GABAergic neurons in vitro. Others have also 
investigated the composition in ions of neuronal media. The study demonstrated that the 
culture media usually used for neuronal differentiation is altering the electrical activity 
thus synaptic communication of neurons. Therefore, they designed a new media in which 
the ions concentration was adjusted in order to mimic physiological condition. Future 
studies should also consider the use of different medias when examining genes whose 
function appear later during development.  
 
To summarize, the data presented in this chapter, we first confirmed that neurons derived 
stem cells are able to recapitulate expression features observed in mouse model of 
22q11.2DS. Secondly, our analysis successfully identified genes that exhibit a specific 
expression profile across lineages. Indeed, our classification revealed genes with a 
preferential expression early or late during the development while others showed a gene 
specific enrichment in dopaminergic neurons when compared to the other cell lineages. 
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Although, the classification was exclusively based on visual assessment at first, statistical 
analysis was enable us to confirm our categories. To conclude, this study gives valuable 
insight on the potential genes associated with early and late neuronal differentiation which 
therefore might be responsible of the underlying pathologies in 22q11.2 carriers. In 
addition to these genes, we demonstrated that the cell type is also important when 
considering studying a gene.  
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4. Generation and characterization of ZDHHC8-deficient 
hESCs lines 
 
4.1. Introduction 
ZDHHC8 is a particularly interesting candidate within the 1.5Mb of 22q11.2DS due to 
its suggested physiological role in neurons. It is a palmitoyl acyltransferase (PAT) protein 
belonging to a family of 23 members that share a conserved cysteine rich domain referred 
to as the DHHC domain (Korycka et al. 2012). Protein palmitoylation (protein S-
acylation) is a process which consists of 16-carbons fatty acids attached onto a cysteine 
residue (Chamberlain et al. 2015). Compared to the other lipid modification such as 
myristoylation or geranylgeranylation, palmitoylation is the only posttranslational lipid 
modification that is reversible which thus has a significant role in the control of cellular 
protein dynamic. Palmitoylation enhances the hydrophobicity of protein thus contributes 
to their membrane association, protein-protein interaction as well as their subcellular 
trafficking (Globa et al. 2017; Holland et al. 2017; Huang et al. 2005). 
 
 
Figure 4-1 Palmitoylation of protein regulates synaptic transmission. This figure shows that several 
key regulators of synaptic transmission located at the pre and post-synaptic neurons require to be
palmitoylated On the presynaptic side, palmitoylation is necessary for protein regulating synaptic vesicle 
fusion and neurotransmitter synthesis and release. We can also found ions channel. On the postsynaptic 
side, protein palmitoylation include protein involved in the scaffolding of receptors but also ionotropic 
receptors. Figure adapted with permission from Springer: Nature reviews. Neuroscience, El-Husseini 2002 
(4296960901940) Copyright (2002). 
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Growing lines of evidence suggest that protein palmitoylation plays a central role in 
synaptic physiology. As illustrated in Figure 4-1 (Fukata et al. 2010), protein 
palmitoylation is suggested to be essential for the proper function of the majority of the 
pre- and post- synaptic proteins, as well as proteins involved in neurons development (el-
Husseini et al. 2002). 
Studies of Zdhhc8 homozygous deficient mice have demonstrated interaction between 
ZDHHC8 and PSD-95, a key component of the postsynaptic density responsible for the 
anchoring of postsynaptic receptors as well as protein that mediates the formation and 
maintenance of synapses (Irie et al. 1997; Sheng 2001; Sheng et al. 2011). Previous 
studies have also shown that ZDHHC8 is the only palmitoylation enzyme for 
Paralemmin-1, a regulator of filopodia (small protrusion on dendrites that serves as 
precursor of spines) (Gauthier-Campbell et al. 2004). Thus, reduction of Paralemmin-1 
palmitoylation was suggested to result in a decrease of functional synapses. Similarly, 
CDC42, a protein regulating actin cytoskeleton has been demonstrated to be 
palmitoylated by ZDHHC8. Thus, impairment of CDC42 palmitoylation results in a 
decrease of dendritic and axonal arborisation (Mukai et al. 2008, 2015; Nishimura et al. 
2013; Wirth et al. 2013). 
ZDHHC8 has been shown to be primarily localized in the vicinity of the nucleus and in 
vesicle-like clusters in the dendritic shafts (Mukai et al. 2004). However, a study from 
Maynard et al. 2008 observed that ZDHHC8 might also be localized in the mitochondria, 
which was demonstrated by its colocalization with a mitochondria specific protein 
UQCRC1 (Maynard et al. 2008; D. W. Meechan et al. 2011).  
It is known that 30% of individuals carrying the 3Mb or 1.5Mb 22q11.2 deletion develop 
schizophrenia (Liu et al. 2002). Recently, it was also demonstrated that individuals with 
22q11.2DS have an increased risk to develop Parkinson disease (Dufournet et al. 2017). 
Furthermore, several studies identified single nucleotide polymorphism (SNP) which 
were shown to increase the risk to develop schizophrenia, one of which is rs175174 A/G 
in ZDHHC8 locus (Chen et al. 2004; Mukai et al. 2004). This specific SNP located in the 
middle of the intron 4 of ZDHHC8 gene is expected to introduce a STOP codon which is 
suggested to lead to a premature stop of translation. However, several other studies 
revealed no association with schizophrenia for this SNP (Demily et al. 2007; Glaser et al. 
2006; Otani et al. 2005).  
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Neuronal migration defect was observed in patients carrying 22q11.2 mutation but also 
in patients developing schizophrenia (Castro et al. 2011; Nadarajah et al. 2003). 
Therefore, it would be interested to identify whether ZDHHC8 alter the migration process 
in culture of neurons.  
Dysregulated neuronal electrical activity has been identified in mouse models of 
22q11.2DS (Earls et al. 2010). These mice exhibited an increase in their short- and long-
term plasticity. Moreover, neurons presented an increase in presynaptic neurotransmitter 
release whilst the postsynaptic function was unaltered. This increase of neurotransmitters 
release was suggested to be linked to the altered calcium kinetics and upregulation of the 
sarco-endoplasmic reticulum calcium ATPase type 2 (SERCA2) which was observed in 
CA3 presynaptic terminal.  
 
Aims  
In this chapter, we investigate the role of ZDHHC8 in cortical neuronal development 
using hESCs as a model. The specific objectives are:  
- To generate and validate hESCs deficient for ZDHHC8 using the CRIPSR/Cas9 
technology 
- To evaluate the effect of ZDHHC8-deficiency in cortical excitatory neuron 
differentiation (kinetics and expression) 
- To investigate the role of ZDHHC8 in glutamatergic progenitors and neurons 
using motility assay as well as calcium imaging  
 
4.2. Results 
4.2.1. Generation of ZDHHC8 KO hESCs using CRISPR/Cas9  
The all in one multiplex CRISPR/Cas9 employed to target and edit ZDHHC8. This 
method is believed to reduce the stress caused by multiple plasmids insertion and increase 
the cutting efficiency. Indeed, in order to efficiently target and maximize the likelihood 
of at least one gRNA inducing INDELs in ZDHHC8, we designed four gRNAs, with two 
targeting exon 3 and two targeting exon 4 respectively named 1, 2, 3 and 4 (Figure 4-4). 
The gRNAs were chosen according to their off-target score; high score closed to 100 
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indicated a low probability of off-target of the specific gRNA. Our gRNAs 1, 2, 3 and 4 
had respectively a score of 76, 91, 85 and 88. 
4.2.1.1. Construction of the multiplex CRISPR/Cas9 plasmid  
To generate a stem cell lines deficient for ZDHHC8, I used the all-in-one multiplex 
CRISPR/Cas9 system. As illustrated in Figure 4-2, two steps were necessary for its 
construction. The first one consisted of the insertion of each gRNA into individual 
plasmid whereas the second step involved the assembly of each individual gRNA into the 
final recipient plasmid by golden gate assembly (Sakuma et al. 2014). 
 
 
 
Figure 4-2 Illustration of the construction of the multiplex CRIPSR/Cas9. Two plasmids are necessary
for the construction of the all-in-one CRISPR/Cas9, one ampicillin resistant plasmid in grey and three
others spectinomycin resistant plasmids in purple. The Cas9 protein is represented in red. The U6 promoter 
in green is necessary to drive the expression of the gRNAs. The BbsI enzyme in black was used to clone 
the gRNAs. The presence of overhangs specific for BbsI (see 2.4.5.2) ensured the correct orientation of the 
gRNAs into their recipient plasmids. Moreover, once ligated, the BbsI site disappeared therefore the 
enzyme can be used to screen for positive clone. Instead, BsaI enzyme in pink was used for the golden gate 
assembly. BsaI first opens the ampicillin plasmid then cut at the restriction site on the spectinomycin 
plasmids (see Figure 2-2). Finally, the AflIII and KpnI enzymes in grey and orange respectively was used 
to control the total number of gRNA cloned following golden gate assembly. Figure adapted from 
Tetsushi Sakuma et al. 2014. 
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In order to determine whether each individual gRNA in step 1 were properly inserted, a 
double digestion using BbsI and EcoRI was performed (Figure 4-3A-D). Figure 4-3A-D 
illustrates the digestion pattern of the four-different gRNAs from which we have five 
samples for the 1st, 2nd and 4th gRNAs and four samples for the 3rd gRNA. The positive 
control (C+) corresponded to the expected pattern for an empty plasmid with two bands 
at 5255 and 3421bp.  
Due to the presence of a difference resistance cassette in the 1st plasmid, ampicillin instead 
of spectinomycin for the remaining plasmids, the size of the 1st plasmid was larger than 
the others (Figure 4-3A). 
Figure 4-3A, B and D, we can observe that the sample 1 of the 1st, 2nd and 4th gRNAs 
have a digestion product similar to the C+ thereby the gRNAs are not inserted. On the 
other hand, as all other samples have one digestion product at 8702bp, we concluded that 
they were cut by EcoRI only and therefore the gRNAs were inserted. To conclude, the 
first step resulted in an 80% of efficiency of insertion. 
The step 2 is illustrated in Figure 4-2 and 2-2 and consisted to the golden gate reaction 
using the BsaI restriction enzyme that enabled to cut and insert the gRNAs of each 
spectinomycin plasmid into the final recipient, the ampicillin resistant plasmid. As 
illustrated in Figure 4-2, the BsaI site of the ampicillin plasmid is located downstream of 
the gRNA insertion site therefore resulting to the opening of the plasmid. On the other 
hand, the remaining three spectinomycin plasmids have two sites for BsaI respectively 
upstream and downstream of the gRNAs and gRNA scaffold which resulted to small 
fragments of 455bp which were then inserted into the recipient ampicillin plasmid. The 
reaction uses the sample 2 from each gRNA (step 1). The restriction enzymes AflIII and 
KpnI were used to screen and identify the number of gRNAs inserted. While an empty 
vector (C+) had a digestion product of 8063bp, a plasmid with 4, 3 or 2 gRNA had an 
additional digested product at 1790bp, 1335bp or 880bp respectively. From the 13 
plasmids screened, 61% appeared to have correctly integrated the four gRNAs. 
To generate the hESCs line deficient for ZDHHC8, we used the plasmid number 2 from 
the second step, Figure 4-3E. 
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4.2.1.2. Generation of ZDHHC8-deficient hESCs  
The iCas9 hESCs line was used to generate the ZDHHC8 KO. Cells were nucleofected 
as described in the methods with the multiplex CRISPR/Cas9 construct along with a 
plasmid containing a neomycin resistant gene. Cells were cultured for five days to form 
individual colonies before being picked.  
As shown in Figure 4-4, exon 3 and 4 of ZDHHC8 were targeted by two gRNAs each. 
This particular region was chosen because it encodes the DHHC domain responsible for 
the enzymatic activity of ZDHHC8. Thus, frame shift mutations in this region is expected 
to disrupt the enzymatic activity of the protein. 
 
reaction without plasmid. E, step 2 of the multiplex CRISPR/Cas, the picture represents a gel 
electrophoresis preceded by a double digestion by AflIII and KpnI to confirm the construction of the all-
in-one CRIPSR/Cas9 by golden gate assembly. These two-restriction enzymes are flanking the region of 
the gRNAs. Thus, as shown, a band at 880, 1335 or 1790bp respectively correspond to a plasmid which 
contained 2, 3 and 4 gRNAs. 
Figure 4-3 Validation of the 
multiplex CRISPR/Cas9 
construct. A-D, first step and E 
second step of the multiplex 
CRIPR/Cas9 generation. A-D, 
gel electrophoresis preceded by 
a double digestion using BbsI 
and EcoRI to confirm the 
cloning of the different gRNAs. 
Control positive (C+) are the 
empty backbone used for the 
cloning while control negative 
(C-) is the double digestion  
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Genomic PCR was employed to examine whether INDELs were generated. A pair of 
primers was designed to encompass the four gRNAs which gave rise to a predicted 470 
nucleotides amplicon in wild type allele (Figure 4-4).  
Figure 4-5 illustrates an example of gel electrophoresis of the amplified PCR fragments 
from the parental isogenic iCas9 hESCs (C+) and four independent clones (297, 510, 539 
and 541) carrying a mutation. The control amplified only one band corresponding to the 
predicted 470bp PCR product. On the other hand, in addition to a 470bp band, an 
additional amplicon of about 300bp in length was also present in clones named 297, 510, 
539 and 541. This pattern suggested that these clones might be heterozygous for 
ZDHHC8. Of the 100 clones screen, 12 clones yielded an additional PCR product, all of 
which are around 300bp. 
 
 
 
Figure 4-4 Genome editing experimental design. Exons 3 and 4 were targeted by four gRNAs
respectively named 1, 2, 3 and 4. The gRNA sequence in red and the PAMs sequences in green are 
represented above the exon 3 and 4 in blue. One set of primers flanking the targeted region was designed 
to screen for INDELs in mauve. The expected PCR product was 470 baise pairs. 
Figure 4-5 Agarose gel electrophoresis displaying screening of control iCas9 hESCs and four 
different clones, 297, 510, 539 and 541. The iCas9 hESCs (C+) allowed to visualize the expected amplicon 
size of about 470bp length. While clones 297, 510, 539 and 541 had a similar amplicon than the C+ at 
470bp we observed another PCR product of 300bp length. This gel therefore implying that these clones 
(297, 510 539 and 541) had a potential deletion within the gDNA sequence. 
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PCR fragment from clones presumably heterozygous for ZDHHC8 were ligated into the 
pGEM-T-easy vector. Due to the presence of two different restriction sites for EcoRI 
flanking the cloning region, a gel electrophoresis was performed to distinguish the 
wildtype and mutated amplicon. The plasmids containing candidate mutant amplicons 
were sent for sequencing with selected wildtype controls. The result is illustrated in 
Figure 4-6. We observed that amongst the four-gRNAs used to target exon 3 and 4, only 
gRNA 2 and 3 successfully cut the DNA sequence and yielded to a deletion of 166bp 
length. Interestingly, the deletion was almost 100% identical between the different mutant 
amplicons. Furthermore, except one amplicon which had a guanine instead of an 
adenosine, the sequences of the WT mutant amplicons were 100% identical. The WT 
amplicons were also almost 100% identical except for couple of bases pairs difference at 
random location. In addition, in mutants and controls the WT amplicons were also similar. 
Overall the difference in several bases pairs was attributed to error in the sequencing 
process rather than mutation.  
While the gDNA sequence was deleted of 166bp, the resulting mRNA sequence which 
contains only exons had a deletion of 83 nucleotides. This deletion was suggested to result 
in the appearance of a premature STOP codon and therefore a truncated protein (Figure 
4-7). Figure 4-7A represents the gDNA sequence of the WT ZDHHC8 which is composed 
of 11 exons. On the other hand, Figure 4-7B shows the resulting gDNA of the mutated 
allele of ZDHHC8 on which we observed the disappearance of the intron 3 as well as the 
truncation of the exon 3 and 4. While WT full length ZDHHC8 protein is 765aa, 
prediction of the resulting heterozygous protein showed a truncated protein of 147aa. In 
addition, it appeared that the enzymatic domain of the protein, the DHHC domain is 
missing. Therefore, it would suggest that the palmitoylation activity would be reduced by 
half in the mutant.  
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Figure 4-6 Sequencing results of different clones. Twenty sequences were sent for sequencing, four controls together with four clones, 297, 510, 539 and 541. The sequences highlighted 
in yellow represent the position of the pair of primers used for the screening while in green are the location of the four-different gRNAs used to edit the ZDHHC8 sequence. In total, we 
sequenced four PCR fragment for each of the clones 
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4.2.2. General phenotypic characterisation of ZDHHC8 deficient hESCs 
4.2.2.1. Stem cell properties 
To determine whether ZDHHC8 heterozygous cells maintain key pluripotency properties, 
we examined the expression of OCT3/4, TRA1-81 and SSEA3 by immunostaining on 
two heterozygous (clones 297 and 541) and the parental iCas9 hESCs (Figure 4-8). 
OCT3/4 is a transcription factor playing a pivotal role in controlling self-renewal of 
embryonic stem cell, while TRA1-1 and SSEA3 are surface markers expressed by 
undifferentiated hESCs. As shown in Figure 4-8A and B, the majority of cells expressed 
OCT4, TRA1-81 and SSEA3. The proportion of cells stain positive for the different 
markers are similar between the control iCas9 hESCs and the two ZDHHC8 heterozygous 
Figure 4-7 Genomic DNA and protein structure of the wild-type and heterozygous mutant for 
ZDHHC8. A, the wild-type DNA sequence encoded for 11 exons. The corresponding protein is composed 
of 4 transmembrane domains as well as the DHHC domain which is responsible of the palmitoyltransferase 
activity of the protein. The red dotted lines indicate that exon 3 and 4 are responsible of the DHHC domain 
translation. The wild-type full length protein is 765aa while its mass is 81.4kDa. The region targeted by the 
gRNA was also indicated on top of exon 3 and 4. B, in the ZDHHC8 heterozygous mutant, we observed 
that the region targeted by the gRNA resulted to the disappearance of intro 3 but also the fusion of exon 3 
and 4. At the protein level, this deletion is expected to give rise to a premature STOP codon resulting to a 
truncated protein of 147aa and a mass of 16.29kDa. The schematic demonstrated that the truncated protein 
is expected to have lost the DHHC domain (Red domain) therefore preventing its enzymatic activity to 
occur. The protein activity therefore should be reduced by half in the heterozygous mutant.  
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lines. Therefore, the major pluripotent characteristics is preserved in ZDHHC8-
heterozygous hESCs.  
 
 
 
In order to determine if the expression level of ZDHHC8 was affected by the deletion, 
RNA was extracted from self-renewing ZDHHC8 KO clones. One set of primers targeting 
the deleted exonic region was designed as illustrated in Figure 4-9 below. Thus, it was 
possible to assess whether the deletion in the genomic DNA (gDNA) remained at the 
mRNA level. 
 
 
 
 
 
 
Figure 4-8 Immunofluorescence of iCas9 hESCs and two ZDHHC8+/-, 297 and 541. (A), (B) represents
pictures acquire using a LEICA DMI6000B Inverted Time-lapse microscope. Those pictures are a tile scan 
with a magnification of 40x in order to acquire the entire colony and stained by the nuclear marker OCT3/4 
and the membrane marker TRA1-81 and SSEA3. In (A), TRA1-81 is co-stained with DAPI and expressed 
all over the cells in all different cell line. (B), SSEA3 and OCT3/4 are co-expressed with DAPI in all cells.
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Figure 4-10 illustrates the relative RNA level of ZDHHC8 in undifferentiated cells using 
a set of primer targeting the deleted region to assess if the deletion resulted to a decrease 
in the mRNA levels of ZDHHC8. The expression in cell line 297, 510 and 541 showed a 
50% reduction of ZDHHC8 mRNA expression. Although the clone 539 carried a similar 
deletion than the cell line 297, 510 and 541, the mRNA expression was unchanged. 
 
 
 
 
Figure 4-9 Real-time PCR screening strategy for ZDHHC8. One set of primer in purple was targeting 
the exon 3 and 4 within the deletion respectively in red and green. In WT condition, primers are targeting 
both allele of ZDHHC8. On the other hand, in the mutant condition, because the primers are targetiting the 
region deleted in the mutant allele of ZDHHC8, we are expecting to observe an expression of ZDHHC8
which is reduced by half when compare to the control. 
Figure 4-10 ZDHHC8 expression 
at the stem cells levels. Quantitavive 
PCR at the stem cells levels using 
primers for ZDHHC8. The primers 
target the region deleted in 
ZDHHC8+/-.Data were normalized 
to the housekeeping gene β-actin. 
297, 510, 539 and 541 are four cell 
type that demosntrated to have a 
deletion between the exon 3 and 4 of 
the ZDHHC8 gene. Statistical 
analysis using one-way ANOVA 
failed to demonstrated significance. 
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4.2.2.2. Expression of key class defining molecular markers during cortical 
differentiation of ZDHHC8+/- hESCs  
Normal brain development can be ‘visualised’ by dynamic temporal and spatial 
expression of region- and cell type-specific gene markers. During pluripotent stem cell in 
vitro differentiation, regulated expression of these markers can be used as readout to 
access whether neural development is in order. To investigate whether ZDHHC8 deletion 
affects the process of cortical neural differentiation, our hESCs were differentiate towards 
the neuroectoderm fate using dual SMAD inhibition with LDN and SB, the concentration 
of each compounds is shown in 2.2.3.1. Cells which are mainly of cortical excitatory 
neurons identity with this protocol were let to mature for the subsequent experiments. We 
performed a panel of immunofluorescence to evaluate the proportion of cells expressing 
specific markers. While we according to chapter 3, ZDHHC8 expression was suggested 
to be preferentially expressed in dopaminergic neurons, experiment in chapter 3 and 4 
were performed in parallel therefore we were unaware of this result at the time.  
PAX6 and FOXG1 were used as markers of cortical identity (Figure 4-11). PAX6 is 
expressed in the neuroepithelial cells in the VZ of the developing pallium. While FOXG1 
is expressed by cells in the neural plate from which the telencephalon is originating. As 
shown in Figure 4-11, a large proportion of cells stain positive for FOXG1 and PAX6 
(Figure 4-11A and B), suggesting efficient conversion of hESCs to the forebrain fate. 
Moreover, we detect no difference in the proportion of PAX6+ or FOXG1+ cells between 
the wild-type and ZDHHC8 +/- cultures (Figure 4-11.C-D). 
Finally, Figure 4-11E represented the temporal expression of PAX6 in control and mutant 
ZDHHC8+/-. The expression of PAX6 was absent from the stem cell stage. The 
expression profile of PAX6 was shown to increase at day 20-30 which corresponded to 
the neural progenitor’s cells (NPCs), while it decreased thereafter and became 
significantly reduced compared to day 10 from day 60 onwards. On the other hand, unlike 
to control, the expression of PAX6 in ZDHHC8+/- showed no increases at the 
progenitor’s stage between day 20-30. However, PAX6 expression decreased from day 
50 and become significantly reduced from day 60 onwards when compared to day10 of 
ZDHHC8+/-. 
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During differentiation, hESCs-derived neural epithelial cells often organize themselves 
in polarized structures referred to as neural rosettes. This structure has a radial 
arrangement that mimic the formation of the neural tube in vitro. To determine if 
Figure 4-11 Glutamatergic precursors A-B, Immunofluorescence of control (A) and ZDHHC8+/- (B)
glutamatergic neurons precursors at day 15 for PAX6 (green), FOXG1 (red) with DAPI counter staining, 
scale bar 50µm. C, quantification of FOXG1 positive cells (Control = 79.57 ± 1.820, ZDHHC8+/- = 83.19 
± 1.612, pvalue NS), two-tailed Mann and Whitney U test. D, quantification of PAX6 positive cells (Control 
= 86.12 ± 1.995, ZDHHC8+/- = 86.70 ± 2.298, pvalue NS), two-tailed unpaired Student’s t-test. Bar chart 
represented the mean ± SEM. E, Temporal expression of PAX6 gene. The data presented correspond to one 
experiment with n = 3 biological replicates. Data were normalised to the housekeeping gene β-actin and 
compared to day 10. Error bars represent +/-SEM. Statistical analysis was performed on the ΔCT value 
with a one-way ANOVA with Bonferroni post-hoc to compare whether for each differentiation, the 
expression at each time point differs from day 10 (Control and ZDHHC8+/-). Time point exhibiting a 
significant different when compared to day 10 were marked by * for control and # for ZDHHC8+/- (541). 
**P<0.01, ***P<0.001 and ****P<0.0001. 
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ZDHHC8+/- influenced the development of the neural rosette, the N-cadherin antibody 
which stains the apical structure of the neural rosette was used (Figure 4-12). A similar 
morphology and number of rosettes was observed in ZDHHC8+/- and control cultures, 
suggesting that reduced levels of ZDHHC8 do not compromise their formation (Figure 4-
12A and B). However, analysis of their area demonstrated that ZDHHC8+/- mutant cells 
have a small but significant neural rosette area (p < 0.0001). 
 
 
 
During the first ten days of differentiation, cells are transiting from pluripotent stem cells 
to neuroectodermal cells. At around days 10-12 of differentiation, the cultures are 
enriched with cycling neural progenitors. To determine whether progenitor proliferation 
was affected in ZDHHC8+/- cultures, an antibody staining for Ki67, a marker for cells in 
all phase of the cells cycle, was performed (Figure 4-13). Figure 4-13A displays the cells 
following immunostaining. Quantification of the number of positive cells demonstrated 
that the proportion of Ki67 positive cells in the WT was 45.71 ± 2.303 (mean ± SEM) 
Figure 4-12 Neural rosette like structure. A, immunofluorescence of 
neuronal progenitors at day 15 stained with N-cadherin in green and 
counterstained with DAPI in blue, scale bar 50µm. B, Histogram 
represents the quantification of the rosette area in µm2 (Control = 93.01 ± 
0.8744, ZDHHC8+/- = 99.97 ± 0.8620, pvalue < 0.0001). The 
quantification was performed in ImageJ. Error bars represent the mean ± 
SEM. Statistical analysis, two-tailed unpaired Student’s t-test 
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while it was 56.94 ± 1.679 in ZDHHC8+/-. Thus, these data suggested that proliferation 
of the neuronal progenitors were increased in ZDHHC8+/-.  
 
 
 
At day 30 of differentiation, neurons start to express proteins of the different cortical 
identity which start by the deep layer 5 and 6 as cortex is generated in an inside out 
manner. CTIP2 antibody was used to evaluate the proportion of neurons from the layer 5 
(Figure 4-14A). Both control and mutant expressed CTIP2 proteins. However, 
quantification revealed a significant decrease of CTIP2 positive neurons in the mutant 
line (Figure 4-14B). Indeed, the proportion of CTIP2 in ZDHHC8+/- was 35.58 ± 1.653 
(mean ± SEM, P < 0.0042) while in the control it was 45.80 ± 3.046 (mean ± SEM). 
Finally, we observed that the temporal expression profile of CTIP2 (Figure 4-14) showed 
a peak of expression at day 30 and decreased thereafter. On the other hand, the expression 
of CTIP2 increased from day 30 but remained relatively constant until day 70 and then 
started to decrease at day 80. 
Figure 4-13 Expression of the proliferative markers Ki67 in 
neuronal progenitor cells. A, immunofluorescence of neuronal 
progenitors at day 15 stained with Ki67 in red and counterstained with 
DAPI in blue, scale bar 50µm. B, histogram of the proportion of Ki67 
positive cells. Bar graph shows mean ± SEM). The quantification was 
performed using CellProfiler. Statistical analysis two-tailed Mann and 
Whitney U test 
102 
 
 
4.2.2.3. Gene expression analysis of ZDHHC8+/- hESCs derived cortical 
neurons 
To investigate whether ZDHHC8 heterozygous deletion affects glutamatergic neuron 
differentiation, we examine the expression of a panel of cortically expressed genes during 
the course of differentiation. RNA samples were extracted and run with the Biomark HD. 
Ct value above 22 were considered as not expressed and thus discarded from the analysis. 
The data were presented to first assess the temporal profile and therefore compared the 
expression to day 0. Next, we compared the expression of ZDHHC8+/- to the control and 
Figure 4-14 CTIP2 expression at the protein and mRNA level. A, immunofluorescence of neuronal 
progenitors at day 30 stained with CTIP2 in red and counterstained with DAPI in green, scale bar 50µm. 
B, the histogram represents the proportion of CTIP2 positive cells. Bar graph represents mean ± SEM. The 
quantification was performed using CellProfiler. Statistical analysis two-tailed Mann and Whitney U test. 
C, Temporal expression profile of CTIP2 gene. The data presented correspond to one experiment with n = 
3 biological replicates. Data were normalised to the housekeeping gene β-actin and compared to day 0. 
Error bars represent +/-SEM. Statistical analysis was performed on the ΔCT value with a one-way ANOVA 
with Bonferroni post-hoc to compare whether for each differentiation (control and ZDHHC8+/-), the 
expression at each time point differs from day 0 (Control and ZDHHC8+/-). +/-). Time point exhibiting a 
significant different when compared to day 0 were marked by * for control and # for ZDHHC8+/- (541). 
The cell line used for the cortical neurons differentiation was iCas9 for the control and 541 for ZDHHC8+/-
. *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001. 
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therefore ZDHHC8+/- expression was compared to the control of the same time point. In 
addition, similar to chapter 3, the statistical analysis performed in this chapter are the 
result of one experiment with n=3 biological replicate. It was noteworthy that some time 
point only exhibited two biological replicates due to the presence of outliers.  
Although, ZDHHC8+/- do not affect the expression of the pluripotency markers at the 
protein levels, the expression of OCT4 (POU5F1) is examined to determine whether 
OCT4 extinction is delayed in ZDHHC8+/- (Figure 4-15). We observed that OCT4 
mRNA expression stopped from being expressed in both control and mutant from day 10. 
Furthermore, the relative level of OCT4 at the stem cell levels was similar between 
ZDHHC8+/- and the control. Thereby, heterozygous mutation of ZDHHC8 do not seem 
to alter pluripotency. 
 
 
 
4.2.2.3.1. Temporal expression profile of key markers of differentiation 
In addition to the temporal expression of PAX6 and CTIP2, we also investigated the 
profile of other key molecular markers to evaluate whether the conversion of ZDHHC8+/- 
cells into glutamatergic neurons followed a similar kinetic than the control. (Figure 4-16). 
These data were used to visualize the expression profile compared to day 0. Thereby, data 
indicated whether the expression at a given time point was different to day 0, see Figure 
legend. In control condition, the expression of ZDHHC8 showed a slight increase for 
couple of time points while the expression in the heterozygous was constant along the 
course of the differentiation when compared to day 0. (Figure 4-16A). We examined the 
Figure 4-15 Expression of OCT4 (POU5F1) during neuronal differentiation. A-B, data were first 
normalized to the house keeping gene β-actin. A, each time points were normalized to day 0 which was set 
up at 1. B, time point for ZDHHC8 were normalized to their respective control thereby the controls time 
points were set up at 1. Statistical analysis revealed no difference at the stem cells levels between the control 
and ZDHHC8+/-. 
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EMX family of transcription factor, EMX1 and EMX2 (Figures 4.16B and C). Both genes 
are expressed by cells in the dorsal telencephalon however, EMX2 is mostly expressed in 
the visual area of the cortex. While the EMX1 expression rapidly decreased and remained 
relatively weakly expressed from day 20 to 80 when compared to day 0 in both the control 
and the ZDHHC8+/- neurons, EMX2 expression appeared to gradually increase from day 
30 to day 80. TUJ1 is a beta tubulin protein encoded by the TUBB3 gene which is 
primarily expressed in neurons (Figure 4-16D). The control and the mutant neurons 
exhibited a similar expression profile of TUBB3 during the course of the differentiation.  
The expression of genes involved in the patterning of the cerebral cortex such as TBR1, 
CUTL1 (CUX1) and FOXP2 were also examined (Figures 4-16E-G). These genes were 
demonstrated to be expressed by cells of a specific cortical layer. TBR1 is specifically 
expressed by new-born neurons from the cortical layer 6. FOXP2 is also expressed by 
deep layer neurons, usually layer 5-6. CUX1 is an upper layer marker, expressed by layer 
II/IV neurons. Similarly, the profile of expression of ZDDHC8+/- followed a similar 
pattern than the control for TBR1, CUTL1 and FOXP2.  
Next, we examined the temporal profile of genes that have a functional role for neurons 
such as genes coding for the NMDA receptors but also presynaptic genes involved in 
neurotransmitter transport such as VGLUTs (Figures 4-16.H-K).  
In the heterozygous neurons for ZDHHC8, we can observe that the expression profile of 
DGL4 and GRIN2B have a similar profile than the control (Figures 4-16H and I). The 
expression profile of GRIN2A and SLC17A7 followed a similar trend which increase 
along the course of differentiation in both mutant and control. However, by day80, we 
observed a stronger expression of GRIN2A in control as well as a stronger expression of 
SLC17A7 from day 50 and onwards in the control condition. 
Thus, we conclude that overall, the temporal expression analysis indicated that the 
kinetics of the differentiation in the ZDHHC8+/- followed a similar profile than the 
control.  
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4.2.2.3.2. Differential expression of key neuronal genes between control and mutant 
In addition to evaluate the temporal expression, we also compared the expression of 
ZDHHC8+/- with its isogenic control to determine whether genes were found to be 
differentially expressed.  
We investigated the expression of PAX6 and OTX2 (Figure 4-17B and C). We observed 
that the expression of PAX6 was particularly downregulated at day 10 and 30 which 
correspond to the progenitor’s stage (Figure 4-17B). The expression of PAX6 remained 
downregulated at day 60 and 80 but in less extend than at day 10 and 30. Conversely, 
OTX2 a gene expressed by forebrain and midbrain neuronal precursors, showed a strong  
Figure 4-16 Temporal expression of key expressed gene in ZDHHC8+/- and the parental line.  Figure 
legend on the next page.  
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upregulation from day 60 and day 80 while its expression was similar at earlier time point 
when compared to the control (Figure 4-17C). EMX1 expression was shown to be 
downregulated of more than 50% in the mutant ZDHHC8 at day 30 and 80 while similar 
at day 10 between control and mutant (Figure 4-17D). EOMES (TBR2), a transcription 
factor expressed by intermediate progenitor cell (IPC) also known as basal progenitors, 
is observed to have an expression comparable to control at day 10, however by day 30 its 
expression was significantly downregulated to be almost null (Figure 4-17E). Despite the 
strong downregulation of EOMES in ZDHHC8+/-, examination of the Ct values revealed 
that they were below 22 therefore the transcript of EOMES was present in enough 
proportion to be detected. FOXP2 expression was also observed to be downregulated of 
about 50% in ZDHHC8+/- (Figure 4-17H). The expression of TBR1 was shown to be 
increased at day 60 and 80 when compared to the control (Figure 4-17F). While the 
expression of BCL11B was downregulated of 50% in ZDHHC8+/-, at day 80 its 
expression was upregulated in ZDHHC8+/- compared to the control (Figure 4-17G). The 
expression of CUTL1 did not appear to be different in ZDHHC8+/- (Figure 4-17I). While 
our differentiation protocol is thought to give rise to excitatory glutamatergic neurons, an 
upregulation of GAD1 was observed at day 80 in ZDHHC8+/- (Figure 4-17J). 
Figure 4-17 Temporal expression of key expressed gene in ZDHHC8+/- and the parental line. The 
control and ZDHHC8+/- were respectively represented in grey and red. A, ZDHHC8. B, EMX1 expression 
was demonstrated to be significantly decreased from day 20 and onwards in both control and ZDHHC8+/-
. At day 20 and 30 in the control and day 30, 50, 60 and 70 in ZDHHC8+/-, we only had one biological 
replicate. C, EMX2 expression profile was significantly increased from day 50 onwards in ZDHHC8+/-
while only significantly increased at day 70 and 80 in the control. Data in control at day 40 had one 
biological replicate. D, TUBB3 (TUJ1) expression was observed to be significantly increased in 
ZDHHC8+/- from day 20 onwards when compared to day 0. Although the expression in the control 
appeared to be increased statistical analysis failed to reach significance. E, TBR1 expression was 
significantly higher at day 30 and 40 then decreased until day 80 in ZDHHC8+/- when compared to day 0. 
While similar trend was observed in the control, statistical analysis did not reach significance as data were 
compared to day 30 because data at day 20 only had one biological replicate. F, CUTL1 (CUX1) was 
observed to be relatively constant along the course of differentiation in control and ZDHHC8+/- when 
compared to their respective day 0. G, FOXP2 expression was observed in both conditions to be 
significantly higher at day 30 then started to decrease until day 80 although data remained significantly 
increased when compared to day 0. H, DLG4 (PSD-95) expression was shown to be significantly increase 
along the course of differentiation in both control and ZDHHC8+/-. I, GRIN2B expression was significantly 
increased from day 30 onwards in both control and ZDHHC8+/- when compared to value at day 0. J, 
GRIN2A expression showed an important and significant increase of its expression towards the end of the 
differentiation at day 80 in control and ZDHHC8+/- when compared to day 0. K, SLC17A7 (VGLUT1) 
expression was observed to significantly increase along the course of differentiation in control. However, 
while the expression in ZDHHC8+/- also appeared to increase the statistical analysis failed to reach 
significance. The data presented correspond to one experiment with n = 3 biological replicates. Data were 
normalised to the housekeeping gene β-actin and compared to day 0. Error bars represent +/-SEM. 
Statistical analysis was performed on the ΔCT value with a one-way ANOVA with Bonferroni post-hoc to 
compare whether for each differentiation (control and ZDHHC8+/-), the expression at each time point 
differs from day 0 (Control and ZDHHC8+/-). The significance is showed using * for the control and # for 
ZDHHC8+/-. The cell line used for the cortical neurons differentiation was iCas9 for the control and 541 
for ZDHHC8+/-. *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001. 
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The NMDA receptor is located at postsynaptic site of the neurons. This receptor is an 
heterotetramer composed of four subunits. We were unable to detect the transcript of 
GRIN2C and GRIN2D in both control and mutant neurons. Despite the expression of 
GRIN2A was similar to the control in the mutant neurons at day 10 and 30, the expression 
was downregulated of almost 50% at day 60 and 80 in the mutant (Figure 4-17K).  
SLC17A7 and SLC17A6 are two important genes encoding the proteins VGLUT1 and 
VGLU2 respectively (Figure 4-17L and 4.17M). The vesicular glutamate transporters 
family allows the loading of glutamate into vesicles. We observed a downregulation of 
SLC17A7 from day 10 which persisted until day 80 (Figure 4-17L). Conversely, 
examination of SLC17A6 mRNA expression in ZDHHC8+/- neurons was observed to be 
similar to the control at day 10 and 30 while it was downregulated at day 60 and 80 
(Figure 4-17M). 
DLG4 encodes for PSD-95, a protein expressed at the postsynaptic membrane of the 
neurons which is part of the postsynaptic density (Figure 4-17N). This scaffolding protein 
is responsible of the anchoring of different synaptic receptors and ions channels to the 
membrane. The data were unable to show an alteration of DLG4 in ZDHHC8 +/- 
differentiation at the mRNA levels except at day 80 which exhibited a downregulation of 
DLG4 expression in ZDHHC8+/- neurons. 
To finish, I also examined whether the expression of ZDHHC8 was impaired during the 
differentiation using a similar set of primers than Figure 4-9 (Figure 4-17A). Overall, a 
50% reduction of ZDHHC8 mRNA expression at each time point was observed 
suggesting that the deletion was still present while undergoing neuronal differentiation.  
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4.2.2.4. Motility defect in ZDHHC8+/- neuronal progenitors 
Homozygous and heterozygous mouse model for Zdhhc8+/- showed alteration of axon 
growth and arborization in vitro due to a decrease of CDC42 palmitoylation by ZDHHC8. 
Figure 4-18 Differentially expressed genes in ZDHHC8 +/- excitatory projection neurons
differentiation. WT and ZDHHC8+/- were represented in grey and red respectively. The histogram 
represents the mean ± SEM. A, ZDHHC8 expression was found to be reduced in ZDHHC8+/- when 
compared to the control, however, statistical analysis only reached significance at day 80. B, PAX6
expression was observed to be significantly reduced at day 10, 30 and 60 in ZDHHC8+/-. C, OTX2
expression was strongly upregulated at day 80 in ZDHHC8+/-. D, EMX1 expression was found to be 
downregulated at day 80 in ZDHHC8+/-. E, EOMES (TBR2) expression in ZDHHC8+/- was found to be 
significantly downregulated from day 30 onwards when compared to the control. F, TBR1. G, BCL11B
(CTIP2). H, FOXP2 expression although decrease failed to reach statistical difference at day 30, however 
FOXP2 expression was significantly reduced in ZDHHC8+/- at day 60 and 80 when compared to the 
control. I, CUTL1 (CUX1). J, GAD1 (GAD67) expression in ZDHHC8+/-  although similar to the control 
at day 10, 30 and 60, was found to be signicantly increased at day 80 in ZDHHC8+/-. K, GRIN2A was 
observed to be decreased at day 60 and 80 in ZDHHC8+/-. L, SLC17A7 (VGLUT1) expression although it 
appeared reduced in the ZDHHC8 mutant was not significant expect at day 60. M, SLC17A6 (VGLUT2) 
was found to be reduced at day 60 in ZDHHC8+/- when compared to the control. N, DLG4 (PSD-95). The 
data presented correspond to one experiment with n = 3 biological replicates. Data were normalised to the 
housekeeping gene β-actin and compared to day 0. Error bars represent +/-SEM. Statistical analysis was 
performed on the ΔCT value with a one-way ANOVA with Bonferroni post-hoc to compare whether for 
each differentiation (control and ZDHHC8+/-), the expression at each time point differs from day 0 (Control 
and ZDHHC8+/-). The significance is showed using * for the control and # for ZDHHC8+/-. The cell line 
used for the cortical neurons differentiation was iCas9 for the control and 541 for ZDHHC8+/-. *P<0.05, 
**P<0.01, ***P<0.001 and ****P<0.0001. 
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In order to investigate whether ZDHHC8 is involved in the migration of excitatory 
neuronal progenitors, we investigated their motility using motility assay. 
Excitatory neuronal progenitors at day 20 of differentiation from two independent 
experiments using the heterozygous mutant 541 and the control iCas9 were imaged over 
12 hours and subsequently analysed. Different parameters were analysed such as the total 
distance, the displacement, the speed and the velocity (Figure 4-18). This analysis 
revealed that neuronal progenitors deficient for ZDHHC8 migrated less when compared 
to the control progenitors (Figure 4-18A). The displacement was also significantly 
decreased in the mutants compared to the control (Figure 4-18B). It also appeared that 
mutant neural progenitors were significantly slower as shown by the speed and the 
velocity (Figures 4.18C and D). 
This data suggests that ZDHHC8+/- impairs migration and motility of the excitatory 
neuronal progenitors. Because cells were too close from each other we were unable to 
trace neurons in order to determine their length and branching number.  
 
 
 
4.2.2.5. Calcium activity is enhanced in ZDHHC8+/- 
Due to the important role of palmitoylation at the synapses (Figure 4-1). We investigated 
whether ZDHHC8 deficiency had an impact on spontaneous neuronal calcium activity in 
excitatory projection neurons. Indeed, as explained in chapter 1, calcium activity is 
responsible of several signalling pathways in neurons amongst them the release of 
Figure 4-19 Glutamatergic progenitor cells motility. Cells were recorded for 12h in a recording chamber 
(Temperature, CO2 and humidity monitored) under a light microscope. Images were acquired every 5min 
with a 10x objective at different location. Data were analysed and visualized using a bar plot which 
represent mean ± SEM. A, total migration in µm.  of the WT and the KO ZDHHC8. Control = 83.92 ± 
2.645 µm; KO = 51.42 ± 1.228 µm, P < 0.0001. B, displacement in µm, WT = 50.50 ± 3.428 µm; KO = 
27.22 ± 2.411 µm, P < 0.0001. C, Migration speed in µm/min, WT = 0.1456 ±0.003627 µm/min; KO = 
0.09055 ± 0.001964 µm/min, P < 0.0001. D, Velocity in µm/min, WT = 0.09155 ± 0.006285 µm/min; KO 
= 0.04955 ± 0.004178 µm/min, P < 0.0001. Statistical analysis was performed using a Mann-Whitney U 
test. N = 2 WT with 218 values and 2 KO with 180 values.  
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neurotransmitter from the presynaptic neurons. Thereby we used the calcium indicator 
Fluo-4AM in order to evaluate the calcium activity in vitro in neurons comparing 
ZDHHC8+/- with the control parental line. The calcium activity from excitatory 
projection neurons in a solution of aCSF was acquired using an inverted fluorescent 
microscope equipped with a LED setup. The questions we were interested were: 1) 
whether the calcium activity was different between the WT and ZDHHC8 mutant 
cultures; 2) how ZDHHC8 neural cells were maturing in the context of calcium activity 
during long time culture. Three different clones of ZDHHC8 heterozygous cells (297, 541 
and 510) and a control (iCas9) were used in this study with neurons recorded at different 
time points as presented in the table 12. 
 
Table 4-1 Time point analysed for each cell line 
Cell line Time points in days 
Control – iCas9 60, 70, 80, 110, 130, 150 
ZDHHC8 +/- 541 60, 70, 80, 110, 130, 150 
ZDHHC8 +/- 297 60, 70, 80, 110 
ZDHHC8 +/- 510 60, 70 
 
To determine the longitudinal calcium activity maturation, we first examined the calcium 
activity in the control cells line (iCas9) (Figure 4-19). The calcium amplitude represented 
the variation of the calcium intensity emitted by the Fluo-4 dye. The amplitude was 
represented as ΔF/F0 from which ΔF represents the variation in the calcium intensity at a 
given time while F0 is representing the fluorescence calcium intensity at the beginning of 
the experiment. We observed that the calcium amplitude remained similar from day 60 to 
80 with a value of ΔF/F0 around 0.06 in the control cell line. However, by day 110 the 
amplitude reached an average of 0.2438 ± 0.008220 but decreased by day 130 until 
day150 to be 0.06028 ± 0.002085 (Figure 4-19A).  
The interspike interval (ISI) represented the interval between two spikes. Instead, the total 
number of events described the average number of spikes occurring at a given time point 
recorded from all the active cells in our different fields of view. During the course of the 
differentiation, an overall decrease of the ISI was observed in the control which was 
correlated by an increase number of spikes (Figure 4-19B and C). Except at day 110 
which exhibited a high ISI and low number of spikes, the average ISI varied from 106 ± 
5.926 seconds at day 60 to 41.64 ± 2.077 seconds at day 150 (Figure 4-19B). Similarly, 
the average number of events varied from 5.386 ±0.2636 at day 60 to 25.39 ± 0.785 at 
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day 150 (Figure 4-19 C). Thereby, when the ISI decreased, the number of events was 
instead increased. 
The rise was defined as the time necessary to reach half of the maximal amplitude while 
the fall time corresponded to decay of the calcium event (Figures 4.19D and E). From day 
60 to 80, the average control rise time was 1.30 ± 0.038 seconds. By day 110, it 
unexpectedly increased to reached 1.745 ± 0.017640 seconds however it decreased to 
reach 0.7563 ± 0.01207 seconds at day 150 (Figure 4-19D). Figure 4-19E illustrates the 
evolution of the calcium decay time. Overall, the average fall time in the control cell line 
kept increasing from 0.8093 ± 0.027410 seconds at day 60 to 1.56 ± 0.01349 seconds at 
day 150 (Figure 4-19E). 
Therefore, we observed that despite the amplitude remained relatively similar during the 
course of the differentiation, the ISI and the number of events were observed to be 
decreased and increased respectively during the course of the differentiation. Therefore, 
these data demonstrated that in vitro excitatory projection neurons derived from 
embryonic stem cells have the ability to mature which was demonstrated by the increase 
in the number of events occurring during spontaneous calcium activity which was 
correlated with the decrease in the ISI. 
 
Next, we decided to investigate whether the ZDHHC8 mutation altered the calcium 
activity in neurons and also compared its activity with the control neurons. Strikingly, the 
ZDHHC8 KO neurons exhibited an overall higher amplitude compared to the control 
from day 60 to 80 (day 70 P297 < 0.0001, P510 < 0.0001, P541 < 0.0001). Although the 
amplitude was higher in the control at day 110 and 130, at day 150 it was higher in the 
mutant clone 541. 
The ISI in the mutant ZDHHC8 was observed to constantly decrease at each recording 
time. In the mutant, except at day 70 at which two mutant clones exhibited similar value 
of ISI than the control, all remaining recording time points displayed a significant 
decrease of the ISI in the mutant (day 80, P297 = 0.0002, P541 < 0.0001; d150, P541 < 
0.0001). The total number of calcium events appeared to also constantly increase while 
ZDHHC8+/- neurons mature. At day 60 they were on average 9.5 ± 0.2813 events during 
the recording while it increased to reach 86.01 ± 1.343 events at day 150 in the mutant 
clone 541.  
112 
 
The rise time in the mutant ZDHHC8 was very heterogenous from day 60 to 80. While 
the rise time was significantly slower (higher values, day 60 P541 = 0.0015, day 70 P541 = 
0.0008) than the control for clone 541 at day 60 and 80, we observed that it was faster 
(lower values) than the control in the clone 297 and 510 (day 60, P297 < 0.0001, P510 = 
0.0001; d70 P297 < 0.0001, P510 = 0.0017). From day 110 and onwards, the mutant 
ZDHHC8+/- had values of rise time that were significantly lower than the control 
therefore the rise time were faster in the mutant neurons. Similarly to the control, the 
decay time of the calcium transient in the mutant kept increasing at each recording time 
point. From 0.8217 ± 0.01373 seconds at day 60 it was 1.763 ± 0.01396 seconds at day 
150 for the clone 541. When compared to the control, we observed that the fall time was 
significantly higher in the mutant ZDHHC8. 
Table 13 depicts the number of cells analysed per cell lineages and time point. 
 
Table 4-2 Number of cells analysed per cell lineages and time point 
Cell lineages D60 D70 D80 D110 D130 D150 
iCas9 210 155 166 816 476 778 
541 549 363 228 581 1347 768 
297 301 334 212 639 / / 
510 267 104 / / / / 
 
To conclude, the control cells demonstrated a maturation of the neurons which was 
demonstrated by a decrease of ISI and increased of the number of events. A similar trend 
was also observed for the different KO for ZDHHC8. However, the data suggested that 
the neurons heterozygous for ZDHHC8 mature faster than the control. Although we 
observed some variability between the different KO, the difference was usually in the 
same direction especially for day 110. However, while maturing, although the rise time 
of the calcium amplitude appeared to be faster, the fall time was observed to be slower.  
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Figure 4-20 illustrated calcium traces recorded and their respective temporal raster plot 
from the control cell Cas9, KO 541 and 297 at day 110 and 150 for the control and the 
KO 541.  
We observed that the control cells only displayed two calcium events (Figure 4-20A). 
However, while analysing different neurons, a similar pattern was observed (Figure 4-
20B). Indeed, the raster plot of six random cell displayed similar spontaneous calcium 
events  
decay of the calcium spike. The data presented in the graphics are the results of the recordings of hundred of 
neurons across different field of view. Data are presented as the mean +/-SEM, howver, they are very small 
therefore not visible. Statistical analysis was performed using a two-tailed unpaired Student’s t-test comparing 
each condition to the control. Calcium activity was analysed in Matlab, using the FluoroSNNAP package. 
Figure 4-20 Longitudinal calcium 
activity analysis in cortical excitatory 
projection neurons. The control isogenic 
line is represented by iCas9 while 541, 
297 and 510 are three heterozygous cell 
lines for ZDHHC8. A. the bar plot 
represented the calcium amplitude ΔF/F0. 
B, Inter Spike Interval (ISI) in seconds. C, 
Total number of events at a given time 
point. The number of events 
corresponded to the total calcium event 
occurring for one neuron. The value is 
then average with all the cells analysed. 
D, rise time of the calcium spike in 
seconds. D, fall time represented the  
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Although the number of events was significantly higher for the KO 541, we observed a 
similar phenomenon than the control in the KO 541 and 297 (Figure 4-20A-B). Therefore, 
by day 110, we start to observe that the spontaneous calcium activity become 
synchronizes across our recordings. Furthermore, this synchronicity was also observed at 
day 130 (data not shown) and 150 (Figure 4-20C-D). It was noteworthy that the number 
of events also increased from day 110 to 150 (Figures 4-19C, 4-20C-D). Figure 4-20D 
represented the calcium activity of six cells randomly selected. Similar than day 110, most 
neurons were active together as a network. 
While calcium is important for the physiology of the cells, in a preliminary experiment 
(data not shown), we examined whether the incubation of specific drugs would block the 
calcium signalling. The main purpose was to determine whether the signal we acquired 
was due to calcium activity mediated by action potential or by the movement of calcium 
from the different internal storage of the cells. We observed that upon incubation of the 
neurons in a solution of aCSF containing Tetrodotoxin (sodium channel blocker), AP5 
and CNQX, the calcium signalling activity of the neurons become quiet. Therefore, we 
conclude that the calcium signal was mediated by synaptic activity as otherwise cells 
would have remained active. 
To conclude, we found that is possible to assess neuronal maturation using calcium 
imaging. Furthermore, while maturing the spontaneous calcium transient evolve from an 
asynchronous to a synchronized activity. 
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Figure 4-21 Calcium trace and raster plot of control and ZDHHC8+/- glutamatergic neurons. 541 and 
297 are two heterozygous line for ZDHHC8 which were differentiated into glutamatergic excitatory 
neurons. A and C represented the calcium trace recorded with their respective spikes recorded for 10min 
or 6000s.  Each traces represented a single cells. B and D, raster plot of couple of cells at day 110 and 150 
respectively. Each bar on the raster plot represented a calcium event. The X-axis represents the time in 
milli-seconds.  
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4.3. Discussion 
While animals carrying either heterozygous or homozygous Zdhhc8 deletions were 
previously generated, investigations of its role in hESCs derived excitatory projection 
neurons has yet to be reported. This study therefore aimed to investigate whether 
ZDHHC8 influenced human cortical projection neuron development. 
While we successfully generated lines carrying a heterozygous deletion using the 
CRIPSR/Cas9 technique, the different clones were genetically the same with disruption 
that occurred in the middle of exon 3 and 4. It resulted to the deletion of the intron 3 and 
the fusion of the upstream and downstream sequence of exon 3 and 4 respectively (Figure 
4-7).  
In order to understand why only gRNA 2 and 3 were able to cut the gDNA sequence, it 
would be interesting to sequence the plasmid used for the generation of our heterozygous 
line. Indeed, although we observed the integration of 4gRNA, it still remains possible that 
we had ligated two gRNA 2 and 3 instead of one of each gRNA. 
Although the heterozygosity of these clones was confirmed by sequencing at the gDNA 
level, we were unable to confirm a change at the protein level. Several ZDHHC8 
antibodies tested yield multiple bands in western blot in the control. Even if all these 
antibodies were expected to detect regions of the protein that is deleted in our 
heterozygous, we were unable to detect the wild-type protein in our control condition. 
Despite several attempts were made using a blocking peptide in order to determine which 
bands corresponded to the wild-type ZDHHC8 protein, it failed to give satisfactory result. 
Other attempts should be made aiming at varying the different incubation time during the 
western blot process, such as the blocking step or else the antibody incubation. 
Several attempts were also made in order to generate a homozygous hESCs line for 
ZDHHC8. We used the same gRNAs that were shown to be efficient and anticipated that 
it would target the second allele. To overcome this issue, we decided to design a multiplex 
lentiviral vector (Alessandra Sperandeo) which was based on the publication from Kabadi 
et al.2014 (Kabadi et al. 2014). Although we successfully managed to generate the 
lentiviral vector, at the moment we did not start the lentivirus production yet. Due to the 
overall higher efficiency of lentivirus compared to conventional plasmids, we would 
expect to generate a homozygous line based on the hemizygous deletion. Although 
22q11.2DS is a hemizygous deletion, using a homozygous will allow us to study in more 
depth the function of ZDHHC8 during neuronal differentiation. 
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Study reporting a decrease of neural stem cells proliferation in patients with schizophrenia 
are thought to result in decrease of the cortical thickness in several brain areas in 
schizophrenic individuals, interestingly such observation was also found in 22q11.2DS 
carriers (Jalbrzikowski et al. 2013; Reif et al. 2006). Interestingly, our data suggested the 
opposite, we observed an increase in proliferation of the neural progenitor cells (Figure 
4-13). As the area of the rosettes was also observed to be increase in ZDHHC8+/- (Figure 
4-12). We suggested that the increase of neural rosettes area and the proliferation of the 
progenitors might be related. Thus, it would be interested to determine first the identity 
of the cells which displayed an increase proliferation, then determine whether these cells 
survived over the course of the differentiation. 
Apart from Nissl staining which were used to evaluate the mouse brain morphology, 
which moreover appeared to be normal in both Zdhhc8+/- and Zdhhc8-/- no extensive 
analysis was performed (Mukai et al. 2004). Overall, although they were slight 
fluctuation in the temporal expression profile of ZDHHC8 in the control condition, the 
temporal profile was considered as being constant along the course of differentiation in 
both control and ZDHHC8+/- (Figure 4-16). 
The temporal expression of key markers of neuronal differentiation was used to examine 
the kinetics of differentiation of the ZDHHC8+/- neurons, therefore to assess whether 
ZDHHC8+/- alter the process of differentiation. Our analysis did not reveal an alteration 
of the kinetics of differentiation in the ZDHHC8 KO neurons. On the other hand, we 
observed that several genes in ZDHHC8+/- are differentially expressed when compared 
to the control. Examination of the relative mRNA expression of crucial developmental 
and synaptic genes in ZDHHC8+/- differentiation revealed a significant downregulation 
of PAX6 mRNA at day 10 and 30 which corresponded to the peak of its expression (Figure 
4-17B). Therefore, it would be interesting to examine whether we also observed a 
decrease of PAX6 protein by quantifying the protein in western blot. 
We observed an overall significant downregulation of the mRNA expression of EMX1, 
EOMES and FOXP2. Emx1 is part of the EMX family, in mouse study, this gene was 
shown to be restricted to the dorsal telencephalon while Emx2 is expressed in the dorsal 
and ventral telencephalon. Our data suggested a downregulation of 55% of EMX1. 
Interestingly, while studies using homozygous knockout for Emx1 provide evidence 
regarding its role in cortical aeralization, others showed that Emx1 knockout reduced the 
migratory capacity of the neural stem cells (Kobeissy et al. 2016; Muzio et al. 2003). It 
would be interested to determine if this decrease at the mRNA level would result to a 
118 
 
decrease at the protein level using western blot. We could also perform 
immunocytochemistry to examine whether the proportion of cells positive for EMX1 are 
also decreased in ZDHHC8+/-. Similarly, Eomes is important for neurogenesis as it 
promotes the generation and proliferation of IPCs in vivo. Thereby, TBR2 depletion in 
the mouse cortex was demonstrated to decrease the proliferation of cells from the SVZ 
but also decrease the proportion of IPCs which overall led to a decrease of the cortical 
plate (Sessa et al. 2008). While we observed an increase in cell proliferation at day 15, it 
would be interested to examine whether this alteration in proliferation still occurs at later 
time point when cells that express TBR2 are generated. FOXP2 encodes a protein which 
is mainly expressed by deep layer neurons in the cortex. Loss of FOXP2 has been 
associated with severe speech and language disorders. As patients with 22q11.2DS were 
also observed to have delay in the emergence of speech it would therefore be interested 
to investigate whether it could be due to ZDHHC8 (Solot et al. 2001). Therefore, 
immunocytochemistry that would examine the proportion of cells positive for EMX1, 
FOXP2 and TBR2 but also the quantification of these proteins by western blot would 
enable us to determine whether these alterations at the mRNA level are associated with a 
difference at the protein level between ZDHHC8+/- and the control condition. 
Interestingly, we observed an upregulation of GAD1 (Figure 4-17J). This gene is known 
to be enriched in inhibitory neurons and is responsible of the decarboxylation of glutamate 
to GABA (Erlander et al. 1991; Fenalti et al. 2007). Although small proportion of 
inhibitory neurons are always found in our excitatory projection neurons protocol, we 
observed an upregulation of GAD1 expression by day 80 in the KO for ZDHHC8 which 
might suggest a higher propensity of the remaining mitotic cells to differentiate towards 
inhibitory neurons. However, two genes are responsible of the decarboxylation of GABA, 
while GAD1 is localized throughout the cell, GAD2 (GAD65) was instead observed to be 
mostly localized at the synapses (Soghomonian et al. 1998). To determine if ZDHHC8 
heterozygous alters the proportion of GABAergic cells it would be interesting to derived 
hESCs deficient for ZDHHC8 using a protocol of cortical interneurons. Furthermore, it 
would also be interested to evaluate the proportion of both GAD65 and GAD67 positive 
cells in our culture. 
The proportion of the synaptic protein PSD-95 and VGLUT1 were shown to be impaired 
in Zdhhc8+/- and Zdhhc8-/- mouse model (Mukai et al. 2008). In this study, we showed 
that both SLC17A7 and SLC17A6 mRNA were downregulated. VGLUT1 and VGLUT2 
are mainly expressed by glutamatergic neurons but not exclusively. These proteins are 
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responsible for glutamate uptake into synaptic vesicles, thus their alteration could affect 
the glutamatergic synaptic transmission (Vigneault et al. 2015; Zander et al. 2010). 
Studies investigating the role of VGLUT1 identified that mice homozygous knockout 
despite not showing phenotypic change at birth, presented severe coordination 
impairment, learning and memory deficits (Takamori 2006). On the other hand, VGLUT2 
is predominantly expressed during embryonic development and homozygous knockout is 
lethal immediately after birth(Wallén-Mackenzie et al. 2010). Although we observed a 
downregulation of both SLC17A7 and SLC17A6, we have no indication whether their 
reductions result in a decrease of their proteins level. It would therefore be interesting to 
address this question by quantifying the proportion of both VGLUT1 and VGLUT2 
proteins in mature neurons but also to identify whether these proteins could be 
palmitoylated by ZDHHC8. 
PSD-95 is a major scaffolding protein localized at the postsynaptic density of excitatory 
glutamatergic neurons (Gomperts 1996). It allows the clustering of the different synaptic 
proteins such as AMPA and NMDA receptors (Chen et al. 2015). PSD-95 alteration has 
been associated with neurodegenerative disorder but also psychiatric disorders such as 
schizophrenia and ASD (Catts et al. 2015; Shao et al. 2011; Xing et al. 2016). Despite 
our study did not reveal an alteration of the DLG4 expression it did not indicate whether 
ZDHHC8+/- protein is altering PSD-95 protein. Indeed, several studies demonstrated that 
in order to be correctly addressed to the postsynaptic membrane, PSD-95 required to be 
palmitoylated (El-Husseini et al. 2000). Interestingly, the palmitoylation enzyme was 
shown to be ZDHHC8 which upon phosphorylation by the brain specific PKC isoform 
protein kinase Mζ (PKMζ) is able to palmitoylate PSD-95 (Yoshii et al. 2011; Yoshii et 
al. 2014). In addition, mouse model of 22q11.2DS demonstrated a decrease proportion of 
PSD-95, interestingly a similar phenotype was observed in mouse deficient for Zdhhc8. 
Therefore it was postulated that the decrease of PSD-95 in mouse model of 22q11.2DS 
could be attributed to the loss or the alteration of the palmitoyl activity of ZDHHC8 
(Mukai et al. 2008). Using acyl-biotin exchange in our ZDHHC8+/- heterozygous, we 
could identify whether PSD-95 requires to be palmitoylated by ZDHHC8 furthermore it 
would allow us to identify additional proteins that are targeted by ZDHHC8.  
Neuronal migration occurred in two distinct mechanism in the forebrain, by radial or 
tangential migration (Nadarajah et al. 2002). While radial migration is thought to be the 
principal mode of migration of cortical excitatory neurons, the cortical interneurons are 
migrating from the MGE and LGE through tangential migration. Thus, the correct 
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position of neurons within the brain is essential for the correct neuronal circuitry. 
Alteration can therefore be responsible of several disorders such as schizophrenia (Rehn 
et al. 2005). Migrating neurons are known to be highly polarized in the direction of their 
movement (Marín et al. 2010). Neuronal migration which is also called locomotion is 
composed of three steps. First, cells extend a leading process which then lead to the 
translocation of the nucleus and finally, the cell retracts all its processes. The leading 
process usually acts as a compass by migration toward or avoiding chemotactic cues. 
Migration is dependent on different mechanisms which involved adhesion molecule such 
as N-cadherin or SEMA3A receptor, both were shown to be important for the regulation 
and stability of the processes (Chen et al. 2008; Jossin et al. 2011). On the other hand, 
regulation of intracellular signalling involves proteins like slit-robo or GTPase activating 
protein (srGAP2) which stimulates branching and thus slows the migration (Guerrier et 
al. 2009). Our data identified that neuronal progenitor cells deficient for ZDHHC8 
showed indication of migration defect. Future work would be needed to identify which 
steps of the migration process was altered and also identified which genes/proteins is 
associated with this alteration. Neurons from primary neuronal culture of Zdhhc8+/- mice 
was shown to exhibit shorter axons and dendritic arborisation which were demonstrated 
to be due to a defect in CDC42 palmitoylation, a protein part of the Rho GTPase family. 
As Rho GTPases are a regulator of radial migration it might therefore be interesting to 
identify whether other members of this family are affected by ZDHHC8 mutation such as 
Rac1 which is known to affects lamellipodia and therefore important for axonal growth 
(Ng et al. 2004; Woo et al. 2006). 
In order to determine whether ZDHHC8 mutation altered the physiology of the neurons, 
we decided to use calcium imaging as a readout for neuronal function. Here, we identified 
that glutamatergic neurons deficient for ZDHHC8 exhibited an increased calcium activity 
compared to control. Indeed, these neurons have a higher amplitude as well as an increase 
in the number of spontaneous calcium transients. We also identified that the calcium 
activity was first asynchronous but over the course of differentiation gradually become 
synchronous, suggesting that these neurons form connexion. This switch in their activity 
might explain the strong decrease in spontaneous calcium events occurring in the control 
at day 110. Indeed, by day 130, control neurons exhibited a large increase in the number 
of events which kept increasing until day 150 therefore the pattern at day 110 is likely to 
be due to the switch from an asynchronous to a synchronous activity. In addition, these 
data also showed that this switch might happen earlier in the ZDHHC8 heterozygous 
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mutant compared to control as we did not observe alteration of the number of calcium 
events in this population during our recordings. To determine whether synchronisation 
involves the appearance of more synaptic connexion, we could use the advantage of the 
modified rabies virus (Reardon et al. 2016). Indeed, this technique allow to map 
monosynaptic connexion through retrograde trans-synaptic transfer. Furthermore, during 
neuronal development, spontaneous calcium activity regulates many processes including 
neuronal migration, axonal outgrowth, dendritic patterning and synaptic receptors 
maturation (Komuro et al. 1998; Spitzer 2006; Wong et al. 2002). Calcium concentration 
is characterized by the balance between influx and efflux (Grienberger et al. 2012). 
Therefore, several studies focused on identifying the compartment or receptors from 
which the calcium activity arise (Kirwan et al. 2015). It would therefore be interesting to 
identify in a similar way which synaptic receptors are responsible of the spontaneous 
calcium activity. This could be achieved by using drugs which are known to block 
specifically a receptor and then record the subsequent calcium activity. Furthermore, it 
was demonstrated that ion channels as well as voltage gated calcium channels required to 
be palmitoylated to be correctly addressed to the pre and post-synaptic membrane 
(Shipston 2011). Furthermore, study have suggested that palmitoylation might regulate 
calcium channel inactivation (Hurley et al. 2000). As in our study we observed an overall 
increase in spontaneous calcium activity it might suggest that one of these channels 
require palmitoylation by ZDHHC8 and therefore might explain the increase in the 
calcium activity in ZDHHC8+/-. 
 
Previous studies have demonstrated the utility of protein palmitoylation for their correct 
function and localization. While in this study we obtained a heterozygous mutant for 
ZDHHC8, we currently have no data assessing the resulting proteins level of potential 
target of ZDHHC8. However, the Figure below represents a schematic representation of 
what we should expect with our mutant ZDHHC8 and therefore might explain our motility 
and calcium data. While in normal condition, PSD-95 proteins receive the addition of a 
palmitate by ZDHHC8 and therefore are properly targeted to the postsynaptic membrane. 
In ZDHHC8+/- due to the expected reduction in the palmitoyl activity, we suggest, that 
ZDHHC8 protein would be unable to palmitoylate all PSD-95 proteins therefore would 
result to a PSD-95 impairment at the postsynaptic membrane. It was noteworthy that this 
example is expected to apply for other proteins than PSD-95. Indeed, the impaired 
motility observed in our NPCs heterozygous for ZDHHC8+/- could result from impaired 
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CDC42 palmitoylation which are thought to be a protein involved actin cytoskeleton. In 
addition, we also suggest that the increase of calcium activity in ZDHHC8+/- could result 
from either a decrease palmitoylation of a protein responsible of calcium channel 
inactivation or else the decrease of a specific channel or voltage gated channel at the 
surface of neurons. 
 
 
To summarize our data from this chapter, it is the first time a hESC line heterozygous for 
ZDHHC8 was generated. While no defect was observed at the embryonic stem cells level, 
we identified several genes (Figure below) whose expression was suggested to be 
downregulated in red and upregulated in green by the ZDHHC8 heterozygous mutation. 
Figure 4-22 Putative PSD-95 protein palmitoylation defect at the postsynaptic membrane. In normal 
condition, vesicle carrying ZDHHC8 protein are transported towards the dendritic spine (1). The 
palmitoyltransferase activity of ZDHHC8 will result to the addition of a 16C fatty acid onto the protein (2) 
which will enable its targeting and insertion to the postsynaptic membrane (3 and 4). PSD-95 will then be 
depalmitoylated (5, 6). In ZDHHC8+/-, while the protein is expected to still be able to be transported to the 
spine (1’), the palmitoyltransferase activity which is expected to be reduced by half (2’) would result to 
only a fraction of the proteins to be palmitoylated which imply that only proteins with the palmitate will be 
able to be properly adressed to the membrane (3’ and 4’). The protein will similar to control be 
depalmitoylated (5’ and 6’). 
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Furthermore, phenotypic characteristic of the motility and spontaneous calcium activity 
respectively identified decrease (red) and increase (green) in NPCs and neurons deficient 
for ZDHHC8.  
While motility defect has been observed in 22q11.2 carriers, it’s too early to conclude 
whether the increase in spontaneous calcium activity resulted with an increase in 
neurotransmitter release as demonstrated in patient carrying a 22q11.2 deletion (Earls et 
al. 2010), however further study should consider to identify the proteins targeted by 
ZDHHC8 in order to elucidate its role during these processes. 
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5. Transcriptomic analysis of neural progenitors derived from 
ZDHHC8 +/- hESCs and 22q11.2DS iPSCs 
 
5.1. Introduction 
Individuals with 22q11.2DS have higher probability to develop psychiatric disorders such 
as schizophrenia. Whereas the 22q11.2 pathology has already been intensively studied 
using engineered animal model, the possibility of reprogramming fibroblast into iPSCs 
allows investigations into 22q11.2DS in a human setting. Several studies already reported 
the successful reprogramming fibroblasts from 22q11.2 patients into iPSCs which were 
subsequently differentiated into neuronal fate (M. Lin et al. 2016; Pedrosa et al. 2011). 
Lin et al. has previously performed a RNA sequencing (RNA-seq) study using iPSCs 
lines derived from eight 22q11.2 patients and seven control subjects (M. Lin et al. 2016). 
IPSCs were differentiated to a mix population of glutamatergic and GABAergic cortical 
neurons (Marchetto et al. 2010). The study revealed a 2-fold reduction of almost all of 
the transcripts from genes of the 22q11.2 region except CLDN5 and TBX1. Amongst the 
12981-proteins coding transcripts identified, 782 were differentially expressed between 
the controls and 22q11.2 neurons. Gene ontology (GO) terms enrichment analysis 
identified dysregulated genes related to apoptosis as well as immune response while GO 
terms related to cell cycle, glutamate metabolic process and synaptic transmission were 
upregulated.  
Despite the generation of mouse model homozygous and heterozygous for zdhhc8, the 
transcriptome of these mice remains unknown. In the previous chapter, we showed that 
hESCs heterozygous for ZDHHC8 had an increase neuronal rosette area. Neuronal 
rosettes express several markers of neurectoderm and form columnar structure that mimic 
the formation of the neural tube in vivo. Cells within the rosettes are capable of 
symmetrical division to constitute the pool of cells which will become neurons. 
Furthermore, our study on neurons derived from hESC heterozygous for ZDHHC8 
revealed an increase in cells proliferation which was assessed by Ki67 immunostaining. 
In addition, we discovered that excitatory neuronal progenitors were migrating slower 
and less when compared to neuronal progenitors from an isogenic control. Finally, 
evaluation of the neuronal calcium activity revealed alterations in neurons mutant for 
ZDHHC8. As several aspects of the development of neuronal progenitor was suggested 
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to be affected in ZDHHC8+/- progenitor cells, we decided to investigate whether specific 
neuronal pathways were affected in our model. To our knowledge, how ZDHHC8 
deficiency affects gene expression has not been reported. Therefore, transcriptomic 
analysis would be able to shed light on molecular pathways regulated by ZDHHC8.  
Due to the availably of fibroblasts from carrier of a 22q11.2DS, we generated our own 
22q11.2 iPSCs. In a pilot experiment performed by Alessandro Sperandeo, both control 
and 22q11.2 iPSCs were differentiated using a protocol of cortical excitatory projection 
neurons. During neuronal rosettes formation that usually occurs at the NPCs stage, we 
observed an alteration of their morphologies exhibiting various shapes (unpublished 
data). While, immunofluorescences examination of the developing forebrain marker 
FOXG1 and the neuroectodermal marker PAX6 suggest that both cells line correctly 
convert to neuronal fate, the proportion of cells positive to PAX6 was observed to be 
significantly decreased in 22q11.2 NPCs. In addition, the proportion of SOX2 positive 
cells, was observed to be decreased in 22q11.2 NPCs. SOX2 is a transcriptional factor 
crucial for stem cells regulation, furthermore, this protein is also important for the 
proliferation and maintenance of dorsal telencephalic neuronal progenitor cells (Zappone 
et al. 2000). 
Therefore, in this chapter we performed a genome wide transcriptomic analysis using 
excitatory neuronal progenitors at day 15 derived from a line of 22q11.2 iPSCs (E11), a 
line of control iPSCs (900), a hESCs line heterozygous for ZDHHC8 (541) and its 
isogenic control (cas9).  
 
Aims 
- To differentiation hESCs and iPSCs (iCas9’control’, 541’ZDHHC8+/-’, 
900’control’ and E11’22q11.2’) in a protocol of excitatory projection neurons. 
- To compare the transcriptome of ZDHHC8 mutant with the control 
- To determine whether genes overlap between ZDHHC8+/- and 22q11.2 neuronal 
progenitors 
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5.2. Results 
5.2.1. Experimental design and quality control of RNA samples 
Four different cell lines were used for the purpose of this experiment a ZDHHC8 
heterozygous line (541) and its isogenic control (iCas9), a control iPSCs from a healthy 
subject (900) and a 22q11.2 line. All four-cell line were differentiated using a protocol of 
cortical excitatory projection neurons (Chambers et al. 2009; Espuny-Camacho et al. 
2013). The experimental procedure for neuronal differentiation was illustrated in Figure 
5.1. At day 15 of differentiation, RNA samples from 6 biological replicates per cells line 
were extracted. 
 
 
 
5.2.1.1. Immunofluorescence of glutamatergic progenitors 
To verify whether our different cells line properly commit to neural fate, we stained our 
cultures of cortical progenitors which were fixed on the same day of the RNA extraction 
at day 15 (Figure 5.2). PAX6 and FOXG1 antibody were used as markers of 
neuroepithelial and telencephalic cell markers respectively. A high proportion of PAX6 
and FOXG1 positive cells were observed in all four lines which suggest a proper 
induction into cortical progenitors. 
Figure 5-1 Glutamatergic neurons differentiation. Schematic of the cortical excitatory neuronal 
progenitor’s differentiation. The grey area is representing the timeline; the blue area represents the different 
coating composition while the red area is the media composition. At day 15 all RNA samples were 
extracted, 6 biological replicates per cell line. The concentration of LDN and SB are described in 2.2.3.1 
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5.2.1.2. RNA and cDNA quality control 
RNA samples were run on a bioanalyzer in order to control for the purity of the RNA. 
This technique allows to determine whether the two ribosomal RNA subunits 28S and 
18S are intact. Over the 24 samples (6 biological replicate per cell line), all had a RNA 
integrity Number (RIN) over 8.70.  
Samples were further processed for the library preparation and subsequently the quality 
of the cDNA was examined using the Qubit DNA High Sensitivity Kit (life technologies) 
while the size was controlled with the DNA High Sensitivity Kits (Agilent) The results 
indicated that all cDNA samples achieved an appropriate purity for being processed on 
the sequencer (HiSeq 4000, Illumina).  
 
 
 
Figure 5-2 Glutamatergic neurons progenitors. NPC at day 15 were fixed and subsequently stained with 
antibodies against PAX6 (green) and FOXG1 (red). Cells were counterstained with the nuclear marker 
DAPI (blue). A, NPCs control Cas9. B, NPCs deficient for ZDHHC8. C, control NPCs derived from iPSCs 
900. D, 22q11.2 NPCs derived iPSCs from 22q11.2 patient. Scale = 50µm.  
128 
 
5.2.2. Analysis of the heterozygous ZDHHC8 transcriptome 
To analyse the data collected by the Illumina HiSeq4000, the reads were first aligned on 
the human genome, hg38. To perform this step, the Spliced Transcripts Alignment to a 
Reference (STAR) protocol was used in Unix (Dobin et al. 2013). The outcome of the 
STAR analysis was a text file which contained all the different genes with their respective 
number of reads per samples. To determine the differentially expressed genes, data were 
processed using DESeq2 package in R (Love et al. 2014).  
Genome wide RNA-Seq coverage of the ZDHHC8 sequences were visualized using IGV 
(Integrative Genomic viewer). Figure 5.3A illustrates an image encompassing the region 
of exon 3 and 4 of ZDHHC8 from 6 biological replicates for the mutants and controls. 
There was a decrease in the number of reads in the ZDHHC8 mutation region compared 
to the controls. It was noteworthy that IGV only displayed a random number of samples 
on the alignment, thereby, region with high reads were downsampled. Therefore, exons 
count would be more suitable to evaluate whether the number of reads in the region of 
ZDHHC8 deletion is reduced. 
The Principal Component Analysis (PCA) is a useful tool to visualize genetic distance 
between populations and reveals which components of the data cause variability in the 
data set (Figure 5.3B). PC1 captures the direction with the most variation in gene 
expression while PC2 captures the direction with the second most variation in gene 
expression. Thereby, Figure 5.3B displayed that all samples for cas9 and 541 respectively 
controls and mutants are located on the left and right of the PCA. This graphic therefore 
indicated that 70% of the variation, which is the biggest variation in our samples, is 
attributed to the deletion. On the other hand,13% of the variation which corresponded to 
the PC2 was attributed to the variation between our biological replicates. 
DESeq2 analysis identified 23421 genes in total (Figure 5.3C). Of which, 64.24% of the 
genes (15046 genes) are protein coding. By applying a specific cut-off for the pvalue 
adjusted below 0.01, we found that 0.86% (130 genes) of the genes were downregulated 
while 0.41% (62 genes) were upregulated of an absolute FC superior to 1.5. As a result, 
the transcript of 98.73% (14854) of the genes did not show statistical significance 
between ZDHHC8 mutants and controls.  
Together, these data demonstrated that a total of 192 genes were found to be differentially 
expressed in ZDHHC8+/-. 
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Figure 5-3 Variability due to ZDHHC8 mutation. A, 
RNA seq coverage of the exon 3 and 4 of ZDHHC8 which 
represents the number of reads. B, PCA of the biological 
replicates of Cas9 (control) and 541 (ZDHHC8+/-) in blue 
and red respectively. C, Pie chart categorizing all the 
genes in our data set. FC strictly superior or inferior to 0 
are in red and blue respectively. Genes with a p value 
adjusted inferior to 0.01 are in green while those with both 
a p value adjusted inferior at 0.01 and an absolute FC 
superior at 1.5 are in yellow. 
- 
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Figure 5-4 Gene expression of the 22q11.2DS genes. All genes from the 3Mb deletion were displayed on this plot. Control samples (cas9) were represented in grey while the mutant 
ZDHHC8+/- (541) were in red. The pvalue for each gene was written above each boxplot. Only significant pvalue was written in red. Data for each gene represented the normalized 
count. Data are represented as the median ± SD 
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5.2.2.1. Expression of 22q11.2 genes in ZDHHC8-deficient cells 
The expression of the 22q11.2 genes in ZDHHC8 heterozygous knockout cells were 
analysed (Figure 5.4). Only 37 out of 48 genes in the 22q11DS region between LCRA 
and D were detected in our analysis. Amongst them only TXNRD2 and COMT exhibited 
statistical difference between the control and ZDHHC8+/- (PTXNRD2 = 0.00048, PCOMT = 
0.000081). Indeed, these two genes were observed to be upregulated in ZDHHC8+/- 
NPCs. However, it was noteworthy that we had very low reads for these two genes in the 
control condition therefore only a small change could result in a significant change in the 
mutant condition. 
5.2.2.2. Cross comparison of GO terms and KEGG pathways altered in 
ZDHHC8+/- 
5.2.2.2.1. GO terms analysis 
Gene ontology analysis revealed a total of 318 GO terms enriched in our data from which 
the top genes related to neuronal development are displayed in Table 5-1. Interestingly, 
the majority of the GO terms are related to neurons. The top four GO terms with the 
smallest p value relates to synaptic transmission. Furthermore, 18 of the top 30 GO terms 
directly relates to the brain suggesting that ZDHHC8 function is mostly involved in brain 
development and/or its physiology.  
 
Table 5-1 Gene Ontology enrichment analysis 
ID Description p.adjust Gene ratio 
GO:0007268 Chemical synaptic transmission 1.97E-12 122/1597 
GO:0098916 Anterograde trans-synaptic signalling 1.97E-12 122/1597 
GO:0099536 Synaptic signalling 1.97E-12 122/1597 
GO:0099537 Trans-synaptic signalling 1.97E-12 122/1597 
GO:0005578 Proteinaceous extracellular matrix 2.12E-12 82/1682 
GO:0061564 Axon development 3.92E-12 106/1597 
GO:0003002 Regionalization 1.26E-11 75/1597 
GO:0007411 Axon guidance 1.26E-11 65/1597 
GO:0045596 Negative regulation of cell differentiation 1.26E-11 1181597 
GO:0097485 Neuron projection guidance 1.34E-11 65/1597 
GO:0007409 Axonogenesis 1.41E-11 98/1597 
GO:0007389 pattern specification process 1.52E-11 91/1597 
GO:0030900 forebrain development 1.57e-11 86/1597 
GO:0048667 cell morphogenesis involved in neuron differentiation 3.97E-11 112/1597 
GO:0048812 neuron projection morphogenesis 4.07E-11 119/1597 
GO:0010721 negative regulation of cell development 8.02E-11 72/1597 
GO:0001655 urogenital system development 2.48E-10  
GO:0072001 renal system development 4.54E-10  
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GO:0051961 negative regulation of nervous system development 6.85E-10 68/1597 
GO:0050768 negative regulation of neurogenesis 1.12E-09 64/1597 
GO:0001822 kidney development 1.26E-09  
GO:0035295 tube development 2.04E-09 11/1597 
GO:0045165 cell fate commitment 2.45E-09 55/1597 
GO:0021953 central nervous system neuron differentiation 1.33E-08 47/1597 
GO:0031012 extracellular matrix 3.10E-08 96/1682 
GO:0042330 taxis 4.05E-08 94/1597 
GO:0001764 neuron migration 5.27E-08 41/1597 
GO:0048589 developmental growth 5.93E-08 106/1597 
GO:0006935 chemotaxis 7.16E-08 93/1597 
GO:0072073 kidney epithelium development 1.35E-07  
 
Genes from three GO terms, axon development/migration, neurogenesis/brain 
development and synaptic signalling were identified (Figure 5.5A, B and C). Thereby, 
we investigated amongst the 192 differentially expressed genes those belonging to one of 
these categories (p < 0.001; -1.5 < FC > 1.5). Interestingly, when analysing the other 
genes from the different GO terms present in table 5-1, we found that it was the same 
gene. Therefore, we can say that the genes presented below are representative of the genes 
identified by GO terms. 
Interestingly, most of the genes involved in axon development were upregulated. This 
include three members of the SLIT family, SLIT1, SLIT2 and SLIT3. Conversely, 
LRRC4C, SEMA5A and SLITRK3 are three of the top downregulated genes (Figure 5.5A). 
Likewise, several genes involved in neurogenesis/brain development were upregulated in 
our data set (Figure 5.5B). Three genes from of the Wnt family were identified, WNT8B, 
WNT7B and WNT2A were shown to be upregulated in ZDHHC8+/-. On the other hand, 
FOXG1 expression was shown to be downregulated. Two members of the Wnt receptors 
family Frizzled, FZD5 and FZD8 were shown to be also downregulated. 
Although, we were not expecting genes whose expression are only expressed in mature 
cells to be expressed in NPCs, we found, eleven differentially expressed genes part of GO 
terms related to synaptic signalling (Figure 5.5C). CHRM3 gene which encodes for the 
cholinergic/acetylcholine receptor M3 was shown to be downregulated. DRD2 and DRD4 
which are dopaminergic receptors were also upregulated. In addition, GRIA2, a subunit 
of the AMPA receptor was also upregulated in ZDHHC8+/-. 
To conclude, GO terms analysis revealed that several genes belonging to the brain 
development and its physiology were altered in ZDHHC8+/-. 
 
133 
 
Neurogenesis/Brain development   Axon development 
Gene 
Name 
Normalised counts Fold 
change 
 Gene 
Name 
Normalised counts Fold 
change ZDHHC8+/- Control  ZDHHC8+/- Control 
BARHL1 543.14 118.32 3.26  GDF7 102.34 15.87 2.78 
CBLN1 95.94 21.50 2.75  SLIT2 2679.68 924.35 2.69 
WNT8B 4159.32 1597.19 2.41  BAHRL2 63.86 19.45 2.03 
WNT7B 8521.96 4197.0 1.98  LHX1 267.12 119.93 1.97 
RSPO2 199.16 86.63 1.93  SLIT3 441.94 216.94 1.90 
FZD10 49.05 13.57 1.90  FGFR2 4775.62 2725.93 1.71 
WLS 9699.55 4782.76 1.89  POU4F1 35.83 12.17 1.69 
HES3 40.61 12.35 1.84  LMX1A 20.17 3.70 1.65 
S1PR8 82.46 36.15 1.81  SLIT1 606.88 357.36 1.59 
SPOCK1 1589.43 886.97 1.73  NEFM 1723.37 1053.78 1.58 
SOX10 160.22 83.11 1.72  CNTN4 196.07 114.47 1.56 
OLIG3 39.78 14.14 1.67  OLFM1 557.97 349.15 1.55 
VTN 99.02 46.53 1.66  GAP43 246.12 149.04 1.54 
1ERBB4 87.83 38.88 1.62  PTPRM 2174.16 1392.57 1.52 
ONECUT2 389.15 223.48 1.61  FOXB1 40.66 19.78 1.51 
BOK 129.31 71.12 1.60  CNTN2 2208.58 1393.68 1.51 
SALL3 1111.51 659.30 1.57  GFRA1 1773.55 1151.02 -1.50 
WNT2B 1206.41 739.34 1.56  INPP5F 6102.45 9585.42 -1.55 
MSX1 38.88 16.61 1.56  LRRC4C 523.64 836.52 -1.55 
ETS1 171.11 100.76 1.55  GFRA2 178.83 294.44 -1.57 
NGEF 211.38 126.90 1.54  SEMA5A 1113.25 1901.92 -1.60 
TBR1 668.06 395.27 1.54  SLITRK3 57.33 124.83 -1.80 
CNTN1 77.75 41.50 1.54  VAX1 26.75 85.50 -1.95 
HEY2 40.68 19.56 1.52      
DLC1 285.33 171.91 -1.50  Synaptic signalling 
FOXG1 4497.42 7680.20 -1.66  Gene 
Name 
Normalised counts Fold 
Change POU3F3 551.25 988.73 -1.71  ZDHHC8+/- Control 
FZD8 377.38 710.10 -1.75  CBLN1 95.94 21.50 2.75 
ID2 333.86 654.00 -1.82  DRD2 74.18 28.43 1.93 
DIOD3 19.01 86.60 -2.27  P2RX3 702.31 360.70 1.81 
FZD5 1579.45 4687.94 -2.34  DRD4 668.43 379.90 1.70 
     GRIA2 195.57 90.70 1.66 
     PCDHB5 353.06 207.13 1.60 
     SYT5 82.01 42.55 1.59 
     SLC6A1 54.39 27.33 1.56 
     PDYN 16.99 4.25 1.54 
     GJD2 21.79 5.52 1.50 
     CHRM3 63.93 110.85 -1.55 
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5.2.2.2.2. KEGG pathways analysis 
In addition to GO enrichment analysis, data were processed to examine the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathway enrichment which are predicted 
to be altered in ZDHHC8+/-. A total of 18 pathways were shown to be altered by 
ZDHHC8 mutation with several relating to the brain and heart pathologies (Table 15). 
For the purpose of this thesis, only pathways related to the brain will be presented. These 
pathways were associated to neuronal receptors, calcium signalling and axon guidance. 
 
Table 5-2 KEGG pathway enrichment analysis in ZDHHC8+/- 
KEGG ID Description p.adjust 
hsa04080 Neuroactive ligand receptor interaction 0.00074532 
hsa04020 Calcium signalling pathway 0.00074532 
hsa05410 Hypertrophic cardiomyopathy (HCM) 0.00074532 
hsa04512 ECM-receptor interaction 0.00074532 
Figure 5-5 GO enrichment in ZDHHC8+/-. The plots 
are representing genes belonging to three different 
categories identified in our GO analysis. Gene represented 
in red are those which were upregulated while those in 
blue were downregulated. A, genes part of the GO term 
axons development/neuronal migration. B, genes 
identified in the GO term forebrain development. C, gene 
identified in the GO term synaptic signalling. From the 
different GO terms which contains several hundreds of 
genes each, we applied a specific threshold in order to 
only identify genes in our dataset that had a pvalue 
adjusted below 0.01 as well as an absolut FC higher than 
1.5. The X-axis represents the fold change (FC) 
difference. 
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hsa03010 Ribosome 0.00074532 
hsa04514 Cell adhesion molecules (CAMs) 0.000929825 
hsa05414 Dilated cardiomyopathy (DCM) 0.000929825 
hsa05412 Arrhymogenic right ventricular cardiomyopathy (ARVC) 0.002446221 
hsa04713 Circadian entrainment 0.007926987 
hsa04060 Cytokine-cytokine receptor interaction 0.008085623 
hsa03040 Spliceosome 0.014207723 
hsa04974 Protein digestion and absorption 0.016332156 
has04213 Longevity regulating pathway – multiple species 0.034047458 
has04670 Leukocyte transendothelial migration 0.034047458 
has04360 Axon guidance 0.037029985 
has04120 Ubiquitin mediated proteolysis 0.048523161 
hsa04510 Focal Adhesion 0.048523161 
hsa04141 Protein processing in endoplasmic reticulum 0.048523161 
 
Figures 5.6 and 5.7 illustrate three neuronal pathways altered by ZDHHC8 mutation.  
Pathway involved in synaptic receptors Figure 5.6A. This pathway represents a map of 
the different neuronal receptors together with their ligands altered in ZDHHC8+/-. The 
analysis identified that mRNA expression of genes coding for Epinephrine and 
Norepinephrine receptor (ADR) were upregulated. as well as the family of the dopamine 
receptor (DRD). Conversely, the expression of genes coding for the 5-hydroxytryptamin 
(5-HT) also known as serotonin receptor were found to be downregulated. In addition, it 
also appeared that the expression of genes coding for NMDA (GRIN), GABA (GABR) 
and AMPA (GRIA) receptors were also upregulated in ZDHHC8+/-. On the other hand, 
the expression of the CHRN genes family which encoded for the acetylcholine receptors 
were downregulated. However, it was noteworthy that these data did not indicate which 
subunits of these receptors were affected.  
Pathway involved in calcium signalling (Figure 5.6B). As presented in the general 
introduction, extracellular calcium is the main source of Ca2+ for the cells and is involved 
in a multitude of physiological functions even in young NPCs. Many genes coding for 
receptors responsible of calcium uptake were upregulated, which include the voltage gate 
calcium channel CaV2 and CaV3 and also the receptor operated channels (ROC) which 
comprised most of the ionotropic receptors such as AMPA and NMDA. GPCR were also 
observed to be downregulated, upon activation by an extracellular signal which can be a 
neurotransmitter, theses receptors are involved in signal transduction either through 
cAMP or phosphatidylinositol signalling pathway. We also observed that genes such as 
the gene coding for the inositol 1,4,5-trisphosphate receptor, type 1 (ITPR1) and the 
calmodulin are also upregulated by ZDHHC8+/-. 
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Figure 5-6 KEGG enrichment pathways. A-B, the intensity which is represented in the top right corner 
of each schematic shows the FC of each gene, from green and red respectively a FC of -5 and 5. A, 
Neuroactive ligand receptor interaction. B, Calcium signalling pathway. The analysis had as parameter a p 
value cut off of 0.05. Figure can be found at higher magnification in annexe 
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Pathway involved in axon guidance (Figure 5.7). In addition to be one of the top GO term 
enriched in our analysis, the axon guidance pathway was also revealed by KEGG 
enrichment analysis. This pathway is primordial for the proper growth of axons which 
ultimately lead to novel synaptic connexion. As shown in Figure 5.7, the expression of 
genes of the SLIT family were upregulated. It also appeared that the expression of ROBO 
which encodes for the SLIT receptors are likewise upregulated. Similarly, Plexin B, a 
receptor of semaphorins and EphA, a ephrin receptor, were both upregulated in 
ZDHHC8+/-. Conversely, a strong downregulation was observed for TRPC (Transient 
Receptor Potential Channel), which is responsible for axons attraction and outgrowth. 
Finally, NGL-1 also known as LRRC4C, was also downregulated. Together, KEGG 
pathways analysis established that several signalling pathways were found to be altered 
by heterozygous knockout of ZDHHC8. 
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5.2.3. Differentially expressed genes of a 22q11.2 hPSC derived NPCs 
Analysis of the 22q11 iPSCs derived into excitatory NPCs revealed that a CNV might be 
located on the chromosome 17 in the iPSCs from 22q11.2 NPCs as 25 genes in the vicinity 
of TP53 were observed to be half expressed when compared to the control cells. The 
function of this gene was suggested to impact the viability of cells (Amir et al. 2017). 
Therefore, we decided to only investigate the expression of the of the 3Mb deletion in the 
22q11 iPSC derived NPCs (Figure 5.8). 
Figure 5-7 Axon guidance pathway is altered in ZDHHC8+/-. The intensity of red and green represents 
either an upregulation or downregulation of the mRNA relative expression. A, Axonal guidance pathway.
The analysis had as parameter a p value cut off of 0.05. Picture can be found at higher magnification in 
annexe 
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We observed that 37 out of 40 genes were expressed in the 22q11.2 NPCs. However, it 
appeared that not the same genes were present in 22q11.2 and ZDHHC8+/- NPCs. The 
analysis revealed that 24 genes were significantly different in 22q11.2 NPCs when 
compared to the control NPCs. In contrast to the assumption that these genes would show 
reduced expression, many (DGCR6, PRODH, CLTCL1, C22ORF39, C22ORF29, 
RTN4R, MEP15, AIFM3 and HIC2) were in fact upregulated in the 22q11.2 iPSCs when 
compared to the control.  
While other studies did observe a reduction in the expression of the genes of the 22q11 
mutation, our analysis were unable to find similar result. Therefore, it would be interested 
to examine the number of reads per exons which should provide us with more information 
regarding the expression of these genes. 
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Figure 5-8 Gene expression of the 22q11.2DS genes in the iPS cells carrying the 3Mb 22q11.2 deletion. All genes from the 3Mb deletion were displayed on this plot. 
Control samples from the cell line 900 were represented in grey while the mutant E11 (22q11.2 deletion) were in blue. The pvalue for each gene was written above each 
boxplot. Only significant pvalue was written in red. Data for each gene represented the normalized count. The box plot allows to visualize the spread of the data as each point 
is representing a biological replicate. 
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5.2.4. Comparison of the differentially expressed genes in 22q11.2 and 
ZDHHC8+/-.  
To investigate whether ZDHHC8 deficiency and 22q11.2 deletion leads to the alteration 
of similar genes, we compared the overlap between the genes differentially expressed in 
ZDHHC8+/- and 22q11.2 iPSCs derived NPCs.  
Instead of comparing the transcriptome of control and mutant as performed in 5.2.2 and 
5.2.3, the DEseq2 analysis compared the transcriptome of the two mutants (22q11.2 and 
ZDHHC8+/-) and the two controls (900 and iCas9) with each other’s. In total, the analysis 
identified 24748 genes from which we performed a Venn diagram to identify the genes 
coding proteins overlapping between ZDHHC8+/- and 22q11 derived NPCs (Figure 5.9).  
Figure 5.9A illustrates the number of significant genes (pvalue < 0.01) overlapping 
between ZDHHC8+/- and 22q11.2 NPCs. We observed that each group is composed of 
7080 and 1176 for 22q11.2 and ZDHHC8 respectively. From these genes, it appeared that 
978 overlapped. Figures 5.9B and C illustrate the number of genes with a pvalue inferior 
to 0.01 and either a FC higher or below 1.5 or -1.5 respectively. We observed that 36 
genes with a FC superior to 1.5 appeared to overlap while only 15 genes with a FC below 
-1.5 overlapped between ZDHHC8 and 22q11.2 derived NPCs. 
Using similar cut off than in 5.2.2.2.1, we examined whether amongst the genes 
significant in 22q11.2 derived NPCs, we found overlap with significant genes identified 
in ZDHHC8+/-. Table 17 presents the genes identified in the GO terms neurogenesis and 
synaptic signalling that were significant in ZDHHC8+/- and 22q11.2 derived NPCs. 
While no genes from the axon development appeared to overlap, several genes from the 
neurogenesis and synaptic signalling GO terms was found in both populations. 
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Table 5-3 List of genes identified by GO terms in ZDHHC8+/- transcriptome analysis that overlap 
with 22q11.2  
Neurogenesis FC Average normalised counts 
541 (ZDHHC8) 22q11.2 541 (ZDHHC8+/-) 22q11.2 
HES3 2.74 1.72 41.67041321 77.54539634 
S1PR5 2.19 11.80 84.5717733 180.5516844 
SOX10 1.90 2.13 164.3187092 92.4346293 
FOXB1 1.84 1.67 41.70039398 89.3692161 
SPOCK1 1.65 1.65 1629.890056 2086.111991 
ATP8B1 1.83 1.84 38.07521853 48.45993288 
GBX2 1.66 3.08 40.87800978 172.0529326 
MMD2 1.66 2.00 22.21205691 36.49503382 
IRX3 1.62 1.52 88.57409616 236.1496279 
RELN 1.54 2.02 680.0307409 577.2294353 
     
Synaptic signalling     
GLRA4 1.70 2.33 29.22057558 41.04416266 
PCDHB5 1.64 11.27 362.0848839 1437.218139 
 
To conclude, despite 978 genes overlapped between 22q11.2 and ZDHHC8 when we 
apply a cut off for those with a pvalue below 0.01. This number drastically decreased 
when they were also classified depending on their FC. 
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5.3. Discussion 
In this study, we performed a whole transcriptome shotgun sequencing (also known as 
RNA-seq) analysis of ZDHHC8+/- glutamatergic progenitor cells with the aim 1) to 
analyse the transcriptome of ZDHHC8+/- derived NPCs, 2) to determine whether similar 
group of genes overlapped between 22q11.2 and ZDHHC8+/-.  
The first part of the study investigates if the 22q11.2 genes located in the region of the 
3Mb deletion were altered by ZDHHC8+/-. Apart from COMT and TXNRD2, the 
expression of the remaining 22q11.2 genes were similar when compared to the control. 
COMT expression was observed to be altered in individual with schizophrenia. The 
function of COMT was demonstrated to be responsible of the inactivation of dopamine 
neurotransmitter following its releases in the synaptic cleft. Individuals with 
schizophrenia were reported to have an increase mRNA level of COMT in the dorsolateral 
prefrontal cortex which was shown to be detrimental for the dopaminergic innervation 
(Matsumoto et al. 2003). Therefore, we suggest that ZDHHC8+/- might be responsible 
Figure 5-9 Venn diagramm illustrating the overlap between ZDHHC8+/- and 22q11.2 derived NPCs. This 
vendiagram is illustrating the number of significant genes (A) p < 0.01 in both condition while it illustates the 
number of significant genes p < 0.01 with -1.5 < FC > 1.5 in C and B.Green and red circle are respectivelly 
repsenting the number of genes in 22q11.2 and ZDHHC8+/- while both circle crossed correspond to the overlap 
between the22q11 and ZDHHC8. A, The 22q11 population is composed of 7080 genes while it is 1356 for 
ZDHHC8. Therefore, 978 genes were found to be similar. B, genes with a FC superior to 1.5. 22q11 and ZDHHC8 
are composed respetively of 1367 and 267 genes. In this condition, 36 genes overlapped between 22q11 and 
ZDHHC8. C, genes with a FC < -1.5. We found 1085 genes in 22q11,  103 genes in ZDHHC8 and 15 genes 
overlapped between the two. 
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of the increase in COMT expression, which therefore could result in decrease 
dopaminergic innervation in individuals with 22q11.2DS. Further studies should consider 
investigating whether these two genes interact.  
TXNRD2 is important for the development and function of the heart. Mice deficient for 
Txnrd2 die around E13.5 due to severe anaemia which resulted in part to an increase 
apoptosis in the liver that alter haematopoiesis but also due to a thinner ventricular walls 
of the heart and decrease of cardiomyocyte proliferation (Conrad et al. 2004; Kiermayer 
et al. 2015; Soerensen et al. 2008). Conversely, TXNRD2 overexpression was found to be 
associated with an increase lifespan in female Drosophila melanogaster, in addition 
overexpression of this gene was also found decrease the therapeutic effect of bortezomib, 
a proteasome inhibitor in multiple myeloma cells (Fink et al. 2016; Pickering et al. 2017). 
Although we identified several GO terms and KEGG pathways enrichment related to 
cardiac function such as Dilated cardiomyopathy (DCM), the relation between TXNRD2 
and ZDHHC8 if one remains largely unknown.  
The ZDHHC8+/- transcriptomic analysis identified 1203 proteins coding genes whose 
expression were significantly different between ZDHHC8+/- and its isogenic control 
(pvalue < 0.01), from which 192 genes had an absolute FC higher than 1.5. Interestingly, 
most of the GO terms identified were related to neurons development and physiology 
emphasising the role of ZDHHC8 during brain development.  
Axon development was identified as a top GO enriched term. Several genes related to 
axon development were demonstrated to be upregulated in ZDHHC8 +/-, such as the 
SLIT family (SLIT1, SLIT2 and SLIT3), LRRC4C, SEMA5A and SLITRK3. Interestingly, 
KEGG pathway enrichment analysis also identified the axonal guidance pathway as 
altered in ZDHHC8+/-. While axonal guidance defect was demonstrated to be responsible 
for neuronal migration disorder (NMD) such as lissencephaly, polymicrogyria or 
micropolygyria. Neuronal migration was also linked to schizophrenia and Parkinson 
disease (Gilman et al. 2012; Lesnick et al. 2007). 
The SLIT1, SLIT2 and SLIT3 genes was observed to be upregulated in ZDHHC8+/-. The 
SLITs proteins are implicated in a multitude of different physiological processes such as 
axon pathfinding as well as axonal and dendritic branching (Bagri et al. 2002; Wang et 
al. 1999; Whitford et al. 2002). While SLITs homozygous knockout are lethal, the data 
presented in this chapter indicate an upregulation of these three genes with a FC of at least 
1.5. In drosophila, Slit overexpression appears to have a similar phenotype than 
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Roundabout (Robo) loss of function, the receptor of slit. Once crossing midline, high level 
of ROBO are expressed by commissural axons to avoid them to cross again. In the 
vertebrate brain, neurons require to cross the floor plate or midline (drosophila) in order 
to innervate the other part of the brain. Thus ZDHHC8+/- might alter this process resulting 
in an abnormal axons guidance which might result in abnormal axonal connexion. While 
the Slit family is shown to be upregulated in our study, previous report by Mukai et al. 
2008, 2015 using heterozygous mouse model for Zdhhc8 demonstrated an alteration of 
the palmitoylation of CDC42 (Mukai et al. 2008, 2015). This protein is an actin 
cytoskeleton regulator, whose palmitoylation alteration resulted in shorter axons 
arborisation (Tapon  et al. 1997). The SLIT genes are located in the same signalling 
pathway than CDC42 (Figure 5.7) (Huber et al. 2003). It was demonstrated that Slit 
increases the complex of Robo1-srGAP which in turn inactivate CDC42 (Huber et al. 
2003). Although our data suggest that the expression of SLITs genes as well as their 
receptors ROBOs are increased, an increase in the expression of srGAP was not detected. 
Thus, it is possible that this overall upregulation of the SLIT/ROBO might have no effect 
on the expression of CDC42. Therefore, it would be interesting to evaluate the level of 
these proteins by western blot analysis in order to estimate if they influence the 
SLIT/ROBO/CDC42 pathway. 
LRRC4C also known as NGL-1 is the receptor of the guidance cue netrin-G1 which is 
part of the netrin family and was shown to be downregulated in ZDHHC8+/-. NGL-1 is 
thought to be highly expressed in the striatum and cerebral cortex (Lin et al. 2003). While 
its role was suggested to promote thalamic axons outgrowth, it was also demonstrated to 
interact with PSD-95 at the postsynaptic membrane (Lin et al. 2003; Ricciardi et al. 
2012). While our data suggested a downregulation of the NGL-1, knockout experiment 
of this gene revealed that the signalling cue netrin-G1 was also significantly reduced 
(Matsukawa et al. 2014) therefore resulting to a decrease in synaptogenesis and disruption 
of the growth of thalamic axons. As thalamic reduction was also observed in children 
with 22q11.2DS, this phenotype could be attributed to the reduction of LRRC4C (Bish et 
al. 2004) due in part by ZDHHC8. 
In addition, we also observed a downregulation of SEMA5A. Semaphorins are a group of 
proteins that were identified as axon guidance molecules. In the central nervous system, 
this class of proteins acts as both chemoattractant and chemorepellent for the growth of 
axons (Raper 2000). Interestingly, a de novo deletion of SEMA5A was recently identified 
as contributing to ASD and intellectual disability which are pathologies that also arise in 
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patients with 22q11.2DS (Angkustsiri et al. 2014; Radoeva et al. 2014; Subramanian et 
al. 2015). 
SLITRK3 was also found to be downregulated in ZDHHC8+/-. This molecule was 
discovered as a synaptogenesis molecule responsible for inhibitory synapse development. 
Indeed, slitrk3-/- mice was observed to increase the risk for spontaneous epileptic seizure 
due to an unbalance between excitatory and inhibitory synapses (H. Takahashi et al. 
2012). As patients with 22q11.2DS also exhibit spontaneous epileptic seizure it would be 
interested to investigate whether alteration of this gene is also present in 22q11.2DS 
which could therefore be due to ZDHHC8 (Kao et al. 2004; Strehlow et al. 2016).  
While this study revealed migration defect due to ZDHHC8+/-, several studies in 
individuals with 22q11.2DS were also observed to have migration defect such as 
polymicrogyria or reduced corpus callosum volume (Castro et al. 2011; Robin et al. 
2006). However, it is currently not known which genes or groups of genes are associated 
with this pathology in 22q11.2DS. Finally, to determine the implication of the gene listed 
above, it would be interested to perform experiment aiming to identify whether the 
proportion of these different proteins is altered at the growth cone of ZDHHC8+/- NPCs. 
 
Amongst the other GO enrichment identified was the one related to neurogenesis/brain 
development. Three members of the WNT family, WNT8B, WNT7B and WNT2B were 
shown to be upregulated. The WNT family constitutes a major signalling pathway 
involved in neural development. These three genes were shown to be expressed in the 
forebrain during development suggesting their importance for this process (Abu-Khalil et 
al. 2004; Lako et al. 1998). Wnt7b was observed to be highly express throughout the 
cortex but more specifically in the cortical plate while absent from the ventricular zone 
during cortical neurogenesis (Chenn 2008; Funatsu et al. 2004). Wnt8b was shown to be 
mostly expressed in the cortical hem and hippocampus, similarly the expression of Wnt2b 
was shown to be restricted to the cortical hem (Harrison-Uy et al. 2012). While Wnt8b 
knockout was observed to be responsible of decrease Wnt2b expression , the expression 
of Wnt7b was unchanged (Fotaki et al. 2010). In addition, alteration of Wnt2b and Wnt7b 
was shown to affect neuronal development by altering the neural tube formation (Bai et 
al. 2016). Despite their implication in many others signalling pathways apart from the 
brain, these genes should be further investigated, such as quantifying their proteins level 
in ZDHHC8+/- neurons differentiation. 
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FOXG1 is a gene which was demonstrated to be associated with development of Rett 
syndrome. In addition, this gene is also crucial for the development of the telencephalon 
during embryonic development. Indeed, experiments in which mice were deficient for 
Foxg1 were demonstrated to exhibit telencephalon and brain size defects. Instead Foxg1 
overexpression resulted in telencephalon and mesencephalon overgrowth (Ahlgren et al. 
2003). In chapter 4, we observed no difference in the proportion of FOXG1 positive cells 
in ZDHHC8+/- when compared to the control. Also, mice deficient for Zdhhc8+/- or 
Zdhhc8-/- did not have obvious brain morphological defect. Therefore, this decrease in 
the transcript of FOXG1 might not be correlated to a decrease of the subsequent FOXG1 
protein in vitro.  
FZD5 and FZD8 are two genes part of the frizzled family of G-protein coupled receptors 
(Schulte et al. 2007). Interestingly, it was demonstrated that the sequence of both FZD5 
and FZD8 shared 70% identity (Huang et al. 2004). While Fzd8 was shown to be 
expressed throughout the ventricular zone in the dorsal and ventral telencephalon, the 
expression of Fzd5 was observed to be restricted to the ventral telencephalon (Fischer et 
al. 2007; Harrison-Uy et al. 2012). Knockdown of Fzd5 was shown to result in loss of 
neuronal polarity (Slater et al. 2013). While mice heterozygous knockout for Fzd5 are 
viable, homozygous knockout die in utero due to angiogenic defect (Fischer et al. 2007). 
Considering that we observed a decreased expression of both FZD5 and FZD8 it would 
therefore be interested to investigate the resulting phenotype to such a decrease by 
examining their respective proteins.  
To conclude, in addition to the three WNT genes upregulated, we also found that 
ZDHHC8+/- had a decrease of the expression of two WNT receptors FZD5 and FZD8.  
Alteration of signalling pathway related to synaptic receptors. KEGG pathway 
enrichment analysis identified that the “neuroactive ligand receptor interaction” pathways 
were altered in ZDHHC8+/-. While we might not expect these types of genes to have an 
important impact on young neurons, it might demonstrate that their alteration at early 
stage could result to alteration of their expression when expressed in mature neurons. 
Therefore, we decided to present these data in the present thesis. Amongst these genes, 
the DRD and GRI family, respectively dopaminergic and glutamatergic AMPA receptors. 
The dopamine receptor D2 was recently identified as being palmitoylated by ZDHHC8 
(Ebersole et al. 2015). Furthermore, ZDHHC8 was demonstrated to palmitoylate PICK1 
(protein interacting with C-kinase) and GRIP1 (glutamate receptor interacting protein), 
two proteins known to bind the GRIA2 receptors (Thomas et al. 2012, 2013). However, 
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our data are suggesting an upregulation of the GRIA2 receptor which might suggest a 
novel role for ZDHHC8 other than its implication at the protein levels. Thereby it would 
be interested to assess the protein level of GRIA2 to determine whether this upregulation 
is correlated with an increase of the protein translation. Similarly, to GRIA2, the DRD2 
and DRD4 were upregulated. Antipsychotics medication are known to increase the level 
of DRD2 and DRD4 proteins. However it is noteworthy that an elevated level of DRD2 
receptor was observed in patients with schizophrenia prior their psychotic medication 
(Seeman et al. 2000). Whereas it was not previously observed with the DRD4 protein. 
These data are thereby suggesting that ZDHHC8 might alter the expression level DRD2 
and DRD4 thereby we would need to determine if this increase results to an increase 
translation of their respective proteins. 
 
Lastly, the calcium signalling pathway was shown to be enriched by KEGG pathway 
analysis. Calcium signalling is particularly important for neurons (chapter 1). It was 
previously demonstrated that calcium signalling was altered in two different mouse 
models of 22q11.2DS, the Df(16)A/+ and the Df(16)5 (P Devaraju et al. 2017; Earls et al. 
2010) as well as in schizophrenia patients. Although no report described calcium 
alteration with ZDHHC8, the data presented in this study are suggesting otherwise. 
Indeed, Figure 5.6B showed an increase of the voltage dependent calcium channel which 
might suggest an increase in calcium uptake within the neuron which would thereby result 
in an alteration of the neuronal calcium signalling. Furthermore, we observed a slight 
upregulation of SERCA which was observed to be associated with an alteration of calcium 
signalling through increase neurotransmitter release at the presynaptic neurons (Earls et 
al. 2010). Although more than one gene within the 22q11.2DS might be responsible of 
the calcium signalling alteration, our data suggested that ZDHHC8 might be an important 
contributor to this signalling pathway. 
This study investigated for the first time the role of ZDHHC8 at the transcriptional level 
in excitatory neuronal progenitor cells. Therefore, these data will give valuable insight on 
the genes and pathways affected by ZDHHC8 mutation. 
 
The second aim of this study was to examine whether similar genes in ZDHHC8+/- and 
22q11 derived NPCs were found to overlap. Although we aimed to compare the RNA-
seq data from 22q11.2 and ZDHHC8+/- derived NPCs, however, due to issue regarding 
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a potential CNV on the chromosome 17 we did not perform gene enrichment analysis on 
the 22q11.2 NPCs.  
Genomic instabilities in ESCs have already identified several mutations which were 
observed to be mostly located on the chromosome 1, 12 and 17 and X (Lamm et al. 2016). 
Surprisingly, these mutations often correspond to observation made with embryo 
carcinoma (Nouspikel 2013). These observations also note a higher number of CNV in 
iPSCs than hESCs (Hussein et al. 2011; Laurent et al. 2011; Martins-Taylor et al. 2011). 
Thus, in order to avoid similar outcome for future experiments, it would be advised to 
test all new cells lines on SNP arrays. Furthermore, regular SNP array might be useful to 
check for spontaneous deletion or duplication that might be due to the culture condition 
as well as the number of passages. 
Furthermore, it was noteworthy that the iPSCs from the 22q11.2 individual was a female 
while the control iPSCs (900) was a male. Therefore, we could not exclude that several 
genes overlapping between 22q11.2 and ZDHHC8+/- might be influenced by genes 
located on sexual chromosome. 
However, our comparison of the genes overlapping between ZDHHC8+/- and 22q11.2 
NPCs suggested that ZDHHC8 might only have small impact on the pathophysiology of 
22q11.2DS. Indeed, only 36 and 15 genes were significantly different (p < 0.01) with a 
FC superior to 1.5 or below -1.5 respectively. However, because we only had one line for 
ZDHHC8+/- and one line for 22q11.2, it would be interested to test with more line. 
 
To summarize, this chapter allowed us to identify that the expression of the region deleted 
in ZDHHC8+/- was reduced by half when compared to the control. In addition, the 
transcriptomic analysis of ZDHHC8+/- allowed us to identify that several 
genes/pathways involved in neurons development and function appeared to be altered by 
the mutation such as axonal guidance as well as calcium signalling. While it was already 
demonstrated that the function of ZDHHC8 was link to neuronal and axonal arborisation, 
it is the first time that its relation with neurons was shown at the transcriptomic level. The 
study also identified that only few genes deleted in the 22q11.2 mutation overlapped with 
gene deleted in ZDHHC8+/-. 
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Chapter 6. General discussion 
This thesis was divided into two main part, the first part investigates the temporal and cell 
specific expression profile of the genes from the 1.5Mb deletion of the 22q11.2 mutation 
into four different cell lineages while the second and third part was focusing on 
elucidating the function of ZDHHC8 in cortical projection neurons and NPCs. 
Many pathologies are associated with 22q11.2DS, several of which affect the central 
nervous system (Angkustsiri et al. 2014; Bassett et al. 2003; Cascella and Muzio 2015; 
Retnakaran et al. 2010). Although several mouse models have been generated to study 
either the full spectrum or individual genes (Gogos et al. 1998; Kimber et al. 1999; Mukai 
et al. 2008; Paronett et al. 2015; Paylor and Lindsay 2006), only few studies have been 
performed in a human setting. In addition, due to the number of genes present in this 
CNV, the role of individual genes and their relative contribution to multiple pathologies 
remains largely unknown. 
The study from Meechan et al. 2003 performed a comprehensive analysis of the 22q11.2 
genes, they found that most genes were expressed in the developing and adult mouse 
brain, however, the study lacks temporal and spatial resolution (Maynard et al. 2003). On 
the other hand, our study allows to address when and in which cell lineages cells the gene 
present in the 1.5Mb deletion of the 22q11.2 mutation are expressed. Our study identified 
genes with higher expression during period of neuronal progenitors proliferation which 
appears to be in accordance with previous report (D. W. Meechan et al. 2006). Amongst 
them , the loss of Ranbp1 has recently been studied in a mouse model which revealed a 
decrease of the cortical layer II/III due to alteration in the proportion of neuronal 
progenitors (Paronett et al. 2015). Interestingly, our study demonstrated consistent 
findings, indeed RANBP1 was found to be mostly expressed when neuronal progenitors 
are proliferating therefore suggesting similar function in vitro and in vivo. In vitro mouse 
model of 22q11.2DS also reveals that Cdc45 mRNA expression happen to follow the one 
of Ranbp1, however cdc45 appears to exhibit an even higher expression than Ranbp1 
during cortical neurogenesis. Therefore, a loss of Cdc45 might be responsible to a greater 
loss of progenitor cells than in mouse model of Ranbp1-/-. Interestingly, we also 
identified potential genes involved in neuronal maturation such as SEPT5. This gene has 
a role in neurotransmitters release and vesicular trafficking, as well as being a substrate 
of PARKIN. While knockout model of Septin5 did not reveal strong phenotypic alteration 
of the synaptic signalling, its overexpression in dopaminergic neurons was observed to 
be toxic for the cells thus leading to cell death (Son et al. 2005; Tsang et al. 2008). In 
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addition, Sept5 deficiency in mouse reveals behavioural deficit in social interaction but 
also increases of the prepulse inhibition therefore implying a potential underlying 
synaptic alteration that remain unknown. (Harper et al. 2012; Suzuki et al. 2009). 
Surprisingly, we identified novel genes that were not observed to be expressed by 
previous study such as GP1BB. Indeed, this gene is known for its role in platelet, however, 
because it increases over the course of the differentiation our data suggested that it might 
have a role in neuron maturation. While it was recently suggested that mechanisms 
responsible of granules exocytosis are conserved between different cell types (Goubau et 
al. 2013), it was noteworthy that the SEPT5-GP1BB locus can be transcribed due to an 
imperfect polyA signal in SEPT5. Although the resulting SEPT5-GP1BB transcript is 
candidate for nonsense-mediated mRNA decay, it might explain why we detect GP1BB 
in neurons and the reason why it follows similar profile than SEPT5.  
While previous analysis from Maynard et al. in 2003 attempted to investigate the tissue 
specific expression of the 22q11.2 genes, their study 1) did not reveal specific candidates, 
2) they used adult tissue 3) microdissected tissues contain different neuronal and non-
neuronal population therefore is not specific. While the dopaminergic population is 
altered in both schizophrenia and Parkinson’s disease, our study reveals enrichment of 
several genes in dopaminergic neurons. Therefore, this data suggests that the neuronal 
population in which the gene is studied should be taken into consideration.  
In addition, to discover that several of these genes exhibit a specific temporal profile, our 
study also emphasized that neurons derived stem cells can mimic some aspects of the 
development in vivo.  
 
The major part of this thesis then focused at the same time on the phenotypic and 
transcriptomic characteristic of ZDHHC8 in cortical excitatory neurons development.  
The fourth chapter is the first to report the generation of a hESCs line heterozygous for 
ZDHHC8 using the CRIPSR/Cas9 technique. While most study on ZDHHC8 used either 
brain primary culture from mouse model or cellular model (HEK cells), it is the first time 
that ZDHHC8 is studied in the context of neuronal development in vitro. Despite the 
kinetics of differentiation appeared to be unaltered in ZDHHC8+/- when compared to 
control, the differential expression identified that several genes are altered in ZDHHC8+/-
.  
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While several studies reported that individual’s carrier of 22q11.2DS and or affected with 
schizophrenia exhibited neuronal migration defect, a study from Mukai et al., 2005 
demonstrated that in vivo, ZDHHC8 was not essential for radial migration as neurons 
were able to reach the cortical plate in mice Zdhhc8+/- and Zdhhc8-/- (Mukai et al. 2015). 
Conversely, our study reveals that in vitro, ZDHHC8+/- neurons progenitors appear to 
migrate less and slower, therefore we suggest that although the ability of neurons to reach 
the cortical plate is unaltered their ability to populate the appropriate cortical layer might 
be altered. Furthermore, the axonal connexion to other cortical or brain region might also 
be impaired in these neurons. 
Calcium activity is crucial for neurons as it allows the fusion and release of 
neurotransmitters from the presynaptic neurons but it is also involved in mechanisms such 
as synaptic plasticity. Mouse model of 22q11.2DS were shown to display an increase in 
the amplitude of calcium activity, while our data shows similar effect on the amplitude in 
ZDHHC8+/- we also observed an overall increase in the calcium activity resulting to an 
increase in the number of events that had not been reported in the past. It would be 
interesting to examine if this observation is due to an increase in neuronal receptors 
population or proportion or else due to an excessive release of glutamate which therefore 
can result to an hyperexcitability of the neurons. Hyperexcitability has been associated 
with pathology such as Alzheimer disease in which an excessive release of glutamate 
become toxic for the neurons due to an over excitation of extrasynaptic glutamate 
receptors (Hardingham and Bading 2010). It would therefore be interested to examine the 
proportion of synaptic versus extrasynaptic receptors. Furthermore, it would also be 
interested to investigate the population of metabotropic receptors such as CACNA1C or 
else potassium or sodium channel that could also be altered and therefore responsible of 
the underlying phenotype. Due to the function of ZDHHC8 as a palmitoyl transferase and 
the lack of knowledges about the substrates of this protein. It would be interested to 
perform proteomic analysis in order to determine which proteins are palmitoylated by 
ZDHHC8. 
It was also interested to note that our preliminary result using ZDHHC8+/- derived 
neurons also identified an alteration of the dendritic morphology in late 
progenitors/young neurons. Overall, the total length was shorter and neurons appears to 
have less intersections. These results are in accordance with the previous work from 
Mukai et al.2008 which identified that these neurons appear to have a less complex 
dendritic arborization (Mukai et al. 2008) 
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Lastly, we investigated the transcriptome of neuronal progenitors heterozygous for 
ZDHHC8. The analysis reveals that pathways related to axon guidance and calcium 
signalling were altered in ZDHHC8 mutant progenitors which therefore strengthen our 
findings in chapter 4. In addition, these results on axonal guidance complements studies 
performed in human reporting a disruption of the white matter in patient with 22q11.2DS 
which might be due to axon guidance alteration (Kikinis et al. 2012; Radoeva et al. 2012). 
Interestingly, ZDHHC8 mutation appears to alter several pathways and genes related to 
neurons Although our comparison between ZDHHC8+/- and 22q11.2 iPSCs derived 
NPCs reveal that only a small proportion of genes overlap between the two lines, the 
study of ZDHHC8 alone provide us with convincing information on its involvement for 
neurons development. Amongst the several genes associated with neuronal development, 
it was noteworthy that three genes from the WNT signalling pathway were upregulated 
while the two genes coding for the WNT receptors FZB were downregulated. 
Interestingly, Wnt8b overexpression was observed to promote hypothalamic markers. 
Additionally, Wnt7b overexpression was instead showed to impairs neuronal 
differentiation in neuronal progenitors and therefore forebrain development in mouse, 
interestingly, Wnt7b overexpression was also associated with a decrease in the expression 
of Tbr2 and Tbr1 without affecting pax6 (Papachristou et al. 2014). Wnt2b overexpression 
was shown to inhibit differentiation therefore induces growth of tissue in retinal explants 
(Papachristou et al. 2014). While it would be interested to examine whether this gene 
affect early patterning of neurons development in our cellular models, the study would 
also would also benefit to investigate early neuronal patterning in vivo using the mice 
models for Zdhhc8+/- and Zdhhc8-/-(Mukai et al. 2004). Additionally, transcriptomic 
analysis identified that the DRD2 and DRD4 was upregulated in ZDHHC8+/- NPCs, as 
dopaminergic neurotransmission was observed to be disrupted in 22q11.2DS it would be 
interested to investigate whether we observed difference at the protein level between the 
control and the mutant (Boot et al. 2008). ZDHHC8+/- has been associated with 
downregulation of other genes coding synaptic receptors such as GRIA2 and CHRM3 or 
DRD4. Thus, it would be interesting to investigate whether this downregulation lead to a 
decrease expression of specific neuronal receptors at the protein levels. 
Therefore, this thesis in addition to provide valuable information regarding the expression 
of the 22q11.2 genes, demonstrates by the study of ZDHHC8 that a cellular model can be 
a valuable tool to unravel the function of genes and therefore can be used to generate 
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cellular model that would enable to decipher the function of other genes of the 22q11.2 
mutation. 
To summarize, our study identified that several genes of the 22q11.2DS have a specific 
expression profile during neuronal differentiation. In addition, some of these genes 
appeared to be preferentially expressed in dopaminergic neurons. The study of ZDHHC8 
heterozygous mutation in hESCs derived cortical projection neurons addressed that the 
kinetics of neuronal differentiation was similar to control. However, the 
motility/migration of the cells lacking ZDHHC8 was abnormal compared to control. 
Furthermore, the calcium signalling activity of the neurons was also found to be altered 
by the lack of ZDHHC8. Lastly, transcriptomic analysis demonstrated that the role of 
ZDHHC8 appeared to be associated with the development of neurons and its physiology. 
Finally, although only few genes appeared to overlap with a hiPSCs derived from 22q11.2 
patients, our study strongly suggest the importance of ZDHHC8 for neuronal 
development. 
 
Limitations and future directions 
Limitations 
Although my RT-PCR analysis (Chapter 3) on 22q11.2DS genes offer potentially 
valuable insight on their temporal profile, the study remains preliminary and requires 
repeat with independent sets of samples. I had similar issues regarding the differential 
expression between ZDHHC8+/- and control neurons. Therefore, future experiments 
should consider having more samples to solve this issue.  
Genome editing using CRISPR/Cas technique successfully allowed the generation of 
several cell lines heterozygous for ZDHHC8. Despite confirmation of heterozygosity by 
sequencing, we were unable to verify a change of protein expression. Despite being used 
in previous studies to evaluate the ZDHHC8 protein in human cells, I observed multiple 
unspecific bands in western blot and therefore were unable to evaluate the protein 
expression of ZDHHC8. 
My preliminary phenotypic analysis of ZDHHC8 KO cells revealed an increase in cortical 
neural progenitor proliferation, accompanied by a decrease in the number of CTIP2 
positive deep layer neurons. However, further investigation will be necessary to assess 
whether this increase in progenitor proliferation leads to a subsequent alteration in the 
155 
 
number of neurons expressing cortical layer-specific markers, such as CUX1, TBR1, 
TBR2. 
The transcriptomic analysis of the 22q11.2 iPSCs revealed the presence of a potential 
CNV on chromosome 17. Therefore, we did not carry on with gene enrichment analysis 
as well as KEGG pathways enrichment. My observation points to the importance of 
performing SNP array on all PSC lines to detect spontaneous mutation that may 
accumulate.  
 
Future Experiments 
As already mentioned in chapter 3, in addition to the temporal expression performed using 
control cells, we aimed to investigate the temporal profile of the 22q11.2 genes using 
iPSCs from individual carrier of a 22q11.2 mutation.  
Although we have identified some deficits using heterozygous ZDHHC8 cells, a 
ZDHHC8-null mutant model would provide a better model to decipher the functional role 
of ZDHHC8 in neurons. Towards this goal, we have constructed a lentiviral vector 
expressing ZDHHC8 gRNAs. Future work is needed to produce the virus in HEK cells, 
which can then be used to transduce either the ZDHHC8+/- or wildtype hESCs. In 
addition, the temporal expression analysis identified that ZDHHC8 is preferentially 
expressed in dopaminergic neurons, therefore future experiments will investigate the 
function of ZDHHC8 in this neuronal population. 
My calcium activity assay suggests that heterozygous neurons for ZDHHC8 exhibit more 
spontaneous calcium events but also appear to mature faster than the control neurons. 
Future experiments should aim to investigate whether blocking synaptic receptors with 
specific antagonist alter spontaneous calcium activity differently in the ZDHHC8+/- 
compared to the control neurons. The drugs could be used for such studies include 2R-
amino-5-phosphonovaleric acid (AP5), a selective NMDA antagonist and 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX), a competitive AMPA antagonist. In addition, the 
administration of these drugs during calcium recording could determine whether mutant 
cells are maturing in a similar fashion to the controls. Other drugs targeting GABAergic 
receptors could also be tested such as bicuculine or picrotoxin which are a GABAa 
antagonist. 
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To further investigate whether the synaptic activity and electrical activity of neurons 
heterozygous for ZDHHC8 is altered we thought to use MEA. Indeed, our institute has 
the expertise and the equipment necessary for such experiment. MEA allows to study the 
network activity in group of neurons. We previously observed an increase calcium 
spontaneous activity in ZDHHC8 KO therefore we are interesting to determine if it also 
results in an increase of the electrical activity but also if it affects the overall network 
activity.  
Finally, a rescue experiment in which we reintroduce ZDHHC8 back into our 
ZDHHC8+/- line would be interested to determine whether we can reverse the phenotype 
due to heterozygous loss of ZDHHC8. In addition, due to the availability of 22q11.2 
iPSCs, it would also be interested to perform similar experiment in which we would 
reintroduction the ZDHHC8 in 22q11.2 iPSCs. Therefore, it would enable us to determine 
whether the phenotype we would observe in 22q11.2 derived neurons can be rescue by 
ZDHHC8. 
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Supplementary Figure 3 Axon guidance 
